id	sid	tid	token	lemma	pos
dpc-2582	1	1	dermatology	dermatology	NOUN
dpc-2582	1	2	:	:	PUNCT
dpc-2582	1	3	practical	practical	ADJ
dpc-2582	1	4	and	and	CCONJ
dpc-2582	1	5	conceptual	conceptual	ADJ
dpc-2582	1	6	original	original	ADJ
dpc-2582	1	7	article	article	NOUN
dpc-2582	1	8	|	|	ADV
dpc-2582	1	9	dermatol	dermatol	ADJ
dpc-2582	1	10	pract	pract	NOUN
dpc-2582	1	11	concept	concept	NOUN
dpc-2582	1	12	.	.	PUNCT
dpc-2582	2	1	2023;13(1):e2023057	2023;13(1):e2023057	NUM
dpc-2582	2	2	1	1	NUM
dpc-2582	2	3	clinical	clinical	ADJ
dpc-2582	2	4	review	review	NOUN
dpc-2582	2	5	of	of	ADP
dpc-2582	2	6	mucosal	mucosal	ADJ
dpc-2582	2	7	melanoma	melanoma	NOUN
dpc-2582	2	8	:	:	PUNCT
dpc-2582	2	9	the	the	DET
dpc-2582	2	10	11	11	NUM
dpc-2582	2	11	-	-	PUNCT
dpc-2582	2	12	year	year	NOUN
dpc-2582	2	13	experience	experience	NOUN
dpc-2582	2	14	of	of	ADP
dpc-2582	2	15	a	a	DET
dpc-2582	2	16	referral	referral	ADJ
dpc-2582	2	17	center	center	NOUN
dpc-2582	2	18	marco	marco	PROPN
dpc-2582	2	19	spadafora1,2	spadafora1,2	PROPN
dpc-2582	2	20	,	,	PUNCT
dpc-2582	2	21	giacomo	giacomo	PROPN
dpc-2582	2	22	santandrea1,3	santandrea1,3	PROPN
dpc-2582	2	23	,	,	PUNCT
dpc-2582	2	24	michela	michela	PROPN
dpc-2582	2	25	lai1,2	lai1,2	PROPN
dpc-2582	2	26	,	,	PUNCT
dpc-2582	2	27	stafania	stafania	NOUN
dpc-2582	2	28	borsari2	borsari2	PROPN
dpc-2582	2	29	,	,	PUNCT
dpc-2582	2	30	shaniko	shaniko	NOUN
dpc-2582	2	31	kaleci4	kaleci4	PROPN
dpc-2582	2	32	,	,	PUNCT
dpc-2582	2	33	chiara	chiara	X
dpc-2582	2	34	banzi5	banzi5	PROPN
dpc-2582	2	35	,	,	PUNCT
dpc-2582	2	36	vincenzo	vincenzo	PROPN
dpc-2582	2	37	dario	dario	PROPN
dpc-2582	2	38	mandato6	mandato6	PROPN
dpc-2582	2	39	,	,	PUNCT
dpc-2582	2	40	giovanni	giovanni	PROPN
dpc-2582	2	41	pellacani7	pellacani7	PROPN
dpc-2582	2	42	,	,	PUNCT
dpc-2582	2	43	simonetta	simonetta	PROPN
dpc-2582	2	44	piana3	piana3	PROPN
dpc-2582	2	45	,	,	PUNCT
dpc-2582	2	46	caterina	caterina	PROPN
dpc-2582	2	47	longo2,4	longo2,4	PROPN
dpc-2582	2	48	1	1	NUM
dpc-2582	2	49	clinical	clinical	ADJ
dpc-2582	2	50	and	and	CCONJ
dpc-2582	2	51	experimental	experimental	ADJ
dpc-2582	2	52	medicine	medicine	NOUN
dpc-2582	2	53	phd	phd	NOUN
dpc-2582	2	54	program	program	NOUN
dpc-2582	2	55	,	,	PUNCT
dpc-2582	2	56	university	university	NOUN
dpc-2582	2	57	of	of	ADP
dpc-2582	2	58	modena	modena	PROPN
dpc-2582	2	59	and	and	CCONJ
dpc-2582	2	60	reggio	reggio	PROPN
dpc-2582	2	61	emilia	emilia	PROPN
dpc-2582	2	62	,	,	PUNCT
dpc-2582	2	63	modena	modena	PROPN
dpc-2582	2	64	,	,	PUNCT
dpc-2582	2	65	italy	italy	PROPN
dpc-2582	2	66	2	2	NUM
dpc-2582	2	67	centro	centro	X
dpc-2582	2	68	oncologico	oncologico	NOUN
dpc-2582	2	69	ad	ad	PROPN
dpc-2582	2	70	alta	alta	PROPN
dpc-2582	2	71	tecnologia	tecnologia	PROPN
dpc-2582	2	72	diagnostica	diagnostica	PROPN
dpc-2582	2	73	,	,	PUNCT
dpc-2582	2	74	azienda	azienda	PROPN
dpc-2582	2	75	unità	unità	PROPN
dpc-2582	2	76	sanitaria	sanitaria	PROPN
dpc-2582	2	77	locale	locale	PROPN
dpc-2582	2	78	irccs	ircc	VERB
dpc-2582	2	79	di	di	PROPN
dpc-2582	2	80	reggio	reggio	PROPN
dpc-2582	2	81	emilia	emilia	PROPN
dpc-2582	2	82	,	,	PUNCT
dpc-2582	2	83	reggio	reggio	PROPN
dpc-2582	2	84	emilia	emilia	PROPN
dpc-2582	2	85	,	,	PUNCT
dpc-2582	2	86	italy	italy	PROPN
dpc-2582	2	87	3	3	NUM
dpc-2582	2	88	pathology	pathology	NOUN
dpc-2582	2	89	unit	unit	NOUN
dpc-2582	2	90	,	,	PUNCT
dpc-2582	2	91	azienda	azienda	PROPN
dpc-2582	2	92	unità	unità	PROPN
dpc-2582	2	93	sanitaria	sanitaria	PROPN
dpc-2582	2	94	locale	locale	PROPN
dpc-2582	2	95	irccs	ircc	VERB
dpc-2582	2	96	di	di	PROPN
dpc-2582	2	97	reggio	reggio	PROPN
dpc-2582	2	98	emilia	emilia	PROPN
dpc-2582	2	99	,	,	PUNCT
dpc-2582	2	100	reggio	reggio	PROPN
dpc-2582	2	101	emilia	emilia	PROPN
dpc-2582	2	102	,	,	PUNCT
dpc-2582	2	103	italy	italy	PROPN
dpc-2582	2	104	4	4	NUM
dpc-2582	2	105	department	department	PROPN
dpc-2582	2	106	of	of	ADP
dpc-2582	2	107	dermatology	dermatology	NOUN
dpc-2582	2	108	,	,	PUNCT
dpc-2582	2	109	university	university	NOUN
dpc-2582	2	110	of	of	ADP
dpc-2582	2	111	modena	modena	PROPN
dpc-2582	2	112	and	and	CCONJ
dpc-2582	2	113	reggio	reggio	PROPN
dpc-2582	2	114	emilia	emilia	PROPN
dpc-2582	2	115	,	,	PUNCT
dpc-2582	2	116	modena	modena	PROPN
dpc-2582	2	117	,	,	PUNCT
dpc-2582	2	118	italy	italy	PROPN
dpc-2582	2	119	5	5	NUM
dpc-2582	2	120	medical	medical	ADJ
dpc-2582	2	121	oncology	oncology	NOUN
dpc-2582	2	122	unit	unit	NOUN
dpc-2582	2	123	,	,	PUNCT
dpc-2582	2	124	azienda	azienda	PROPN
dpc-2582	2	125	unità	unità	PROPN
dpc-2582	2	126	sanitaria	sanitaria	PROPN
dpc-2582	2	127	locale	locale	PROPN
dpc-2582	2	128	irccs	ircc	VERB
dpc-2582	2	129	di	di	PROPN
dpc-2582	2	130	reggio	reggio	PROPN
dpc-2582	2	131	emilia	emilia	PROPN
dpc-2582	2	132	,	,	PUNCT
dpc-2582	2	133	reggio	reggio	PROPN
dpc-2582	2	134	emilia	emilia	PROPN
dpc-2582	2	135	,	,	PUNCT
dpc-2582	2	136	italy	italy	PROPN
dpc-2582	2	137	6	6	NUM
dpc-2582	2	138	unit	unit	NOUN
dpc-2582	2	139	of	of	ADP
dpc-2582	2	140	obstetrics	obstetric	NOUN
dpc-2582	2	141	and	and	CCONJ
dpc-2582	2	142	gynecology	gynecology	NOUN
dpc-2582	2	143	,	,	PUNCT
dpc-2582	2	144	azienda	azienda	PROPN
dpc-2582	2	145	unità	unità	PROPN
dpc-2582	2	146	sanitaria	sanitaria	PROPN
dpc-2582	2	147	locale	locale	PROPN
dpc-2582	2	148	irccs	irccs	PROPN
dpc-2582	2	149	,	,	PUNCT
dpc-2582	2	150	reggio	reggio	PROPN
dpc-2582	2	151	emilia	emilia	PROPN
dpc-2582	2	152	,	,	PUNCT
dpc-2582	2	153	italy	italy	PROPN
dpc-2582	2	154	7	7	NUM
dpc-2582	2	155	dermatology	dermatology	NOUN
dpc-2582	2	156	clinic	clinic	NOUN
dpc-2582	2	157	,	,	PUNCT
dpc-2582	2	158	department	department	NOUN
dpc-2582	2	159	of	of	ADP
dpc-2582	2	160	clinical	clinical	ADJ
dpc-2582	2	161	internal	internal	ADJ
dpc-2582	2	162	,	,	PUNCT
dpc-2582	2	163	anesthesiological	anesthesiological	ADJ
dpc-2582	2	164	and	and	CCONJ
dpc-2582	2	165	cardiovascular	cardiovascular	ADJ
dpc-2582	2	166	sciences	science	NOUN
dpc-2582	2	167	,	,	PUNCT
dpc-2582	2	168	sapienza	sapienza	PROPN
dpc-2582	2	169	university	university	PROPN
dpc-2582	2	170	of	of	ADP
dpc-2582	2	171	rome	rome	PROPN
dpc-2582	2	172	,	,	PUNCT
dpc-2582	2	173	rome	rome	PROPN
dpc-2582	2	174	,	,	PUNCT
dpc-2582	2	175	italy	italy	PROPN
dpc-2582	2	176	key	key	ADJ
dpc-2582	2	177	words	word	NOUN
dpc-2582	2	178	:	:	PUNCT
dpc-2582	2	179	mucosal	mucosal	ADJ
dpc-2582	2	180	melanoma	melanoma	NOUN
dpc-2582	2	181	,	,	PUNCT
dpc-2582	2	182	diagnosis	diagnosis	NOUN
dpc-2582	2	183	,	,	PUNCT
dpc-2582	2	184	treatments	treatment	NOUN
dpc-2582	2	185	,	,	PUNCT
dpc-2582	2	186	rare	rare	ADJ
dpc-2582	2	187	disease	disease	NOUN
dpc-2582	2	188	citation	citation	NOUN
dpc-2582	2	189	:	:	PUNCT
dpc-2582	2	190	spadafora	spadafora	PROPN
dpc-2582	2	191	m	m	PROPN
dpc-2582	2	192	,	,	PUNCT
dpc-2582	2	193	santandrea	santandrea	VERB
dpc-2582	2	194	g	g	PROPN
dpc-2582	2	195	,	,	PUNCT
dpc-2582	2	196	lai	lai	PROPN
dpc-2582	2	197	m	m	PROPN
dpc-2582	2	198	,	,	PUNCT
dpc-2582	2	199	et	et	PROPN
dpc-2582	2	200	al	al	PROPN
dpc-2582	2	201	.	.	PROPN
dpc-2582	3	1	clinical	clinical	ADJ
dpc-2582	3	2	review	review	NOUN
dpc-2582	3	3	of	of	ADP
dpc-2582	3	4	mucosal	mucosal	ADJ
dpc-2582	3	5	melanoma	melanoma	NOUN
dpc-2582	3	6	:	:	PUNCT
dpc-2582	3	7	the	the	DET
dpc-2582	3	8	11	11	NUM
dpc-2582	3	9	-	-	PUNCT
dpc-2582	3	10	year	year	NOUN
dpc-2582	3	11	experience	experience	NOUN
dpc-2582	3	12	of	of	ADP
dpc-2582	3	13	a	a	DET
dpc-2582	3	14	referral	referral	ADJ
dpc-2582	3	15	center	center	NOUN
dpc-2582	3	16	.	.	PUNCT
dpc-2582	4	1	dermatol	dermatol	NOUN
dpc-2582	4	2	pract	pract	PROPN
dpc-2582	4	3	concept	concept	NOUN
dpc-2582	4	4	.	.	PUNCT
dpc-2582	5	1	2023;13(1):e2023057	2023;13(1):e2023057	X
dpc-2582	5	2	.	.	X
dpc-2582	5	3	doi	doi	NOUN
dpc-2582	5	4	:	:	PUNCT
dpc-2582	5	5	https://doi.org/10.5826/dpc.1301a57	https://doi.org/10.5826/dpc.1301a57	PROPN
dpc-2582	5	6	accepted	accept	VERB
dpc-2582	5	7	:	:	PUNCT
dpc-2582	5	8	june	june	PROPN
dpc-2582	5	9	29	29	NUM
dpc-2582	5	10	,	,	PUNCT
dpc-2582	5	11	2022	2022	NUM
dpc-2582	5	12	;	;	PUNCT
dpc-2582	5	13	published	publish	VERB
dpc-2582	5	14	:	:	PUNCT
dpc-2582	5	15	january	january	NOUN
dpc-2582	5	16	2023	2023	NUM
dpc-2582	5	17	copyright	copyright	NOUN
dpc-2582	5	18	:	:	PUNCT
dpc-2582	6	1	©	©	PROPN
dpc-2582	6	2	2023	2023	NUM
dpc-2582	6	3	spadafora	spadafora	NOUN
dpc-2582	6	4	et	et	PROPN
dpc-2582	6	5	al	al	PROPN
dpc-2582	6	6	.	.	PUNCT
dpc-2582	7	1	this	this	PRON
dpc-2582	7	2	is	be	AUX
dpc-2582	7	3	an	an	DET
dpc-2582	7	4	open	open	ADJ
dpc-2582	7	5	-	-	PUNCT
dpc-2582	7	6	access	access	NOUN
dpc-2582	7	7	article	article	NOUN
dpc-2582	7	8	distributed	distribute	VERB
dpc-2582	7	9	under	under	ADP
dpc-2582	7	10	the	the	DET
dpc-2582	7	11	terms	term	NOUN
dpc-2582	7	12	of	of	ADP
dpc-2582	7	13	the	the	DET
dpc-2582	7	14	creative	creative	ADJ
dpc-2582	7	15	commons	common	NOUN
dpc-2582	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2582	7	17	license	license	NOUN
dpc-2582	7	18	(	(	PUNCT
dpc-2582	7	19	by	by	ADP
dpc-2582	7	20	-	-	PUNCT
dpc-2582	7	21	nc-4.0	nc-4.0	NOUN
dpc-2582	7	22	)	)	PUNCT
dpc-2582	7	23	,	,	PUNCT
dpc-2582	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2582	7	25	,	,	PUNCT
dpc-2582	7	26	which	which	PRON
dpc-2582	7	27	permits	permit	VERB
dpc-2582	7	28	unrestricted	unrestricted	ADJ
dpc-2582	7	29	noncommercial	noncommercial	ADJ
dpc-2582	7	30	use	use	NOUN
dpc-2582	7	31	,	,	PUNCT
dpc-2582	7	32	distribution	distribution	NOUN
dpc-2582	7	33	,	,	PUNCT
dpc-2582	7	34	and	and	CCONJ
dpc-2582	7	35	reproduction	reproduction	NOUN
dpc-2582	7	36	in	in	ADP
dpc-2582	7	37	any	any	DET
dpc-2582	7	38	medium	medium	NOUN
dpc-2582	7	39	,	,	PUNCT
dpc-2582	7	40	provided	provide	VERB
dpc-2582	7	41	the	the	DET
dpc-2582	7	42	original	original	ADJ
dpc-2582	7	43	authors	author	NOUN
dpc-2582	7	44	and	and	CCONJ
dpc-2582	7	45	source	source	NOUN
dpc-2582	7	46	are	be	AUX
dpc-2582	7	47	credited	credit	VERB
dpc-2582	7	48	.	.	PUNCT
dpc-2582	8	1	funding	funding	NOUN
dpc-2582	8	2	:	:	PUNCT
dpc-2582	8	3	none	none	NOUN
dpc-2582	8	4	.	.	PUNCT
dpc-2582	9	1	competing	compete	VERB
dpc-2582	9	2	interests	interest	NOUN
dpc-2582	9	3	:	:	PUNCT
dpc-2582	9	4	none	none	NOUN
dpc-2582	9	5	.	.	PUNCT
dpc-2582	10	1	authorship	authorship	NOUN
dpc-2582	10	2	:	:	PUNCT
dpc-2582	10	3	all	all	DET
dpc-2582	10	4	authors	author	NOUN
dpc-2582	10	5	have	have	AUX
dpc-2582	10	6	contributed	contribute	VERB
dpc-2582	10	7	significantly	significantly	ADV
dpc-2582	10	8	to	to	ADP
dpc-2582	10	9	this	this	DET
dpc-2582	10	10	publication	publication	NOUN
dpc-2582	10	11	.	.	PUNCT
dpc-2582	11	1	corresponding	correspond	VERB
dpc-2582	11	2	author	author	NOUN
dpc-2582	11	3	:	:	PUNCT
dpc-2582	11	4	caterina	caterina	PROPN
dpc-2582	11	5	longo	longo	PROPN
dpc-2582	11	6	,	,	PUNCT
dpc-2582	11	7	department	department	NOUN
dpc-2582	11	8	of	of	ADP
dpc-2582	11	9	dermatology	dermatology	NOUN
dpc-2582	11	10	,	,	PUNCT
dpc-2582	11	11	university	university	NOUN
dpc-2582	11	12	of	of	ADP
dpc-2582	11	13	modena	modena	PROPN
dpc-2582	11	14	and	and	CCONJ
dpc-2582	11	15	reggio	reggio	PROPN
dpc-2582	11	16	emilia	emilia	PROPN
dpc-2582	11	17	,	,	PUNCT
dpc-2582	11	18	italy	italy	PROPN
dpc-2582	11	19	.	.	PUNCT
dpc-2582	12	1	azienda	azienda	PROPN
dpc-2582	12	2	unità	unità	PROPN
dpc-2582	12	3	sanitaria	sanitaria	PROPN
dpc-2582	12	4	locale	locale	PROPN
dpc-2582	12	5	–	–	PUNCT
dpc-2582	12	6	irccs	ircc	VERB
dpc-2582	12	7	di	di	PROPN
dpc-2582	12	8	reggio	reggio	PROPN
dpc-2582	12	9	emilia	emilia	PROPN
dpc-2582	12	10	,	,	PUNCT
dpc-2582	12	11	centro	centro	PROPN
dpc-2582	12	12	oncologico	oncologico	PROPN
dpc-2582	12	13	ad	ad	PROPN
dpc-2582	12	14	alta	alta	PROPN
dpc-2582	12	15	tecnologia	tecnologia	PROPN
dpc-2582	12	16	diagnostica	diagnostica	PROPN
dpc-2582	12	17	-	-	PUNCT
dpc-2582	12	18	dermatologia	dermatologia	PROPN
dpc-2582	12	19	,	,	PUNCT
dpc-2582	12	20	reggio	reggio	PROPN
dpc-2582	12	21	emilia	emilia	PROPN
dpc-2582	12	22	,	,	PUNCT
dpc-2582	12	23	italy	italy	PROPN
dpc-2582	12	24	.	.	PUNCT
dpc-2582	13	1	phone	phone	NOUN
dpc-2582	13	2	:	:	PUNCT
dpc-2582	13	3	+390522295612	+390522295612	NUM
dpc-2582	13	4	e	e	NOUN
dpc-2582	13	5	-	-	NOUN
dpc-2582	13	6	mail	mail	NOUN
dpc-2582	13	7	:	:	PUNCT
dpc-2582	13	8	longo.caterina@gmail.com	longo.caterina@gmail.com	X
dpc-2582	13	9	introduction	introduction	NOUN
dpc-2582	13	10	:	:	PUNCT
dpc-2582	13	11	mucosal	mucosal	ADJ
dpc-2582	13	12	melanoma	melanoma	NOUN
dpc-2582	13	13	is	be	AUX
dpc-2582	13	14	a	a	DET
dpc-2582	13	15	rare	rare	ADJ
dpc-2582	13	16	neoplasm	neoplasm	NOUN
dpc-2582	13	17	.	.	PUNCT
dpc-2582	14	1	late	late	ADJ
dpc-2582	14	2	diagnosis	diagnosis	NOUN
dpc-2582	14	3	is	be	AUX
dpc-2582	14	4	caused	cause	VERB
dpc-2582	14	5	by	by	ADP
dpc-2582	14	6	occult	occult	NOUN
dpc-2582	14	7	anatomic	anatomic	ADJ
dpc-2582	14	8	sites	site	NOUN
dpc-2582	14	9	and	and	CCONJ
dpc-2582	14	10	scarcity	scarcity	NOUN
dpc-2582	14	11	of	of	ADP
dpc-2582	14	12	symptoms	symptom	NOUN
dpc-2582	14	13	.	.	PUNCT
dpc-2582	15	1	novel	novel	ADJ
dpc-2582	15	2	biological	biological	ADJ
dpc-2582	15	3	therapies	therapy	NOUN
dpc-2582	15	4	have	have	AUX
dpc-2582	15	5	now	now	ADV
dpc-2582	15	6	become	become	VERB
dpc-2582	15	7	available	available	ADJ
dpc-2582	15	8	.	.	PUNCT
dpc-2582	16	1	demographic	demographic	ADJ
dpc-2582	16	2	,	,	PUNCT
dpc-2582	16	3	therapeutical	therapeutical	ADJ
dpc-2582	16	4	and	and	CCONJ
dpc-2582	16	5	survival	survival	NOUN
dpc-2582	16	6	records	record	NOUN
dpc-2582	16	7	on	on	ADP
dpc-2582	16	8	mucosal	mucosal	ADJ
dpc-2582	16	9	melanoma	melanoma	NOUN
dpc-2582	16	10	are	be	AUX
dpc-2582	16	11	scarce	scarce	ADJ
dpc-2582	16	12	.	.	PUNCT
dpc-2582	17	1	objectives	objective	NOUN
dpc-2582	17	2	:	:	PUNCT
dpc-2582	17	3	 	 	SPACE
dpc-2582	17	4	to	to	PART
dpc-2582	17	5	provide	provide	VERB
dpc-2582	17	6	an	an	DET
dpc-2582	17	7	11	11	NUM
dpc-2582	17	8	-	-	PUNCT
dpc-2582	17	9	year	year	NOUN
dpc-2582	17	10	retrospective	retrospective	ADJ
dpc-2582	17	11	clinical	clinical	ADJ
dpc-2582	17	12	review	review	NOUN
dpc-2582	17	13	of	of	ADP
dpc-2582	17	14	real	real	ADJ
dpc-2582	17	15	-	-	PUNCT
dpc-2582	17	16	world	world	NOUN
dpc-2582	17	17	data	datum	NOUN
dpc-2582	17	18	on	on	ADP
dpc-2582	17	19	mucosal	mucosal	NOUN
dpc-2582	17	20	melanomas	melanoma	NOUN
dpc-2582	17	21	managed	manage	VERB
dpc-2582	17	22	in	in	ADP
dpc-2582	17	23	a	a	DET
dpc-2582	17	24	tertiary	tertiary	ADJ
dpc-2582	17	25	referral	referral	NOUN
dpc-2582	17	26	center	center	NOUN
dpc-2582	17	27	in	in	ADP
dpc-2582	17	28	italy	italy	PROPN
dpc-2582	17	29	.	.	PUNCT
dpc-2582	18	1	methods	method	NOUN
dpc-2582	18	2	:	:	PUNCT
dpc-2582	18	3	 	 	SPACE
dpc-2582	18	4	we	we	PRON
dpc-2582	18	5	included	include	VERB
dpc-2582	18	6	patients	patient	NOUN
dpc-2582	18	7	with	with	ADP
dpc-2582	18	8	histopathological	histopathological	ADJ
dpc-2582	18	9	mucosal	mucosal	ADJ
dpc-2582	18	10	melanoma	melanoma	NOUN
dpc-2582	18	11	diagnoses	diagnosis	NOUN
dpc-2582	18	12	from	from	ADP
dpc-2582	18	13	january	january	PROPN
dpc-2582	18	14	2011	2011	NUM
dpc-2582	18	15	to	to	ADP
dpc-2582	18	16	december	december	PROPN
dpc-2582	18	17	2021	2021	NUM
dpc-2582	18	18	.	.	PUNCT
dpc-2582	19	1	data	datum	NOUN
dpc-2582	19	2	were	be	AUX
dpc-2582	19	3	collected	collect	VERB
dpc-2582	19	4	until	until	ADP
dpc-2582	19	5	the	the	DET
dpc-2582	19	6	last	last	ADJ
dpc-2582	19	7	known	know	VERB
dpc-2582	19	8	follow	follow	NOUN
dpc-2582	19	9	-	-	PUNCT
dpc-2582	19	10	up	up	NOUN
dpc-2582	19	11	or	or	CCONJ
dpc-2582	19	12	death	death	NOUN
dpc-2582	19	13	.	.	PUNCT
dpc-2582	20	1	survival	survival	NOUN
dpc-2582	20	2	analysis	analysis	NOUN
dpc-2582	20	3	was	be	AUX
dpc-2582	20	4	performed	perform	VERB
dpc-2582	20	5	.	.	PUNCT
dpc-2582	21	1	results	result	NOUN
dpc-2582	21	2	:	:	PUNCT
dpc-2582	21	3	 	 	SPACE
dpc-2582	21	4	among	among	ADP
dpc-2582	21	5	33	33	NUM
dpc-2582	21	6	patients	patient	NOUN
dpc-2582	21	7	,	,	PUNCT
dpc-2582	21	8	we	we	PRON
dpc-2582	21	9	found	find	VERB
dpc-2582	21	10	9	9	NUM
dpc-2582	21	11	sinonasal	sinonasal	ADJ
dpc-2582	21	12	,	,	PUNCT
dpc-2582	21	13	13	13	NUM
dpc-2582	21	14	anorectal	anorectal	ADJ
dpc-2582	21	15	and	and	CCONJ
dpc-2582	21	16	11	11	NUM
dpc-2582	21	17	urogenital	urogenital	ADJ
dpc-2582	21	18	mucosal	mucosal	NOUN
dpc-2582	21	19	melanomas	melanomas	NOUN
dpc-2582	21	20	(	(	PUNCT
dpc-2582	21	21	median	median	ADJ
dpc-2582	21	22	age	age	NOUN
dpc-2582	21	23	82	82	NUM
dpc-2582	21	24	,	,	PUNCT
dpc-2582	21	25	females	female	NOUN
dpc-2582	21	26	66.7	66.7	NUM
dpc-2582	21	27	%	%	NOUN
dpc-2582	21	28	)	)	PUNCT
dpc-2582	21	29	.	.	PUNCT
dpc-2582	22	1	eighteen	eighteen	NUM
dpc-2582	22	2	cases	case	NOUN
dpc-2582	22	3	(	(	PUNCT
dpc-2582	22	4	54.5	54.5	NUM
dpc-2582	22	5	%	%	NOUN
dpc-2582	22	6	)	)	PUNCT
dpc-2582	22	7	presented	present	VERB
dpc-2582	22	8	with	with	ADP
dpc-2582	22	9	metastasis	metastasis	NOUN
dpc-2582	22	10	(	(	PUNCT
dpc-2582	22	11	p<0.05	p<0.05	NOUN
dpc-2582	22	12	)	)	PUNCT
dpc-2582	22	13	.	.	PUNCT
dpc-2582	23	1	abstract	abstract	ADJ
dpc-2582	23	2	2	2	NUM
dpc-2582	23	3	original	original	ADJ
dpc-2582	23	4	article	article	NOUN
dpc-2582	23	5	|	|	ADV
dpc-2582	23	6	dermatol	dermatol	ADJ
dpc-2582	23	7	pract	pract	NOUN
dpc-2582	23	8	concept	concept	NOUN
dpc-2582	23	9	.	.	PUNCT
dpc-2582	24	1	2023;13(1):e2023057	2023;13(1):e2023057	NUM
dpc-2582	24	2	introduction	introduction	NOUN
dpc-2582	24	3	melanoma	melanoma	NOUN
dpc-2582	24	4	is	be	AUX
dpc-2582	24	5	a	a	DET
dpc-2582	24	6	malignant	malignant	ADJ
dpc-2582	24	7	tumor	tumor	NOUN
dpc-2582	24	8	arising	arise	VERB
dpc-2582	24	9	from	from	ADP
dpc-2582	24	10	melanocytes	melanocyte	NOUN
dpc-2582	24	11	 	 	SPACE
dpc-2582	24	12	[	[	X
dpc-2582	24	13	1	1	NUM
dpc-2582	24	14	]	]	PUNCT
dpc-2582	24	15	.	.	PUNCT
dpc-2582	25	1	although	although	SCONJ
dpc-2582	25	2	melanocytes	melanocyte	NOUN
dpc-2582	25	3	are	be	AUX
dpc-2582	25	4	mostly	mostly	ADV
dpc-2582	25	5	localized	localize	VERB
dpc-2582	25	6	in	in	ADP
dpc-2582	25	7	the	the	DET
dpc-2582	25	8	skin	skin	NOUN
dpc-2582	25	9	,	,	PUNCT
dpc-2582	25	10	their	their	PRON
dpc-2582	25	11	precursors	precursor	NOUN
dpc-2582	25	12	reach	reach	VERB
dpc-2582	25	13	also	also	ADV
dpc-2582	25	14	endodermal	endodermal	ADJ
dpc-2582	25	15	and	and	CCONJ
dpc-2582	25	16	ectodermal	ectodermal	ADJ
dpc-2582	25	17	mucosae	mucosa	NOUN
dpc-2582	25	18	migrating	migrating	NOUN
dpc-2582	25	19	from	from	ADP
dpc-2582	25	20	the	the	DET
dpc-2582	25	21	neural	neural	ADJ
dpc-2582	25	22	crest	crest	NOUN
dpc-2582	26	1	[	[	X
dpc-2582	26	2	2	2	NUM
dpc-2582	26	3	]	]	PUNCT
dpc-2582	26	4	.	.	PUNCT
dpc-2582	27	1	primary	primary	ADJ
dpc-2582	27	2	mucosal	mucosal	ADJ
dpc-2582	27	3	melanoma	melanoma	NOUN
dpc-2582	27	4	arises	arise	VERB
dpc-2582	27	5	from	from	ADP
dpc-2582	27	6	mucosal	mucosal	ADJ
dpc-2582	27	7	membranes	membrane	NOUN
dpc-2582	27	8	lining	line	VERB
dpc-2582	27	9	the	the	DET
dpc-2582	27	10	head	head	NOUN
dpc-2582	27	11	and	and	CCONJ
dpc-2582	27	12	neck	neck	NOUN
dpc-2582	27	13	(	(	PUNCT
dpc-2582	27	14	i.e.	i.e.	X
dpc-2582	27	15	nasal	nasal	NOUN
dpc-2582	27	16	and	and	CCONJ
dpc-2582	27	17	oral	oral	ADJ
dpc-2582	27	18	cavities	cavity	NOUN
dpc-2582	27	19	)	)	PUNCT
dpc-2582	27	20	,	,	PUNCT
dpc-2582	27	21	anorectal	anorectal	ADJ
dpc-2582	27	22	,	,	PUNCT
dpc-2582	27	23	vulvovaginal	vulvovaginal	ADJ
dpc-2582	27	24	,	,	PUNCT
dpc-2582	27	25	and	and	CCONJ
dpc-2582	27	26	urinary	urinary	ADJ
dpc-2582	27	27	tract	tract	NOUN
dpc-2582	27	28	in	in	ADP
dpc-2582	27	29	order	order	NOUN
dpc-2582	27	30	of	of	ADP
dpc-2582	27	31	frequency	frequency	NOUN
dpc-2582	27	32	[	[	X
dpc-2582	27	33	3,4	3,4	NUM
dpc-2582	27	34	]	]	PUNCT
dpc-2582	27	35	.	.	PUNCT
dpc-2582	28	1	the	the	DET
dpc-2582	28	2	occult	occult	NOUN
dpc-2582	28	3	locations	location	NOUN
dpc-2582	28	4	in	in	ADP
dpc-2582	28	5	which	which	PRON
dpc-2582	28	6	mucosal	mucosal	ADJ
dpc-2582	28	7	melanoma	melanoma	NOUN
dpc-2582	28	8	occurs	occur	VERB
dpc-2582	28	9	preclude	preclude	VERB
dpc-2582	28	10	sun	sun	NOUN
dpc-2582	28	11	exposure	exposure	NOUN
dpc-2582	28	12	as	as	ADP
dpc-2582	28	13	a	a	DET
dpc-2582	28	14	predisposing	predispose	VERB
dpc-2582	28	15	risk	risk	NOUN
dpc-2582	28	16	factor	factor	NOUN
dpc-2582	28	17	;	;	PUNCT
dpc-2582	28	18	the	the	DET
dpc-2582	28	19	etiologic	etiologic	ADJ
dpc-2582	28	20	factors	factor	NOUN
dpc-2582	28	21	driving	drive	VERB
dpc-2582	28	22	tumorigenesis	tumorigenesis	NOUN
dpc-2582	28	23	in	in	ADP
dpc-2582	28	24	mucosal	mucosal	ADJ
dpc-2582	28	25	melanoma	melanoma	NOUN
dpc-2582	28	26	have	have	AUX
dpc-2582	28	27	not	not	PART
dpc-2582	28	28	been	be	AUX
dpc-2582	28	29	discovered	discover	VERB
dpc-2582	28	30	yet	yet	ADV
dpc-2582	28	31	[	[	X
dpc-2582	28	32	5	5	NUM
dpc-2582	28	33	]	]	PUNCT
dpc-2582	28	34	.	.	PUNCT
dpc-2582	29	1	mucosal	mucosal	ADJ
dpc-2582	29	2	melanoma	melanoma	NOUN
dpc-2582	29	3	represents	represent	VERB
dpc-2582	29	4	0.03	0.03	NUM
dpc-2582	29	5	%	%	NOUN
dpc-2582	29	6	of	of	ADP
dpc-2582	29	7	all	all	DET
dpc-2582	29	8	cancer	cancer	NOUN
dpc-2582	29	9	diagnoses	diagnosis	NOUN
dpc-2582	29	10	and	and	CCONJ
dpc-2582	29	11	0.8	0.8	NUM
dpc-2582	29	12	-	-	SYM
dpc-2582	29	13	3.7	3.7	NUM
dpc-2582	29	14	%	%	NOUN
dpc-2582	29	15	of	of	ADP
dpc-2582	29	16	all	all	DET
dpc-2582	29	17	melanomas	melanomas	NOUN
dpc-2582	30	1	[	[	X
dpc-2582	30	2	5,6	5,6	NUM
dpc-2582	30	3	]	]	PUNCT
dpc-2582	30	4	,	,	PUNCT
dpc-2582	30	5	with	with	ADP
dpc-2582	30	6	a	a	DET
dpc-2582	30	7	higher	high	ADJ
dpc-2582	30	8	incidence	incidence	NOUN
dpc-2582	30	9	in	in	ADP
dpc-2582	30	10	women	woman	NOUN
dpc-2582	30	11	than	than	ADP
dpc-2582	30	12	men	man	NOUN
dpc-2582	30	13	;	;	PUNCT
dpc-2582	30	14	different	different	ADJ
dpc-2582	30	15	gender	gender	NOUN
dpc-2582	30	16	incidence	incidence	NOUN
dpc-2582	30	17	is	be	AUX
dpc-2582	30	18	mainly	mainly	ADV
dpc-2582	30	19	due	due	ADJ
dpc-2582	30	20	to	to	ADP
dpc-2582	30	21	vulvovaginal	vulvovaginal	ADJ
dpc-2582	30	22	neoplasia	neoplasia	NOUN
dpc-2582	30	23	,	,	PUNCT
dpc-2582	30	24	which	which	PRON
dpc-2582	30	25	represents	represent	VERB
dpc-2582	30	26	alone	alone	ADV
dpc-2582	30	27	18	18	NUM
dpc-2582	30	28	%	%	NOUN
dpc-2582	30	29	of	of	ADP
dpc-2582	30	30	mucosal	mucosal	ADJ
dpc-2582	30	31	melanomas	melanoma	NOUN
dpc-2582	31	1	[	[	X
dpc-2582	31	2	1	1	NUM
dpc-2582	31	3	]	]	PUNCT
dpc-2582	31	4	.	.	PUNCT
dpc-2582	32	1	most	most	ADJ
dpc-2582	32	2	patients	patient	NOUN
dpc-2582	32	3	with	with	ADP
dpc-2582	32	4	mucosal	mucosal	ADJ
dpc-2582	32	5	melanoma	melanoma	NOUN
dpc-2582	32	6	are	be	AUX
dpc-2582	32	7	diagnosed	diagnose	VERB
dpc-2582	32	8	in	in	ADP
dpc-2582	32	9	a	a	DET
dpc-2582	32	10	metastatic	metastatic	ADJ
dpc-2582	32	11	stage	stage	NOUN
dpc-2582	32	12	because	because	SCONJ
dpc-2582	32	13	of	of	ADP
dpc-2582	32	14	the	the	DET
dpc-2582	32	15	late	late	ADJ
dpc-2582	32	16	occurrence	occurrence	NOUN
dpc-2582	32	17	of	of	ADP
dpc-2582	32	18	symptoms	symptom	NOUN
dpc-2582	32	19	and	and	CCONJ
dpc-2582	32	20	the	the	DET
dpc-2582	32	21	occult	occult	NOUN
dpc-2582	32	22	location	location	NOUN
dpc-2582	32	23	of	of	ADP
dpc-2582	32	24	the	the	DET
dpc-2582	32	25	primary	primary	ADJ
dpc-2582	32	26	tumor	tumor	NOUN
dpc-2582	33	1	[	[	X
dpc-2582	33	2	7	7	NUM
dpc-2582	33	3	]	]	PUNCT
dpc-2582	33	4	.	.	PUNCT
dpc-2582	34	1	the	the	DET
dpc-2582	34	2	most	most	ADV
dpc-2582	34	3	common	common	ADJ
dpc-2582	34	4	symptoms	symptom	NOUN
dpc-2582	34	5	in	in	ADP
dpc-2582	34	6	nasal	nasal	ADJ
dpc-2582	34	7	cavity	cavity	NOUN
dpc-2582	34	8	melanomas	melanoma	NOUN
dpc-2582	34	9	are	be	AUX
dpc-2582	34	10	unilateral	unilateral	ADJ
dpc-2582	34	11	nasal	nasal	ADJ
dpc-2582	34	12	obstruction	obstruction	NOUN
dpc-2582	34	13	,	,	PUNCT
dpc-2582	34	14	mass	mass	ADJ
dpc-2582	34	15	lesion	lesion	NOUN
dpc-2582	34	16	,	,	PUNCT
dpc-2582	34	17	and	and	CCONJ
dpc-2582	34	18	epistaxis	epistaxis	ADJ
dpc-2582	34	19	while	while	SCONJ
dpc-2582	34	20	in	in	ADP
dpc-2582	34	21	the	the	DET
dpc-2582	34	22	oral	oral	ADJ
dpc-2582	34	23	cavity	cavity	NOUN
dpc-2582	34	24	symptoms	symptom	NOUN
dpc-2582	34	25	such	such	ADJ
dpc-2582	34	26	as	as	ADP
dpc-2582	34	27	swelling	swell	VERB
dpc-2582	34	28	,	,	PUNCT
dpc-2582	34	29	ulceration	ulceration	NOUN
dpc-2582	34	30	,	,	PUNCT
dpc-2582	34	31	bleeding	bleeding	NOUN
dpc-2582	34	32	,	,	PUNCT
dpc-2582	34	33	pain	pain	NOUN
dpc-2582	34	34	,	,	PUNCT
dpc-2582	34	35	or	or	CCONJ
dpc-2582	34	36	tooth	tooth	NOUN
dpc-2582	34	37	mobility	mobility	NOUN
dpc-2582	34	38	can	can	AUX
dpc-2582	34	39	occur	occur	VERB
dpc-2582	34	40	.	.	PUNCT
dpc-2582	35	1	anorectal	anorectal	ADJ
dpc-2582	35	2	melanomas	melanoma	NOUN
dpc-2582	35	3	usually	usually	ADV
dpc-2582	35	4	manifest	manifest	VERB
dpc-2582	35	5	with	with	ADP
dpc-2582	35	6	rectal	rectal	ADJ
dpc-2582	35	7	bleeding	bleeding	NOUN
dpc-2582	35	8	,	,	PUNCT
dpc-2582	35	9	anorectal	anorectal	ADJ
dpc-2582	35	10	discomfort	discomfort	NOUN
dpc-2582	35	11	,	,	PUNCT
dpc-2582	35	12	or	or	CCONJ
dpc-2582	35	13	prolapse	prolapse	NOUN
dpc-2582	35	14	of	of	ADP
dpc-2582	35	15	the	the	DET
dpc-2582	35	16	tumor	tumor	NOUN
dpc-2582	35	17	mass	mass	PROPN
dpc-2582	35	18	.	.	PUNCT
dpc-2582	36	1	in	in	ADP
dpc-2582	36	2	vulvovaginal	vulvovaginal	ADJ
dpc-2582	36	3	melanomas	melanomas	NOUN
dpc-2582	36	4	presenting	present	VERB
dpc-2582	36	5	symptoms	symptom	NOUN
dpc-2582	36	6	are	be	AUX
dpc-2582	36	7	bleeding	bleed	VERB
dpc-2582	36	8	,	,	PUNCT
dpc-2582	36	9	vulvar	vulvar	NOUN
dpc-2582	36	10	mass	mass	PROPN
dpc-2582	36	11	,	,	PUNCT
dpc-2582	36	12	pruritus	pruritus	NOUN
dpc-2582	36	13	,	,	PUNCT
dpc-2582	36	14	pain	pain	NOUN
dpc-2582	36	15	or	or	CCONJ
dpc-2582	36	16	irritation	irritation	NOUN
dpc-2582	36	17	,	,	PUNCT
dpc-2582	36	18	micturition	micturition	NOUN
dpc-2582	36	19	discomfort	discomfort	NOUN
dpc-2582	36	20	,	,	PUNCT
dpc-2582	36	21	and	and	CCONJ
dpc-2582	36	22	discharge	discharge	VERB
dpc-2582	36	23	[	[	X
dpc-2582	36	24	4	4	NUM
dpc-2582	36	25	]	]	PUNCT
dpc-2582	36	26	.	.	PUNCT
dpc-2582	37	1	there	there	PRON
dpc-2582	37	2	is	be	VERB
dpc-2582	37	3	no	no	DET
dpc-2582	37	4	universal	universal	ADJ
dpc-2582	37	5	staging	staging	NOUN
dpc-2582	37	6	system	system	NOUN
dpc-2582	37	7	for	for	ADP
dpc-2582	37	8	mucosal	mucosal	ADJ
dpc-2582	37	9	melanomas	melanoma	NOUN
dpc-2582	37	10	.	.	PUNCT
dpc-2582	38	1	head	head	NOUN
dpc-2582	38	2	and	and	CCONJ
dpc-2582	38	3	neck	neck	NOUN
dpc-2582	38	4	mucosal	mucosal	NOUN
dpc-2582	38	5	melanomas	melanoma	NOUN
dpc-2582	38	6	are	be	AUX
dpc-2582	38	7	usually	usually	ADV
dpc-2582	38	8	staged	stage	VERB
dpc-2582	38	9	according	accord	VERB
dpc-2582	38	10	to	to	ADP
dpc-2582	38	11	the	the	DET
dpc-2582	38	12	american	american	PROPN
dpc-2582	38	13	joint	joint	PROPN
dpc-2582	38	14	committee	committee	PROPN
dpc-2582	38	15	on	on	ADP
dpc-2582	38	16	cancer	cancer	NOUN
dpc-2582	38	17	(	(	PUNCT
dpc-2582	38	18	ajcc	ajcc	PROPN
dpc-2582	38	19	)	)	PUNCT
dpc-2582	38	20	criteria	criterion	NOUN
dpc-2582	38	21	for	for	ADP
dpc-2582	38	22	head	head	NOUN
dpc-2582	38	23	and	and	CCONJ
dpc-2582	38	24	neck	neck	NOUN
dpc-2582	38	25	cancer	cancer	NOUN
dpc-2582	38	26	;	;	PUNCT
dpc-2582	38	27	vulvar	vulvar	NOUN
dpc-2582	38	28	melanoma	melanoma	NOUN
dpc-2582	38	29	can	can	AUX
dpc-2582	38	30	be	be	AUX
dpc-2582	38	31	staged	stage	VERB
dpc-2582	38	32	following	follow	VERB
dpc-2582	38	33	the	the	DET
dpc-2582	38	34	ajcc	ajcc	PROPN
dpc-2582	38	35	criteria	criterion	NOUN
dpc-2582	38	36	for	for	ADP
dpc-2582	38	37	cutaneous	cutaneous	ADJ
dpc-2582	38	38	melanoma	melanoma	NOUN
dpc-2582	38	39	,	,	PUNCT
dpc-2582	38	40	while	while	SCONJ
dpc-2582	38	41	no	no	DET
dpc-2582	38	42	staging	staging	NOUN
dpc-2582	38	43	criteria	criterion	NOUN
dpc-2582	38	44	have	have	AUX
dpc-2582	38	45	been	be	AUX
dpc-2582	38	46	established	establish	VERB
dpc-2582	38	47	for	for	ADP
dpc-2582	38	48	mucosal	mucosal	ADJ
dpc-2582	38	49	melanoma	melanoma	NOUN
dpc-2582	38	50	arising	arise	VERB
dpc-2582	38	51	in	in	ADP
dpc-2582	38	52	the	the	DET
dpc-2582	38	53	urethra	urethra	NOUN
dpc-2582	38	54	,	,	PUNCT
dpc-2582	38	55	vagina	vagina	ADJ
dpc-2582	38	56	,	,	PUNCT
dpc-2582	38	57	rectum	rectum	NOUN
dpc-2582	38	58	,	,	PUNCT
dpc-2582	38	59	and	and	CCONJ
dpc-2582	38	60	anus	anus	NOUN
dpc-2582	39	1	[	[	X
dpc-2582	39	2	8	8	NUM
dpc-2582	39	3	]	]	PUNCT
dpc-2582	39	4	.	.	PUNCT
dpc-2582	40	1	surgical	surgical	ADJ
dpc-2582	40	2	excision	excision	NOUN
dpc-2582	40	3	with	with	ADP
dpc-2582	40	4	negative	negative	ADJ
dpc-2582	40	5	margins	margin	NOUN
dpc-2582	40	6	,	,	PUNCT
dpc-2582	40	7	which	which	PRON
dpc-2582	40	8	is	be	AUX
dpc-2582	40	9	the	the	DET
dpc-2582	40	10	treatment	treatment	NOUN
dpc-2582	40	11	of	of	ADP
dpc-2582	40	12	choice	choice	NOUN
dpc-2582	40	13	in	in	ADP
dpc-2582	40	14	mucosal	mucosal	ADJ
dpc-2582	40	15	melanomas	melanoma	NOUN
dpc-2582	40	16	,	,	PUNCT
dpc-2582	40	17	is	be	AUX
dpc-2582	40	18	often	often	ADV
dpc-2582	40	19	unfeasible	unfeasible	ADJ
dpc-2582	40	20	because	because	SCONJ
dpc-2582	40	21	of	of	ADP
dpc-2582	40	22	an	an	DET
dpc-2582	40	23	anatomically	anatomically	ADV
dpc-2582	40	24	complex	complex	ADJ
dpc-2582	40	25	site	site	NOUN
dpc-2582	40	26	of	of	ADP
dpc-2582	40	27	origin	origin	NOUN
dpc-2582	40	28	[	[	X
dpc-2582	40	29	7,9	7,9	NUM
dpc-2582	40	30	]	]	PUNCT
dpc-2582	40	31	.	.	PUNCT
dpc-2582	41	1	patients	patient	NOUN
dpc-2582	41	2	with	with	ADP
dpc-2582	41	3	unresectable	unresectable	ADJ
dpc-2582	41	4	or	or	CCONJ
dpc-2582	41	5	metastatic	metastatic	ADJ
dpc-2582	41	6	mucosal	mucosal	NOUN
dpc-2582	41	7	melanomas	melanomas	NOUN
dpc-2582	41	8	can	can	AUX
dpc-2582	41	9	be	be	AUX
dpc-2582	41	10	treated	treat	VERB
dpc-2582	41	11	with	with	ADP
dpc-2582	41	12	the	the	DET
dpc-2582	41	13	same	same	ADJ
dpc-2582	41	14	regimen	regimen	NOUN
dpc-2582	41	15	proposed	propose	VERB
dpc-2582	41	16	for	for	ADP
dpc-2582	41	17	cutaneous	cutaneous	ADJ
dpc-2582	41	18	melanoma	melanoma	NOUN
dpc-2582	41	19	[	[	X
dpc-2582	41	20	10	10	NUM
dpc-2582	41	21	]	]	PUNCT
dpc-2582	41	22	,	,	PUNCT
dpc-2582	41	23	although	although	SCONJ
dpc-2582	41	24	the	the	DET
dpc-2582	41	25	frequency	frequency	NOUN
dpc-2582	41	26	of	of	ADP
dpc-2582	41	27	common	common	ADJ
dpc-2582	41	28	driver	driver	NOUN
dpc-2582	41	29	braf	braf	NOUN
dpc-2582	41	30	is	be	AUX
dpc-2582	41	31	low	low	ADJ
dpc-2582	41	32	compared	compare	VERB
dpc-2582	41	33	to	to	ADP
dpc-2582	41	34	the	the	DET
dpc-2582	41	35	cutaneous	cutaneous	ADJ
dpc-2582	41	36	counterpart	counterpart	NOUN
dpc-2582	41	37	(	(	PUNCT
dpc-2582	41	38	50	50	NUM
dpc-2582	41	39	%	%	NOUN
dpc-2582	41	40	vs	vs	ADP
dpc-2582	41	41	3	3	NUM
dpc-2582	41	42	-	-	SYM
dpc-2582	41	43	5	5	NUM
dpc-2582	41	44	%	%	NOUN
dpc-2582	41	45	)	)	PUNCT
dpc-2582	41	46	,	,	PUNCT
dpc-2582	41	47	with	with	ADP
dpc-2582	41	48	reduced	reduced	ADJ
dpc-2582	41	49	usefulness	usefulness	NOUN
dpc-2582	41	50	of	of	ADP
dpc-2582	41	51	targeted	target	VERB
dpc-2582	41	52	therapy	therapy	NOUN
dpc-2582	42	1	[	[	X
dpc-2582	42	2	1	1	NUM
dpc-2582	42	3	]	]	PUNCT
dpc-2582	42	4	.	.	PUNCT
dpc-2582	43	1	mutation	mutation	NOUN
dpc-2582	43	2	of	of	ADP
dpc-2582	43	3	the	the	DET
dpc-2582	43	4	kit	kit	NOUN
dpc-2582	43	5	gene	gene	NOUN
dpc-2582	43	6	is	be	AUX
dpc-2582	43	7	detected	detect	VERB
dpc-2582	43	8	in	in	ADP
dpc-2582	43	9	about	about	ADV
dpc-2582	43	10	25	25	NUM
dpc-2582	43	11	%	%	NOUN
dpc-2582	43	12	of	of	ADP
dpc-2582	43	13	mucosal	mucosal	ADJ
dpc-2582	43	14	melanomas	melanoma	NOUN
dpc-2582	44	1	[	[	X
dpc-2582	44	2	1	1	NUM
dpc-2582	44	3	]	]	PUNCT
dpc-2582	44	4	;	;	PUNCT
dpc-2582	44	5	to	to	ADP
dpc-2582	44	6	date	date	NOUN
dpc-2582	44	7	,	,	PUNCT
dpc-2582	44	8	guidelines	guideline	NOUN
dpc-2582	44	9	suggest	suggest	VERB
dpc-2582	44	10	kit	kit	NOUN
dpc-2582	44	11	testing	testing	NOUN
dpc-2582	44	12	only	only	ADV
dpc-2582	44	13	when	when	SCONJ
dpc-2582	44	14	braf	braf	NOUN
dpc-2582	44	15	and	and	CCONJ
dpc-2582	44	16	,	,	PUNCT
dpc-2582	44	17	eventually	eventually	ADV
dpc-2582	44	18	,	,	PUNCT
dpc-2582	44	19	nras	nras	PROPN
dpc-2582	44	20	,	,	PUNCT
dpc-2582	44	21	mutational	mutational	ADJ
dpc-2582	44	22	status	status	NOUN
dpc-2582	44	23	have	have	AUX
dpc-2582	44	24	been	be	AUX
dpc-2582	44	25	established	establish	VERB
dpc-2582	44	26	;	;	PUNCT
dpc-2582	44	27	kit	kit	NOUN
dpc-2582	44	28	targeted	target	VERB
dpc-2582	44	29	therapy	therapy	NOUN
dpc-2582	44	30	is	be	AUX
dpc-2582	44	31	usually	usually	ADV
dpc-2582	44	32	administered	administer	VERB
dpc-2582	44	33	as	as	ADP
dpc-2582	44	34	a	a	DET
dpc-2582	44	35	second	second	ADJ
dpc-2582	44	36	line	line	NOUN
dpc-2582	44	37	therapy	therapy	NOUN
dpc-2582	44	38	[	[	X
dpc-2582	44	39	8	8	NUM
dpc-2582	44	40	]	]	PUNCT
dpc-2582	44	41	.	.	PUNCT
dpc-2582	45	1	in	in	ADP
dpc-2582	45	2	the	the	DET
dpc-2582	45	3	last	last	ADJ
dpc-2582	45	4	few	few	ADJ
dpc-2582	45	5	years	year	NOUN
dpc-2582	45	6	,	,	PUNCT
dpc-2582	45	7	immune	immune	ADJ
dpc-2582	45	8	checkpoint	checkpoint	NOUN
dpc-2582	45	9	inhibitors	inhibitor	NOUN
dpc-2582	45	10	(	(	PUNCT
dpc-2582	45	11	icis	icis	NOUN
dpc-2582	45	12	)	)	PUNCT
dpc-2582	45	13	have	have	AUX
dpc-2582	45	14	become	become	VERB
dpc-2582	45	15	a	a	DET
dpc-2582	45	16	preferred	preferred	ADJ
dpc-2582	45	17	first	first	ADJ
dpc-2582	45	18	-	-	PUNCT
dpc-2582	45	19	line	line	NOUN
dpc-2582	45	20	approach	approach	NOUN
dpc-2582	45	21	for	for	ADP
dpc-2582	45	22	patients	patient	NOUN
dpc-2582	45	23	with	with	ADP
dpc-2582	45	24	advanced	advanced	ADJ
dpc-2582	45	25	or	or	CCONJ
dpc-2582	45	26	metastatic	metastatic	ADJ
dpc-2582	45	27	cutaneous	cutaneous	ADJ
dpc-2582	45	28	melanoma	melanoma	NOUN
dpc-2582	45	29	.	.	PUNCT
dpc-2582	46	1	a	a	DET
dpc-2582	46	2	recent	recent	ADJ
dpc-2582	46	3	review	review	NOUN
dpc-2582	46	4	[	[	X
dpc-2582	46	5	7	7	NUM
dpc-2582	46	6	]	]	PUNCT
dpc-2582	46	7	showed	show	VERB
dpc-2582	46	8	that	that	SCONJ
dpc-2582	46	9	anti	anti	ADJ
dpc-2582	46	10	-	-	ADJ
dpc-2582	46	11	ctla-4	ctla-4	ADJ
dpc-2582	46	12	antibody	antibody	NOUN
dpc-2582	46	13	ipilimumab	ipilimumab	NOUN
dpc-2582	46	14	has	have	VERB
dpc-2582	46	15	less	less	ADJ
dpc-2582	46	16	efficacy	efficacy	NOUN
dpc-2582	46	17	as	as	ADP
dpc-2582	46	18	monotherapy	monotherapy	NOUN
dpc-2582	46	19	than	than	ADP
dpc-2582	46	20	monoclonal	monoclonal	NOUN
dpc-2582	46	21	antibodies	antibody	NOUN
dpc-2582	46	22	targeting	target	VERB
dpc-2582	46	23	the	the	DET
dpc-2582	46	24	pd-1	pd-1	ADJ
dpc-2582	46	25	and	and	CCONJ
dpc-2582	46	26	pd	pd	PROPN
dpc-2582	46	27	-	-	PROPN
dpc-2582	46	28	l1	l1	PROPN
dpc-2582	46	29	,	,	PUNCT
dpc-2582	46	30	which	which	PRON
dpc-2582	46	31	have	have	AUX
dpc-2582	46	32	proven	prove	VERB
dpc-2582	46	33	more	more	ADV
dpc-2582	46	34	effective	effective	ADJ
dpc-2582	46	35	in	in	ADP
dpc-2582	46	36	the	the	DET
dpc-2582	46	37	treatment	treatment	NOUN
dpc-2582	46	38	of	of	ADP
dpc-2582	46	39	mms	mms	NOUN
dpc-2582	46	40	,	,	PUNCT
dpc-2582	46	41	with	with	ADP
dpc-2582	46	42	prolonged	prolonged	ADJ
dpc-2582	46	43	survival	survival	NOUN
dpc-2582	46	44	and	and	CCONJ
dpc-2582	46	45	acceptable	acceptable	ADJ
dpc-2582	46	46	toxicity	toxicity	NOUN
dpc-2582	46	47	.	.	PUNCT
dpc-2582	47	1	a	a	DET
dpc-2582	47	2	sub	sub	NOUN
dpc-2582	47	3	-	-	NOUN
dpc-2582	47	4	analysis	analysis	NOUN
dpc-2582	47	5	of	of	ADP
dpc-2582	47	6	mucosal	mucosal	NOUN
dpc-2582	47	7	melanomas	melanomas	NOUN
dpc-2582	47	8	performed	perform	VERB
dpc-2582	47	9	in	in	ADP
dpc-2582	47	10	a	a	DET
dpc-2582	47	11	five	five	NUM
dpc-2582	47	12	-	-	PUNCT
dpc-2582	47	13	year	year	NOUN
dpc-2582	47	14	survival	survival	NOUN
dpc-2582	47	15	trial	trial	NOUN
dpc-2582	47	16	showed	show	VERB
dpc-2582	47	17	similar	similar	ADJ
dpc-2582	47	18	data	datum	NOUN
dpc-2582	47	19	on	on	ADP
dpc-2582	47	20	efficacy	efficacy	NOUN
dpc-2582	47	21	[	[	X
dpc-2582	47	22	8,11	8,11	X
dpc-2582	47	23	]	]	PUNCT
dpc-2582	47	24	.	.	PUNCT
dpc-2582	48	1	the	the	DET
dpc-2582	48	2	treatment	treatment	NOUN
dpc-2582	48	3	regimen	regiman	NOUN
dpc-2582	48	4	currently	currently	ADV
dpc-2582	48	5	authorized	authorize	VERB
dpc-2582	48	6	by	by	ADP
dpc-2582	48	7	agenzia	agenzia	PROPN
dpc-2582	48	8	italiana	italiana	PROPN
dpc-2582	48	9	del	del	PROPN
dpc-2582	48	10	farmaco	farmaco	PROPN
dpc-2582	48	11	for	for	ADP
dpc-2582	48	12	advanced	advanced	ADJ
dpc-2582	48	13	mucosal	mucosal	ADJ
dpc-2582	48	14	melanoma	melanoma	NOUN
dpc-2582	48	15	includes	include	VERB
dpc-2582	48	16	ipilimumab	ipilimumab	NOUN
dpc-2582	48	17	and	and	CCONJ
dpc-2582	48	18	anti	anti	ADJ
dpc-2582	48	19	-	-	ADJ
dpc-2582	48	20	pd1	pd1	NOUN
dpc-2582	48	21	antibodies	antibodie	VERB
dpc-2582	48	22	,	,	PUNCT
dpc-2582	48	23	while	while	SCONJ
dpc-2582	48	24	imatinib	imatinib	NOUN
dpc-2582	48	25	is	be	AUX
dpc-2582	48	26	approved	approve	VERB
dpc-2582	48	27	for	for	ADP
dpc-2582	48	28	unresectable	unresectable	ADJ
dpc-2582	48	29	metastatic	metastatic	ADJ
dpc-2582	48	30	melanoma	melanoma	NOUN
dpc-2582	48	31	in	in	ADP
dpc-2582	48	32	progression	progression	NOUN
dpc-2582	48	33	after	after	ADP
dpc-2582	48	34	immunotherapy	immunotherapy	NOUN
dpc-2582	48	35	[	[	X
dpc-2582	48	36	8	8	NUM
dpc-2582	48	37	]	]	PUNCT
dpc-2582	48	38	.	.	PUNCT
dpc-2582	49	1	as	as	ADP
dpc-2582	49	2	primary	primary	ADJ
dpc-2582	49	3	mucosal	mucosal	NOUN
dpc-2582	49	4	melanoma	melanoma	NOUN
dpc-2582	49	5	is	be	AUX
dpc-2582	49	6	an	an	DET
dpc-2582	49	7	exceedingly	exceedingly	ADV
dpc-2582	49	8	rare	rare	ADJ
dpc-2582	49	9	neoplasm	neoplasm	NOUN
dpc-2582	49	10	,	,	PUNCT
dpc-2582	49	11	demographic	demographic	ADJ
dpc-2582	49	12	,	,	PUNCT
dpc-2582	49	13	histopathological	histopathological	ADJ
dpc-2582	49	14	,	,	PUNCT
dpc-2582	49	15	therapeutical	therapeutical	ADJ
dpc-2582	49	16	,	,	PUNCT
dpc-2582	49	17	and	and	CCONJ
dpc-2582	49	18	survival	survival	NOUN
dpc-2582	49	19	records	record	NOUN
dpc-2582	49	20	on	on	ADP
dpc-2582	49	21	this	this	DET
dpc-2582	49	22	topic	topic	NOUN
dpc-2582	49	23	are	be	AUX
dpc-2582	49	24	scarce	scarce	ADJ
dpc-2582	49	25	.	.	PUNCT
dpc-2582	50	1	the	the	DET
dpc-2582	50	2	current	current	ADJ
dpc-2582	50	3	study	study	NOUN
dpc-2582	50	4	aims	aim	VERB
dpc-2582	50	5	to	to	PART
dpc-2582	50	6	provide	provide	VERB
dpc-2582	50	7	an	an	DET
dpc-2582	50	8	11	11	NUM
dpc-2582	50	9	-	-	PUNCT
dpc-2582	50	10	year	year	NOUN
dpc-2582	50	11	retrospective	retrospective	ADJ
dpc-2582	50	12	clinical	clinical	ADJ
dpc-2582	50	13	review	review	NOUN
dpc-2582	50	14	of	of	ADP
dpc-2582	50	15	the	the	DET
dpc-2582	50	16	real	real	ADJ
dpc-2582	50	17	-	-	PUNCT
dpc-2582	50	18	world	world	NOUN
dpc-2582	50	19	data	datum	NOUN
dpc-2582	50	20	on	on	ADP
dpc-2582	50	21	mucosal	mucosal	NOUN
dpc-2582	50	22	melanomas	melanoma	NOUN
dpc-2582	50	23	managed	manage	VERB
dpc-2582	50	24	in	in	ADP
dpc-2582	50	25	a	a	DET
dpc-2582	50	26	tertiary	tertiary	ADJ
dpc-2582	50	27	referral	referral	NOUN
dpc-2582	50	28	center	center	NOUN
dpc-2582	50	29	in	in	ADP
dpc-2582	50	30	italy	italy	PROPN
dpc-2582	50	31	.	.	PUNCT
dpc-2582	51	1	in	in	ADP
dpc-2582	51	2	 	 	SPACE
dpc-2582	51	3	the	the	DET
dpc-2582	51	4	urogenital	urogenital	PROPN
dpc-2582	51	5	subgroup	subgroup	NOUN
dpc-2582	51	6	,	,	PUNCT
dpc-2582	51	7	only	only	ADV
dpc-2582	51	8	4	4	NUM
dpc-2582	51	9	patients	patient	NOUN
dpc-2582	51	10	(	(	PUNCT
dpc-2582	51	11	36.4	36.4	NUM
dpc-2582	51	12	%	%	NOUN
dpc-2582	51	13	)	)	PUNCT
dpc-2582	51	14	had	have	VERB
dpc-2582	51	15	metastasis	metastasis	NOUN
dpc-2582	51	16	at	at	ADP
dpc-2582	51	17	diagnosis	diagnosis	NOUN
dpc-2582	51	18	,	,	PUNCT
dpc-2582	51	19	all	all	PRON
dpc-2582	51	20	in	in	ADP
dpc-2582	51	21	regional	regional	ADJ
dpc-2582	51	22	lymph	lymph	NOUN
dpc-2582	51	23	nodes	node	NOUN
dpc-2582	51	24	.	.	PUNCT
dpc-2582	52	1	sinonasal	sinonasal	ADJ
dpc-2582	52	2	melanomas	melanomas	PROPN
dpc-2582	52	3	were	be	AUX
dpc-2582	52	4	surgically	surgically	ADV
dpc-2582	52	5	managed	manage	VERB
dpc-2582	52	6	with	with	ADP
dpc-2582	52	7	a	a	DET
dpc-2582	52	8	debulking	debulke	VERB
dpc-2582	52	9	procedure	procedure	NOUN
dpc-2582	52	10	(	(	PUNCT
dpc-2582	52	11	44.4	44.4	NUM
dpc-2582	52	12	%	%	NOUN
dpc-2582	52	13	)	)	PUNCT
dpc-2582	52	14	;	;	PUNCT
dpc-2582	52	15	every	every	DET
dpc-2582	52	16	case	case	NOUN
dpc-2582	52	17	of	of	ADP
dpc-2582	52	18	anorectal	anorectal	ADJ
dpc-2582	52	19	and	and	CCONJ
dpc-2582	52	20	urogenital	urogenital	ADJ
dpc-2582	52	21	melanomas	melanomas	NOUN
dpc-2582	52	22	underwent	undergo	VERB
dpc-2582	52	23	radical	radical	ADJ
dpc-2582	52	24	surgery	surgery	NOUN
dpc-2582	52	25	(	(	PUNCT
dpc-2582	52	26	30.8	30.8	NUM
dpc-2582	52	27	%	%	NOUN
dpc-2582	52	28	and	and	CCONJ
dpc-2582	52	29	45.5	45.5	NUM
dpc-2582	52	30	%	%	NOUN
dpc-2582	52	31	)	)	PUNCT
dpc-2582	52	32	.	.	PUNCT
dpc-2582	53	1	fifteen	fifteen	NUM
dpc-2582	53	2	patients	patient	NOUN
dpc-2582	53	3	were	be	AUX
dpc-2582	53	4	treated	treat	VERB
dpc-2582	53	5	with	with	ADP
dpc-2582	53	6	biological	biological	ADJ
dpc-2582	53	7	therapy	therapy	NOUN
dpc-2582	53	8	(	(	PUNCT
dpc-2582	53	9	p<0.05	p<0.05	NOUN
dpc-2582	53	10	)	)	PUNCT
dpc-2582	53	11	.	.	PUNCT
dpc-2582	54	1	radiation	radiation	NOUN
dpc-2582	54	2	therapy	therapy	NOUN
dpc-2582	54	3	was	be	AUX
dpc-2582	54	4	used	use	VERB
dpc-2582	54	5	in	in	ADP
dpc-2582	54	6	all	all	DET
dpc-2582	54	7	melanomas	melanomas	NOUN
dpc-2582	54	8	of	of	ADP
dpc-2582	54	9	the	the	DET
dpc-2582	54	10	sinonasal	sinonasal	ADJ
dpc-2582	54	11	region	region	NOUN
dpc-2582	54	12	(	(	PUNCT
dpc-2582	54	13	p<0.05	p<0.05	NOUN
dpc-2582	54	14	)	)	PUNCT
dpc-2582	54	15	.	.	PUNCT
dpc-2582	55	1	overall	overall	ADJ
dpc-2582	55	2	survival	survival	NOUN
dpc-2582	55	3	was	be	AUX
dpc-2582	55	4	longer	long	ADJ
dpc-2582	55	5	for	for	ADP
dpc-2582	55	6	urogenital	urogenital	ADJ
dpc-2582	55	7	melanomas	melanomas	NOUN
dpc-2582	55	8	(	(	PUNCT
dpc-2582	55	9	26	26	NUM
dpc-2582	55	10	months	month	NOUN
dpc-2582	55	11	)	)	PUNCT
dpc-2582	55	12	.	.	PUNCT
dpc-2582	56	1	univariate	univariate	ADJ
dpc-2582	56	2	analysis	analysis	NOUN
dpc-2582	56	3	showed	show	VERB
dpc-2582	56	4	an	an	DET
dpc-2582	56	5	increased	increase	VERB
dpc-2582	56	6	hazard	hazard	NOUN
dpc-2582	56	7	ratio	ratio	NOUN
dpc-2582	56	8	for	for	ADP
dpc-2582	56	9	death	death	NOUN
dpc-2582	56	10	in	in	ADP
dpc-2582	56	11	patients	patient	NOUN
dpc-2582	56	12	with	with	ADP
dpc-2582	56	13	metastasis	metastasis	NOUN
dpc-2582	56	14	.	.	PUNCT
dpc-2582	57	1	a	a	DET
dpc-2582	57	2	negative	negative	ADJ
dpc-2582	57	3	prognostic	prognostic	ADJ
dpc-2582	57	4	value	value	NOUN
dpc-2582	57	5	of	of	ADP
dpc-2582	57	6	metastatic	metastatic	ADJ
dpc-2582	57	7	status	status	NOUN
dpc-2582	57	8	was	be	AUX
dpc-2582	57	9	reported	report	VERB
dpc-2582	57	10	by	by	ADP
dpc-2582	57	11	the	the	DET
dpc-2582	57	12	multivariate	multivariate	NOUN
dpc-2582	57	13	model	model	NOUN
dpc-2582	57	14	,	,	PUNCT
dpc-2582	57	15	while	while	SCONJ
dpc-2582	57	16	administration	administration	NOUN
dpc-2582	57	17	of	of	ADP
dpc-2582	57	18	first	first	ADJ
dpc-2582	57	19	-	-	PUNCT
dpc-2582	57	20	line	line	NOUN
dpc-2582	57	21	immunotherapy	immunotherapy	NOUN
dpc-2582	57	22	demonstrated	demonstrate	VERB
dpc-2582	57	23	a	a	DET
dpc-2582	57	24	protective	protective	ADJ
dpc-2582	57	25	role	role	NOUN
dpc-2582	57	26	.	.	PUNCT
dpc-2582	58	1	conclusions	conclusion	NOUN
dpc-2582	58	2	:	:	PUNCT
dpc-2582	58	3	 	 	SPACE
dpc-2582	58	4	at	at	ADP
dpc-2582	58	5	diagnosis	diagnosis	NOUN
dpc-2582	58	6	,	,	PUNCT
dpc-2582	58	7	the	the	DET
dpc-2582	58	8	absence	absence	NOUN
dpc-2582	58	9	of	of	ADP
dpc-2582	58	10	metastatic	metastatic	ADJ
dpc-2582	58	11	disease	disease	NOUN
dpc-2582	58	12	is	be	AUX
dpc-2582	58	13	the	the	DET
dpc-2582	58	14	most	most	ADV
dpc-2582	58	15	relevant	relevant	ADJ
dpc-2582	58	16	factor	factor	NOUN
dpc-2582	58	17	that	that	PRON
dpc-2582	58	18	influences	influence	VERB
dpc-2582	58	19	the	the	DET
dpc-2582	58	20	survival	survival	NOUN
dpc-2582	58	21	of	of	ADP
dpc-2582	58	22	mucosal	mucosal	ADJ
dpc-2582	58	23	melanomas	melanoma	NOUN
dpc-2582	58	24	.	.	PUNCT
dpc-2582	59	1	moreover	moreover	ADV
dpc-2582	59	2	,	,	PUNCT
dpc-2582	59	3	the	the	DET
dpc-2582	59	4	use	use	NOUN
dpc-2582	59	5	of	of	ADP
dpc-2582	59	6	immunotherapy	immunotherapy	NOUN
dpc-2582	59	7	might	might	AUX
dpc-2582	59	8	prolong	prolong	VERB
dpc-2582	59	9	the	the	DET
dpc-2582	59	10	survival	survival	NOUN
dpc-2582	59	11	of	of	ADP
dpc-2582	59	12	metastatic	metastatic	ADJ
dpc-2582	59	13	mucosal	mucosal	ADJ
dpc-2582	59	14	melanoma	melanoma	NOUN
dpc-2582	59	15	patients	patient	NOUN
dpc-2582	59	16	.	.	PUNCT
dpc-2582	60	1	original	original	ADJ
dpc-2582	60	2	article	article	NOUN
dpc-2582	60	3	|	|	ADV
dpc-2582	60	4	dermatol	dermatol	ADJ
dpc-2582	60	5	pract	pract	NOUN
dpc-2582	60	6	concept	concept	NOUN
dpc-2582	60	7	.	.	PUNCT
dpc-2582	61	1	2023;13(1):e2023057	2023;13(1):e2023057	NUM
dpc-2582	61	2	3	3	NUM
dpc-2582	61	3	methods	method	NOUN
dpc-2582	61	4	this	this	PRON
dpc-2582	61	5	was	be	AUX
dpc-2582	61	6	a	a	DET
dpc-2582	61	7	retrospective	retrospective	ADJ
dpc-2582	61	8	study	study	NOUN
dpc-2582	61	9	performed	perform	VERB
dpc-2582	61	10	between	between	ADP
dpc-2582	61	11	01/01/2011	01/01/2011	NUM
dpc-2582	61	12	to	to	ADP
dpc-2582	61	13	31/12/2021	31/12/2021	NUM
dpc-2582	61	14	.	.	PUNCT
dpc-2582	62	1	this	this	DET
dpc-2582	62	2	study	study	NOUN
dpc-2582	62	3	was	be	AUX
dpc-2582	62	4	approved	approve	VERB
dpc-2582	62	5	by	by	ADP
dpc-2582	62	6	the	the	DET
dpc-2582	62	7	institutional	institutional	PROPN
dpc-2582	62	8	review	review	PROPN
dpc-2582	62	9	board	board	NOUN
dpc-2582	62	10	of	of	ADP
dpc-2582	62	11	azienda	azienda	PROPN
dpc-2582	62	12	unità	unità	PROPN
dpc-2582	62	13	sanitaria	sanitaria	PROPN
dpc-2582	62	14	locale	locale	PROPN
dpc-2582	62	15	–	–	PUNCT
dpc-2582	62	16	irccs	ircc	VERB
dpc-2582	62	17	di	di	PROPN
dpc-2582	62	18	reggio	reggio	PROPN
dpc-2582	62	19	emilia	emilia	PROPN
dpc-2582	62	20	,	,	PUNCT
dpc-2582	62	21	italy	italy	PROPN
dpc-2582	62	22	(	(	PUNCT
dpc-2582	62	23	protocol	protocol	NOUN
dpc-2582	62	24	number	number	NOUN
dpc-2582	62	25	#	#	SYM
dpc-2582	62	26	2011/02347213	2011/02347213	NUM
dpc-2582	62	27	)	)	PUNCT
dpc-2582	62	28	.	.	PUNCT
dpc-2582	63	1	we	we	PRON
dpc-2582	63	2	included	include	VERB
dpc-2582	63	3	consecutive	consecutive	ADJ
dpc-2582	63	4	patients	patient	NOUN
dpc-2582	63	5	with	with	ADP
dpc-2582	63	6	a	a	DET
dpc-2582	63	7	histopathologically	histopathologically	ADV
dpc-2582	63	8	confirmed	confirm	VERB
dpc-2582	63	9	diagnosis	diagnosis	NOUN
dpc-2582	63	10	of	of	ADP
dpc-2582	63	11	mucosal	mucosal	ADJ
dpc-2582	63	12	melanomas	melanoma	NOUN
dpc-2582	63	13	.	.	PUNCT
dpc-2582	64	1	we	we	PRON
dpc-2582	64	2	excluded	exclude	VERB
dpc-2582	64	3	recurrent	recurrent	ADJ
dpc-2582	64	4	tumors	tumor	NOUN
dpc-2582	64	5	,	,	PUNCT
dpc-2582	64	6	unknown	unknown	ADJ
dpc-2582	64	7	primary	primary	ADJ
dpc-2582	64	8	melanomas	melanomas	NOUN
dpc-2582	64	9	,	,	PUNCT
dpc-2582	64	10	and	and	CCONJ
dpc-2582	64	11	cases	case	NOUN
dpc-2582	64	12	for	for	ADP
dpc-2582	64	13	which	which	PRON
dpc-2582	64	14	histological	histological	ADJ
dpc-2582	64	15	slides	slide	NOUN
dpc-2582	64	16	were	be	AUX
dpc-2582	64	17	not	not	PART
dpc-2582	64	18	available	available	ADJ
dpc-2582	64	19	for	for	ADP
dpc-2582	64	20	re	re	NOUN
dpc-2582	64	21	-	-	NOUN
dpc-2582	64	22	evaluation	evaluation	NOUN
dpc-2582	64	23	.	.	PUNCT
dpc-2582	65	1	data	datum	NOUN
dpc-2582	65	2	from	from	ADP
dpc-2582	65	3	the	the	DET
dpc-2582	65	4	first	first	ADJ
dpc-2582	65	5	clinical	clinical	ADJ
dpc-2582	65	6	or	or	CCONJ
dpc-2582	65	7	instrumental	instrumental	ADJ
dpc-2582	65	8	diagnosis	diagnosis	NOUN
dpc-2582	65	9	to	to	ADP
dpc-2582	65	10	the	the	DET
dpc-2582	65	11	date	date	NOUN
dpc-2582	65	12	of	of	ADP
dpc-2582	65	13	each	each	DET
dpc-2582	65	14	patient	patient	NOUN
dpc-2582	65	15	’s	’s	PART
dpc-2582	65	16	last	last	ADJ
dpc-2582	65	17	known	know	VERB
dpc-2582	65	18	follow	follow	NOUN
dpc-2582	65	19	-	-	PUNCT
dpc-2582	65	20	up	up	NOUN
dpc-2582	65	21	appointment	appointment	NOUN
dpc-2582	65	22	or	or	CCONJ
dpc-2582	65	23	death	death	NOUN
dpc-2582	65	24	was	be	AUX
dpc-2582	65	25	obtained	obtain	VERB
dpc-2582	65	26	from	from	ADP
dpc-2582	65	27	digital	digital	ADJ
dpc-2582	65	28	medical	medical	ADJ
dpc-2582	65	29	records	record	NOUN
dpc-2582	65	30	.	.	PUNCT
dpc-2582	66	1	we	we	PRON
dpc-2582	66	2	recorded	record	VERB
dpc-2582	66	3	patient	patient	ADJ
dpc-2582	66	4	age	age	NOUN
dpc-2582	66	5	,	,	PUNCT
dpc-2582	66	6	gender	gender	NOUN
dpc-2582	66	7	,	,	PUNCT
dpc-2582	66	8	location	location	NOUN
dpc-2582	66	9	of	of	ADP
dpc-2582	66	10	the	the	DET
dpc-2582	66	11	lesion	lesion	NOUN
dpc-2582	66	12	,	,	PUNCT
dpc-2582	66	13	presenting	present	VERB
dpc-2582	66	14	symptoms	symptom	NOUN
dpc-2582	66	15	,	,	PUNCT
dpc-2582	66	16	site	site	NOUN
dpc-2582	66	17	of	of	ADP
dpc-2582	66	18	metastasis	metastasis	NOUN
dpc-2582	66	19	at	at	ADP
dpc-2582	66	20	diagnosis	diagnosis	NOUN
dpc-2582	66	21	if	if	SCONJ
dpc-2582	66	22	any	any	DET
dpc-2582	66	23	(	(	PUNCT
dpc-2582	66	24	locoregional	locoregional	ADJ
dpc-2582	66	25	lymph	lymph	NOUN
dpc-2582	66	26	node	node	NOUN
dpc-2582	66	27	involvement	involvement	NOUN
dpc-2582	66	28	,	,	PUNCT
dpc-2582	66	29	cerebral	cerebral	ADJ
dpc-2582	66	30	,	,	PUNCT
dpc-2582	66	31	visceral	visceral	ADJ
dpc-2582	66	32	,	,	PUNCT
dpc-2582	66	33	or	or	CCONJ
dpc-2582	66	34	multiple	multiple	ADJ
dpc-2582	66	35	metastases	metastasis	NOUN
dpc-2582	66	36	when	when	SCONJ
dpc-2582	66	37	more	more	ADJ
dpc-2582	66	38	than	than	ADP
dpc-2582	66	39	one	one	NUM
dpc-2582	66	40	of	of	ADP
dpc-2582	66	41	the	the	DET
dpc-2582	66	42	previous	previous	ADJ
dpc-2582	66	43	sites	site	NOUN
dpc-2582	66	44	was	be	AUX
dpc-2582	66	45	involved	involve	VERB
dpc-2582	66	46	)	)	PUNCT
dpc-2582	66	47	and	and	CCONJ
dpc-2582	66	48	histopathological	histopathological	ADJ
dpc-2582	66	49	and	and	CCONJ
dpc-2582	66	50	molecular	molecular	ADJ
dpc-2582	66	51	features	feature	NOUN
dpc-2582	66	52	(	(	PUNCT
dpc-2582	66	53	cell	cell	NOUN
dpc-2582	66	54	morphology	morphology	NOUN
dpc-2582	66	55	,	,	PUNCT
dpc-2582	66	56	breslow	breslow	ADJ
dpc-2582	66	57	thickness	thickness	NOUN
dpc-2582	66	58	and	and	CCONJ
dpc-2582	66	59	ulceration	ulceration	NOUN
dpc-2582	66	60	when	when	SCONJ
dpc-2582	66	61	not	not	PART
dpc-2582	66	62	compromised	compromise	VERB
dpc-2582	66	63	by	by	ADP
dpc-2582	66	64	fragmentation	fragmentation	NOUN
dpc-2582	66	65	or	or	CCONJ
dpc-2582	66	66	orientation	orientation	NOUN
dpc-2582	66	67	of	of	ADP
dpc-2582	66	68	biopsy	biopsy	NOUN
dpc-2582	66	69	specimen	speciman	NOUN
dpc-2582	66	70	,	,	PUNCT
dpc-2582	66	71	and	and	CCONJ
dpc-2582	66	72	mutational	mutational	ADJ
dpc-2582	66	73	status	status	NOUN
dpc-2582	66	74	)	)	PUNCT
dpc-2582	66	75	.	.	PUNCT
dpc-2582	67	1	surgery	surgery	NOUN
dpc-2582	67	2	was	be	AUX
dpc-2582	67	3	recorded	record	VERB
dpc-2582	67	4	as	as	ADP
dpc-2582	67	5	debulking	debulke	VERB
dpc-2582	67	6	procedure	procedure	NOUN
dpc-2582	67	7	or	or	CCONJ
dpc-2582	67	8	radical	radical	ADJ
dpc-2582	67	9	treatment	treatment	NOUN
dpc-2582	67	10	.	.	PUNCT
dpc-2582	68	1	systemic	systemic	ADJ
dpc-2582	68	2	treatments	treatment	NOUN
dpc-2582	68	3	were	be	AUX
dpc-2582	68	4	categorized	categorize	VERB
dpc-2582	68	5	according	accord	VERB
dpc-2582	68	6	to	to	ADP
dpc-2582	68	7	current	current	ADJ
dpc-2582	68	8	recommendations	recommendation	NOUN
dpc-2582	68	9	[	[	X
dpc-2582	68	10	8,10	8,10	NOUN
dpc-2582	68	11	]	]	PUNCT
dpc-2582	68	12	as	as	ADP
dpc-2582	68	13	first	first	ADJ
dpc-2582	68	14	-	-	PUNCT
dpc-2582	68	15	line	line	NOUN
dpc-2582	68	16	biological	biological	ADJ
dpc-2582	68	17	treatment	treatment	NOUN
dpc-2582	68	18	(	(	PUNCT
dpc-2582	68	19	nivolumab	nivolumab	NOUN
dpc-2582	68	20	,	,	PUNCT
dpc-2582	68	21	pembrolizumab	pembrolizumab	NOUN
dpc-2582	68	22	,	,	PUNCT
dpc-2582	68	23	or	or	CCONJ
dpc-2582	68	24	imatinib	imatinib	NOUN
dpc-2582	68	25	)	)	PUNCT
dpc-2582	68	26	,	,	PUNCT
dpc-2582	68	27	as	as	ADP
dpc-2582	68	28	first	first	ADJ
dpc-2582	68	29	-	-	PUNCT
dpc-2582	68	30	line	line	NOUN
dpc-2582	68	31	chemotherapy	chemotherapy	NOUN
dpc-2582	68	32	when	when	SCONJ
dpc-2582	68	33	the	the	DET
dpc-2582	68	34	patient	patient	NOUN
dpc-2582	68	35	was	be	AUX
dpc-2582	68	36	administered	administer	VERB
dpc-2582	68	37	with	with	ADP
dpc-2582	68	38	systemic	systemic	ADJ
dpc-2582	68	39	therapy	therapy	NOUN
dpc-2582	68	40	in	in	ADP
dpc-2582	68	41	the	the	DET
dpc-2582	68	42	pre	pre	ADJ
dpc-2582	68	43	-	-	ADJ
dpc-2582	68	44	biological	biological	ADJ
dpc-2582	68	45	era	era	NOUN
dpc-2582	68	46	,	,	PUNCT
dpc-2582	68	47	and	and	CCONJ
dpc-2582	68	48	as	as	ADP
dpc-2582	68	49	second	second	ADJ
dpc-2582	68	50	-	-	PUNCT
dpc-2582	68	51	line	line	NOUN
dpc-2582	68	52	treatments	treatment	NOUN
dpc-2582	68	53	when	when	SCONJ
dpc-2582	68	54	therapy	therapy	NOUN
dpc-2582	68	55	was	be	AUX
dpc-2582	68	56	switched	switch	VERB
dpc-2582	68	57	to	to	ADP
dpc-2582	68	58	a	a	DET
dpc-2582	68	59	different	different	ADJ
dpc-2582	68	60	therapy	therapy	NOUN
dpc-2582	68	61	because	because	SCONJ
dpc-2582	68	62	of	of	ADP
dpc-2582	68	63	disease	disease	NOUN
dpc-2582	68	64	progression	progression	NOUN
dpc-2582	68	65	.	.	PUNCT
dpc-2582	69	1	we	we	PRON
dpc-2582	69	2	also	also	ADV
dpc-2582	69	3	recorded	record	VERB
dpc-2582	69	4	if	if	SCONJ
dpc-2582	69	5	the	the	DET
dpc-2582	69	6	patient	patient	ADJ
dpc-2582	69	7	underwent	underwent	NOUN
dpc-2582	69	8	radiation	radiation	NOUN
dpc-2582	69	9	therapy	therapy	NOUN
dpc-2582	69	10	on	on	ADP
dpc-2582	69	11	the	the	DET
dpc-2582	69	12	primary	primary	ADJ
dpc-2582	69	13	tumor	tumor	NOUN
dpc-2582	69	14	,	,	PUNCT
dpc-2582	69	15	which	which	PRON
dpc-2582	69	16	was	be	AUX
dpc-2582	69	17	always	always	ADV
dpc-2582	69	18	managed	manage	VERB
dpc-2582	69	19	with	with	ADP
dpc-2582	69	20	a	a	DET
dpc-2582	69	21	cytoreductive	cytoreductive	ADJ
dpc-2582	69	22	-	-	PUNCT
dpc-2582	69	23	palliative	palliative	NOUN
dpc-2582	69	24	purpose	purpose	NOUN
dpc-2582	69	25	in	in	ADP
dpc-2582	69	26	our	our	PRON
dpc-2582	69	27	series	series	NOUN
dpc-2582	69	28	[	[	X
dpc-2582	69	29	12	12	NUM
dpc-2582	69	30	]	]	PUNCT
dpc-2582	69	31	.	.	PUNCT
dpc-2582	70	1	statistics	statistic	NOUN
dpc-2582	70	2	statistical	statistical	ADJ
dpc-2582	70	3	analysis	analysis	NOUN
dpc-2582	70	4	was	be	AUX
dpc-2582	70	5	performed	perform	VERB
dpc-2582	70	6	using	use	VERB
dpc-2582	70	7	stata	stata	PROPN
dpc-2582	70	8	®	®	NOUN
dpc-2582	70	9	software	software	NOUN
dpc-2582	70	10	version	version	NOUN
dpc-2582	70	11	17	17	NUM
dpc-2582	70	12	(	(	PUNCT
dpc-2582	70	13	statacorp	statacorp	PROPN
dpc-2582	70	14	,	,	PUNCT
dpc-2582	70	15	4905	4905	NUM
dpc-2582	70	16	lakeway	lakeway	NOUN
dpc-2582	70	17	drive	drive	NOUN
dpc-2582	70	18	,	,	PUNCT
dpc-2582	70	19	college	college	NOUN
dpc-2582	70	20	station	station	NOUN
dpc-2582	70	21	,	,	PUNCT
dpc-2582	70	22	texas	texas	PROPN
dpc-2582	70	23	77845	77845	NUM
dpc-2582	70	24	usa	usa	PROPN
dpc-2582	70	25	)	)	PUNCT
dpc-2582	70	26	.	.	PUNCT
dpc-2582	71	1	descriptive	descriptive	ADJ
dpc-2582	71	2	statistics	statistic	NOUN
dpc-2582	71	3	were	be	AUX
dpc-2582	71	4	presented	present	VERB
dpc-2582	71	5	for	for	ADP
dpc-2582	71	6	baseline	baseline	ADJ
dpc-2582	71	7	demographic	demographic	ADJ
dpc-2582	71	8	clinical	clinical	ADJ
dpc-2582	71	9	characteristics	characteristic	NOUN
dpc-2582	71	10	for	for	ADP
dpc-2582	71	11	the	the	DET
dpc-2582	71	12	entire	entire	ADJ
dpc-2582	71	13	group	group	NOUN
dpc-2582	71	14	,	,	PUNCT
dpc-2582	71	15	as	as	ADV
dpc-2582	71	16	well	well	ADV
dpc-2582	71	17	as	as	ADP
dpc-2582	71	18	for	for	ADP
dpc-2582	71	19	the	the	DET
dpc-2582	71	20	groups	group	NOUN
dpc-2582	71	21	of	of	ADP
dpc-2582	71	22	patients	patient	NOUN
dpc-2582	71	23	with	with	ADP
dpc-2582	71	24	different	different	ADJ
dpc-2582	71	25	locations	location	NOUN
dpc-2582	71	26	.	.	PUNCT
dpc-2582	72	1	continuous	continuous	ADJ
dpc-2582	72	2	variables	variable	NOUN
dpc-2582	72	3	were	be	AUX
dpc-2582	72	4	presented	present	VERB
dpc-2582	72	5	as	as	ADP
dpc-2582	72	6	the	the	DET
dpc-2582	72	7	number	number	NOUN
dpc-2582	72	8	of	of	ADP
dpc-2582	72	9	patients	patient	NOUN
dpc-2582	72	10	(	(	PUNCT
dpc-2582	72	11	n	n	CCONJ
dpc-2582	72	12	)	)	PUNCT
dpc-2582	72	13	,	,	PUNCT
dpc-2582	72	14	mean	mean	VERB
dpc-2582	72	15	,	,	PUNCT
dpc-2582	72	16	standard	standard	ADJ
dpc-2582	72	17	deviation	deviation	NOUN
dpc-2582	72	18	(	(	PUNCT
dpc-2582	72	19	sd	sd	NOUN
dpc-2582	72	20	)	)	PUNCT
dpc-2582	72	21	,	,	PUNCT
dpc-2582	72	22	minimum	minimum	NOUN
dpc-2582	72	23	  	  	SPACE
dpc-2582	72	24	(	(	PUNCT
dpc-2582	72	25	min	min	NOUN
dpc-2582	72	26	)	)	PUNCT
dpc-2582	72	27	,	,	PUNCT
dpc-2582	72	28	and	and	CCONJ
dpc-2582	72	29	maximum	maximum	ADJ
dpc-2582	72	30	(	(	PUNCT
dpc-2582	72	31	max	max	PROPN
dpc-2582	72	32	)	)	PUNCT
dpc-2582	72	33	and	and	CCONJ
dpc-2582	72	34	compared	compare	VERB
dpc-2582	72	35	between	between	ADP
dpc-2582	72	36	subgroups	subgroup	NOUN
dpc-2582	72	37	using	use	VERB
dpc-2582	72	38	unpaired	unpaired	ADJ
dpc-2582	72	39	student	student	NOUN
dpc-2582	72	40	’s	’s	PART
dpc-2582	72	41	t	t	PROPN
dpc-2582	72	42	-	-	PUNCT
dpc-2582	72	43	test	test	NOUN
dpc-2582	72	44	;	;	PUNCT
dpc-2582	72	45	categorical	categorical	ADJ
dpc-2582	72	46	variables	variable	NOUN
dpc-2582	72	47	were	be	AUX
dpc-2582	72	48	presented	present	VERB
dpc-2582	72	49	as	as	ADP
dpc-2582	72	50	frequency	frequency	NOUN
dpc-2582	72	51	(	(	PUNCT
dpc-2582	72	52	n	n	CCONJ
dpc-2582	72	53	,	,	PUNCT
dpc-2582	72	54	percentage	percentage	NOUN
dpc-2582	73	1	[	[	X
dpc-2582	73	2	%	%	X
dpc-2582	73	3	]	]	X
dpc-2582	73	4	)	)	PUNCT
dpc-2582	74	1	and	and	CCONJ
dpc-2582	74	2	compared	compare	VERB
dpc-2582	74	3	using	use	VERB
dpc-2582	74	4	pearson	pearson	PROPN
dpc-2582	74	5	’s	’s	PART
dpc-2582	74	6	chi‐squared	chi‐square	VERB
dpc-2582	74	7	test	test	NOUN
dpc-2582	74	8	.	.	PUNCT
dpc-2582	75	1	survival	survival	NOUN
dpc-2582	75	2	analysis	analysis	NOUN
dpc-2582	75	3	was	be	AUX
dpc-2582	75	4	performed	perform	VERB
dpc-2582	75	5	using	use	VERB
dpc-2582	75	6	the	the	DET
dpc-2582	75	7	kaplan	kaplan	PROPN
dpc-2582	75	8	-	-	PUNCT
dpc-2582	75	9	meier	meier	PROPN
dpc-2582	75	10	method	method	NOUN
dpc-2582	75	11	and	and	CCONJ
dpc-2582	75	12	comparison	comparison	NOUN
dpc-2582	75	13	between	between	ADP
dpc-2582	75	14	the	the	DET
dpc-2582	75	15	survival	survival	NOUN
dpc-2582	75	16	curves	curve	NOUN
dpc-2582	75	17	was	be	AUX
dpc-2582	75	18	done	do	VERB
dpc-2582	75	19	using	use	VERB
dpc-2582	75	20	log	log	NOUN
dpc-2582	75	21	-	-	PUNCT
dpc-2582	75	22	rank	rank	NOUN
dpc-2582	75	23	test	test	NOUN
dpc-2582	75	24	.	.	PUNCT
dpc-2582	76	1	univariate	univariate	ADJ
dpc-2582	76	2	and	and	CCONJ
dpc-2582	76	3	multivariate	multivariate	NOUN
dpc-2582	76	4	analyses	analysis	NOUN
dpc-2582	76	5	were	be	AUX
dpc-2582	76	6	done	do	VERB
dpc-2582	76	7	using	use	VERB
dpc-2582	76	8	the	the	DET
dpc-2582	76	9	cox	cox	NOUN
dpc-2582	76	10	-	-	PUNCT
dpc-2582	76	11	regression	regression	PROPN
dpc-2582	76	12	hazard	hazard	NOUN
dpc-2582	76	13	model	model	NOUN
dpc-2582	76	14	.	.	PUNCT
dpc-2582	77	1	data	datum	NOUN
dpc-2582	77	2	from	from	ADP
dpc-2582	77	3	the	the	DET
dpc-2582	77	4	univariate	univariate	ADJ
dpc-2582	77	5	and	and	CCONJ
dpc-2582	77	6	multivariate	multivariate	NOUN
dpc-2582	77	7	regression	regression	NOUN
dpc-2582	77	8	analyses	analysis	NOUN
dpc-2582	77	9	were	be	AUX
dpc-2582	77	10	expressed	express	VERB
dpc-2582	77	11	as	as	ADP
dpc-2582	77	12	hazard	hazard	NOUN
dpc-2582	77	13	ratio	ratio	NOUN
dpc-2582	77	14	(	(	PUNCT
dpc-2582	77	15	hr	hr	NOUN
dpc-2582	77	16	)	)	PUNCT
dpc-2582	77	17	with	with	ADP
dpc-2582	77	18	it	it	PRON
dpc-2582	77	19	95	95	NUM
dpc-2582	77	20	%	%	NOUN
dpc-2582	77	21	confidence	confidence	NOUN
dpc-2582	77	22	interval	interval	NOUN
dpc-2582	77	23	(	(	PUNCT
dpc-2582	77	24	ci	ci	NOUN
dpc-2582	77	25	)	)	PUNCT
dpc-2582	77	26	.	.	PUNCT
dpc-2582	78	1	a	a	DET
dpc-2582	78	2	p<0.05	p<0.05	NOUN
dpc-2582	78	3	was	be	AUX
dpc-2582	78	4	considered	consider	VERB
dpc-2582	78	5	statistically	statistically	ADV
dpc-2582	78	6	significant	significant	ADJ
dpc-2582	78	7	.	.	PUNCT
dpc-2582	79	1	results	result	NOUN
dpc-2582	79	2	demographic	demographic	ADJ
dpc-2582	79	3	,	,	PUNCT
dpc-2582	79	4	clinical	clinical	ADJ
dpc-2582	79	5	,	,	PUNCT
dpc-2582	79	6	and	and	CCONJ
dpc-2582	79	7	treatment	treatment	NOUN
dpc-2582	79	8	data	datum	NOUN
dpc-2582	79	9	among	among	ADP
dpc-2582	79	10	33	33	NUM
dpc-2582	79	11	patients	patient	NOUN
dpc-2582	79	12	with	with	ADP
dpc-2582	79	13	primary	primary	ADJ
dpc-2582	79	14	mucosal	mucosal	NOUN
dpc-2582	79	15	melanomas	melanomas	NOUN
dpc-2582	79	16	who	who	PRON
dpc-2582	79	17	were	be	AUX
dpc-2582	79	18	included	include	VERB
dpc-2582	79	19	in	in	ADP
dpc-2582	79	20	our	our	PRON
dpc-2582	79	21	analyses	analysis	NOUN
dpc-2582	79	22	,	,	PUNCT
dpc-2582	79	23	we	we	PRON
dpc-2582	79	24	found	find	VERB
dpc-2582	79	25	9	9	NUM
dpc-2582	79	26	melanomas	melanoma	NOUN
dpc-2582	79	27	of	of	ADP
dpc-2582	79	28	the	the	DET
dpc-2582	79	29	sinonasal	sinonasal	PROPN
dpc-2582	79	30	region	region	NOUN
dpc-2582	79	31	,	,	PUNCT
dpc-2582	79	32	13	13	NUM
dpc-2582	79	33	anorectal	anorectal	ADJ
dpc-2582	79	34	melanomas	melanomas	NOUN
dpc-2582	79	35	and	and	CCONJ
dpc-2582	79	36	11	11	NUM
dpc-2582	79	37	urogenital	urogenital	ADJ
dpc-2582	79	38	melanomas	melanomas	NOUN
dpc-2582	79	39	(	(	PUNCT
dpc-2582	79	40	of	of	ADP
dpc-2582	79	41	which	which	PRON
dpc-2582	79	42	10	10	NUM
dpc-2582	79	43	vulvovaginal	vulvovaginal	ADJ
dpc-2582	79	44	melanomas	melanoma	NOUN
dpc-2582	79	45	and	and	CCONJ
dpc-2582	79	46	1	1	NUM
dpc-2582	79	47	bladder	bladder	NOUN
dpc-2582	79	48	melanoma	melanoma	NOUN
dpc-2582	79	49	)	)	PUNCT
dpc-2582	79	50	,	,	PUNCT
dpc-2582	79	51	as	as	SCONJ
dpc-2582	79	52	reported	report	VERB
dpc-2582	79	53	in	in	ADP
dpc-2582	79	54	table	table	NOUN
dpc-2582	79	55	1	1	NUM
dpc-2582	79	56	and	and	CCONJ
dpc-2582	79	57	figure	figure	VERB
dpc-2582	79	58	1	1	NUM
dpc-2582	79	59	.	.	PUNCT
dpc-2582	80	1	median	median	ADJ
dpc-2582	80	2	age	age	NOUN
dpc-2582	80	3	at	at	ADP
dpc-2582	80	4	diagnosis	diagnosis	NOUN
dpc-2582	80	5	was	be	AUX
dpc-2582	80	6	82	82	NUM
dpc-2582	80	7	years	year	NOUN
dpc-2582	80	8	(	(	PUNCT
dpc-2582	80	9	75	75	NUM
dpc-2582	80	10	-	-	SYM
dpc-2582	80	11	83	83	NUM
dpc-2582	80	12	)	)	PUNCT
dpc-2582	80	13	,	,	PUNCT
dpc-2582	80	14	with	with	ADP
dpc-2582	80	15	no	no	DET
dpc-2582	80	16	substantial	substantial	ADJ
dpc-2582	80	17	differences	difference	NOUN
dpc-2582	80	18	by	by	ADP
dpc-2582	80	19	anatomical	anatomical	ADJ
dpc-2582	80	20	site	site	NOUN
dpc-2582	80	21	.	.	PUNCT
dpc-2582	81	1	more	more	ADJ
dpc-2582	81	2	women	woman	NOUN
dpc-2582	81	3	than	than	SCONJ
dpc-2582	81	4	men	man	NOUN
dpc-2582	81	5	had	have	VERB
dpc-2582	81	6	mucosal	mucosal	ADJ
dpc-2582	81	7	melanoma	melanoma	NOUN
dpc-2582	81	8	(	(	PUNCT
dpc-2582	81	9	n=	n=	ADJ
dpc-2582	81	10	22	22	NUM
dpc-2582	81	11	,	,	PUNCT
dpc-2582	81	12	66.7	66.7	NUM
dpc-2582	81	13	%	%	NOUN
dpc-2582	81	14	)	)	PUNCT
dpc-2582	81	15	.	.	PUNCT
dpc-2582	82	1	median	median	ADJ
dpc-2582	82	2	follow	follow	VERB
dpc-2582	82	3	-	-	PUNCT
dpc-2582	82	4	up	up	NOUN
dpc-2582	82	5	period	period	NOUN
dpc-2582	82	6	was	be	AUX
dpc-2582	82	7	11.5	11.5	NUM
dpc-2582	82	8	months	month	NOUN
dpc-2582	82	9	.	.	PUNCT
dpc-2582	83	1	presenting	present	VERB
dpc-2582	83	2	symptoms	symptom	NOUN
dpc-2582	83	3	for	for	ADP
dpc-2582	83	4	which	which	PRON
dpc-2582	83	5	physicians	physician	NOUN
dpc-2582	83	6	were	be	AUX
dpc-2582	83	7	consulted	consult	VERB
dpc-2582	83	8	by	by	ADP
dpc-2582	83	9	the	the	DET
dpc-2582	83	10	patient	patient	NOUN
dpc-2582	83	11	were	be	AUX
dpc-2582	83	12	recorded	record	VERB
dpc-2582	83	13	in	in	ADP
dpc-2582	83	14	table	table	NOUN
dpc-2582	83	15	2	2	NUM
dpc-2582	83	16	(	(	PUNCT
dpc-2582	83	17	in	in	ADP
dpc-2582	83	18	our	our	PRON
dpc-2582	83	19	series	series	NOUN
dpc-2582	83	20	dermatologists	dermatologist	NOUN
dpc-2582	83	21	,	,	PUNCT
dpc-2582	83	22	otolaryngologists	otolaryngologist	NOUN
dpc-2582	83	23	,	,	PUNCT
dpc-2582	83	24	gynecologists	gynecologist	NOUN
dpc-2582	83	25	,	,	PUNCT
dpc-2582	83	26	and	and	CCONJ
dpc-2582	83	27	endoscopists	endoscopist	NOUN
dpc-2582	83	28	)	)	PUNCT
dpc-2582	83	29	;	;	PUNCT
dpc-2582	83	30	most	most	ADJ
dpc-2582	83	31	patients	patient	NOUN
dpc-2582	83	32	were	be	AUX
dpc-2582	83	33	then	then	ADV
dpc-2582	83	34	managed	manage	VERB
dpc-2582	83	35	by	by	ADP
dpc-2582	83	36	the	the	DET
dpc-2582	83	37	skin	skin	NOUN
dpc-2582	83	38	cancer	cancer	NOUN
dpc-2582	83	39	tumor	tumor	PROPN
dpc-2582	83	40	board	board	PROPN
dpc-2582	83	41	.	.	PUNCT
dpc-2582	84	1	we	we	PRON
dpc-2582	84	2	observed	observe	VERB
dpc-2582	84	3	that	that	SCONJ
dpc-2582	84	4	18	18	NUM
dpc-2582	84	5	cases	case	NOUN
dpc-2582	84	6	of	of	ADP
dpc-2582	84	7	mucosal	mucosal	ADJ
dpc-2582	84	8	melanoma	melanoma	NOUN
dpc-2582	84	9	(	(	PUNCT
dpc-2582	84	10	54.5	54.5	NUM
dpc-2582	84	11	%	%	NOUN
dpc-2582	84	12	)	)	PUNCT
dpc-2582	84	13	out	out	ADP
dpc-2582	84	14	of	of	ADP
dpc-2582	84	15	33	33	NUM
dpc-2582	84	16	presented	present	VERB
dpc-2582	84	17	with	with	ADP
dpc-2582	84	18	metastasis	metastasis	PRON
dpc-2582	84	19	at	at	ADP
dpc-2582	84	20	diagnosis	diagnosis	NOUN
dpc-2582	84	21	(	(	PUNCT
dpc-2582	84	22	p<0.05	p<0.05	NOUN
dpc-2582	84	23	)	)	PUNCT
dpc-2582	84	24	and	and	CCONJ
dpc-2582	84	25	that	that	SCONJ
dpc-2582	84	26	91	91	NUM
dpc-2582	84	27	%	%	NOUN
dpc-2582	84	28	and	and	CCONJ
dpc-2582	84	29	66	66	NUM
dpc-2582	84	30	%	%	NOUN
dpc-2582	84	31	of	of	ADP
dpc-2582	84	32	patients	patient	NOUN
dpc-2582	84	33	with	with	ADP
dpc-2582	84	34	anorectal	anorectal	ADJ
dpc-2582	84	35	and	and	CCONJ
dpc-2582	84	36	sinonasal	sinonasal	ADJ
dpc-2582	84	37	melanomas	melanomas	PROPN
dpc-2582	84	38	had	have	VERB
dpc-2582	84	39	at	at	ADV
dpc-2582	84	40	least	least	ADV
dpc-2582	84	41	one	one	NUM
dpc-2582	84	42	metastatic	metastatic	ADJ
dpc-2582	84	43	site	site	NOUN
dpc-2582	84	44	at	at	ADP
dpc-2582	84	45	diagnosis	diagnosis	NOUN
dpc-2582	84	46	.	.	PUNCT
dpc-2582	85	1	in	in	ADP
dpc-2582	85	2	urogenital	urogenital	ADJ
dpc-2582	85	3	melanomas	melanoma	NOUN
dpc-2582	85	4	,	,	PUNCT
dpc-2582	85	5	4	4	NUM
dpc-2582	85	6	out	out	ADP
dpc-2582	85	7	of	of	ADP
dpc-2582	85	8	11	11	NUM
dpc-2582	85	9	(	(	PUNCT
dpc-2582	85	10	36.4	36.4	NUM
dpc-2582	85	11	%	%	NOUN
dpc-2582	85	12	)	)	PUNCT
dpc-2582	85	13	showed	show	VERB
dpc-2582	85	14	metastases	metastasis	NOUN
dpc-2582	85	15	which	which	PRON
dpc-2582	85	16	were	be	AUX
dpc-2582	85	17	all	all	PRON
dpc-2582	85	18	diagnosed	diagnose	VERB
dpc-2582	85	19	in	in	ADP
dpc-2582	85	20	locoregional	locoregional	ADJ
dpc-2582	85	21	lymph	lymph	NOUN
dpc-2582	85	22	nodes	node	NOUN
dpc-2582	85	23	(	(	PUNCT
dpc-2582	85	24	inguinofemoral	inguinofemoral	ADJ
dpc-2582	85	25	nodes	node	NOUN
dpc-2582	85	26	)	)	PUNCT
dpc-2582	85	27	and	and	CCONJ
dpc-2582	85	28	no	no	DET
dpc-2582	85	29	distant	distant	ADJ
dpc-2582	85	30	metastases	metastasis	NOUN
dpc-2582	85	31	.	.	PUNCT
dpc-2582	86	1	surgery	surgery	NOUN
dpc-2582	86	2	:	:	PUNCT
dpc-2582	86	3	clinical	clinical	ADJ
dpc-2582	86	4	records	record	NOUN
dpc-2582	86	5	reported	report	VERB
dpc-2582	86	6	that	that	SCONJ
dpc-2582	86	7	39.4	39.4	NUM
dpc-2582	86	8	%	%	NOUN
dpc-2582	86	9	of	of	ADP
dpc-2582	86	10	patients	patient	NOUN
dpc-2582	86	11	underwent	undergo	VERB
dpc-2582	86	12	surgical	surgical	ADJ
dpc-2582	86	13	treatment	treatment	NOUN
dpc-2582	86	14	(	(	PUNCT
dpc-2582	86	15	p<0.05	p<0.05	NOUN
dpc-2582	86	16	)	)	PUNCT
dpc-2582	86	17	.	.	PUNCT
dpc-2582	87	1	all	all	DET
dpc-2582	87	2	the	the	DET
dpc-2582	87	3	sinonasal	sinonasal	ADJ
dpc-2582	87	4	melanomas	melanomas	NOUN
dpc-2582	87	5	which	which	PRON
dpc-2582	87	6	were	be	AUX
dpc-2582	87	7	surgically	surgically	ADV
dpc-2582	87	8	managed	manage	VERB
dpc-2582	87	9	(	(	PUNCT
dpc-2582	87	10	44.4	44.4	NUM
dpc-2582	87	11	%	%	NOUN
dpc-2582	87	12	)	)	PUNCT
dpc-2582	87	13	underwent	undergo	VERB
dpc-2582	87	14	a	a	DET
dpc-2582	87	15	debulking	debulking	NOUN
dpc-2582	87	16	procedure	procedure	NOUN
dpc-2582	87	17	,	,	PUNCT
dpc-2582	87	18	while	while	SCONJ
dpc-2582	87	19	every	every	DET
dpc-2582	87	20	surgically	surgically	ADV
dpc-2582	87	21	managed	manage	VERB
dpc-2582	87	22	anorectal	anorectal	ADJ
dpc-2582	87	23	and	and	CCONJ
dpc-2582	87	24	urogenital	urogenital	ADJ
dpc-2582	87	25	melanoma	melanoma	NOUN
dpc-2582	87	26	had	have	VERB
dpc-2582	87	27	a	a	DET
dpc-2582	87	28	radical	radical	ADJ
dpc-2582	87	29	intent	intent	NOUN
dpc-2582	87	30	procedure	procedure	NOUN
dpc-2582	87	31	(	(	PUNCT
dpc-2582	87	32	30.8	30.8	NUM
dpc-2582	87	33	%	%	NOUN
dpc-2582	87	34	and	and	CCONJ
dpc-2582	87	35	45.5	45.5	NUM
dpc-2582	87	36	%	%	NOUN
dpc-2582	87	37	)	)	PUNCT
dpc-2582	87	38	.	.	PUNCT
dpc-2582	88	1	most	most	ADJ
dpc-2582	88	2	patients	patient	NOUN
dpc-2582	88	3	did	do	AUX
dpc-2582	88	4	not	not	PART
dpc-2582	88	5	undergo	undergo	VERB
dpc-2582	88	6	surgery	surgery	NOUN
dpc-2582	88	7	because	because	SCONJ
dpc-2582	88	8	of	of	ADP
dpc-2582	88	9	metastasis	metastasis	NOUN
dpc-2582	88	10	at	at	ADP
dpc-2582	88	11	diagnosis	diagnosis	NOUN
dpc-2582	88	12	(	(	PUNCT
dpc-2582	88	13	n=14	n=14	NOUN
dpc-2582	88	14	)	)	PUNCT
dpc-2582	88	15	,	,	PUNCT
dpc-2582	88	16	detection	detection	NOUN
dpc-2582	88	17	of	of	ADP
dpc-2582	88	18	different	different	ADJ
dpc-2582	88	19	neoplasia	neoplasia	NOUN
dpc-2582	88	20	at	at	ADP
dpc-2582	88	21	primary	primary	ADJ
dpc-2582	88	22	staging	staging	NOUN
dpc-2582	88	23	(	(	PUNCT
dpc-2582	88	24	n=2	n=2	ADV
dpc-2582	88	25	)	)	PUNCT
dpc-2582	88	26	,	,	PUNCT
dpc-2582	88	27	unresectable	unresectable	ADJ
dpc-2582	88	28	tumor	tumor	NOUN
dpc-2582	88	29	(	(	PUNCT
dpc-2582	88	30	n=3	n=3	NOUN
dpc-2582	88	31	)	)	PUNCT
dpc-2582	88	32	,	,	PUNCT
dpc-2582	88	33	age	age	NOUN
dpc-2582	88	34	of	of	ADP
dpc-2582	88	35	the	the	DET
dpc-2582	88	36	patient	patient	NOUN
dpc-2582	88	37	(	(	PUNCT
dpc-2582	88	38	n=1	n=1	PROPN
dpc-2582	88	39	)	)	PUNCT
dpc-2582	88	40	,	,	PUNCT
dpc-2582	88	41	death	death	NOUN
dpc-2582	88	42	of	of	ADP
dpc-2582	88	43	the	the	DET
dpc-2582	88	44	patient	patient	NOUN
dpc-2582	88	45	before	before	ADP
dpc-2582	88	46	surgery	surgery	NOUN
dpc-2582	88	47	(	(	PUNCT
dpc-2582	88	48	n=1	n=1	PROPN
dpc-2582	88	49	)	)	PUNCT
dpc-2582	88	50	.	.	PUNCT
dpc-2582	89	1	systemic	systemic	ADJ
dpc-2582	89	2	treatment	treatment	NOUN
dpc-2582	89	3	:	:	PUNCT
dpc-2582	89	4	we	we	PRON
dpc-2582	89	5	identified	identify	VERB
dpc-2582	89	6	15	15	NUM
dpc-2582	89	7	patients	patient	NOUN
dpc-2582	89	8	treated	treat	VERB
dpc-2582	89	9	with	with	ADP
dpc-2582	89	10	systemic	systemic	ADJ
dpc-2582	89	11	biological	biological	ADJ
dpc-2582	89	12	therapy	therapy	NOUN
dpc-2582	89	13	as	as	ADP
dpc-2582	89	14	first	first	ADJ
dpc-2582	89	15	-	-	PUNCT
dpc-2582	89	16	line	line	NOUN
dpc-2582	89	17	treatment	treatment	NOUN
dpc-2582	89	18	(	(	PUNCT
dpc-2582	89	19	p<0.05	p<0.05	NOUN
dpc-2582	89	20	)	)	PUNCT
dpc-2582	89	21	;	;	PUNCT
dpc-2582	89	22	13	13	NUM
dpc-2582	89	23	received	receive	VERB
dpc-2582	89	24	nivolumab	nivolumab	NOUN
dpc-2582	89	25	,	,	PUNCT
dpc-2582	89	26	2	2	NUM
dpc-2582	89	27	subjects	subject	NOUN
dpc-2582	89	28	were	be	AUX
dpc-2582	89	29	treated	treat	VERB
dpc-2582	89	30	with	with	ADP
dpc-2582	89	31	pembrolizumab	pembrolizumab	NOUN
dpc-2582	89	32	and	and	CCONJ
dpc-2582	89	33	1	1	NUM
dpc-2582	89	34	subject	subject	NOUN
dpc-2582	89	35	with	with	ADP
dpc-2582	89	36	imatinib	imatinib	NOUN
dpc-2582	89	37	.	.	PUNCT
dpc-2582	90	1	only	only	ADV
dpc-2582	90	2	1	1	NUM
dpc-2582	90	3	patient	patient	NOUN
dpc-2582	90	4	received	receive	VERB
dpc-2582	90	5	first	first	ADJ
dpc-2582	90	6	-	-	PUNCT
dpc-2582	90	7	line	line	NOUN
dpc-2582	90	8	chemotherapy	chemotherapy	NOUN
dpc-2582	90	9	(	(	PUNCT
dpc-2582	90	10	cyclophosphamide	cyclophosphamide	NOUN
dpc-2582	90	11	,	,	PUNCT
dpc-2582	90	12	vincristine	vincristine	NOUN
dpc-2582	90	13	,	,	PUNCT
dpc-2582	90	14	and	and	CCONJ
dpc-2582	90	15	dacarbazine	dacarbazine	NOUN
dpc-2582	90	16	combination	combination	NOUN
dpc-2582	90	17	treatment	treatment	NOUN
dpc-2582	90	18	)	)	PUNCT
dpc-2582	90	19	.	.	PUNCT
dpc-2582	91	1	furthermore	furthermore	ADV
dpc-2582	91	2	,	,	PUNCT
dpc-2582	91	3	5	5	NUM
dpc-2582	91	4	patients	patient	NOUN
dpc-2582	91	5	were	be	AUX
dpc-2582	91	6	switched	switch	VERB
dpc-2582	91	7	to	to	ADP
dpc-2582	91	8	a	a	DET
dpc-2582	91	9	second	second	ADJ
dpc-2582	91	10	-	-	PUNCT
dpc-2582	91	11	line	line	NOUN
dpc-2582	91	12	systemic	systemic	ADJ
dpc-2582	91	13	therapy	therapy	NOUN
dpc-2582	91	14	;	;	PUNCT
dpc-2582	91	15	3	3	NUM
dpc-2582	91	16	of	of	ADP
dpc-2582	91	17	them	they	PRON
dpc-2582	91	18	were	be	AUX
dpc-2582	91	19	switched	switch	VERB
dpc-2582	91	20	to	to	PART
dpc-2582	91	21	ipilimumab	ipilimumab	VERB
dpc-2582	91	22	,	,	PUNCT
dpc-2582	91	23	1	1	NUM
dpc-2582	91	24	to	to	PART
dpc-2582	91	25	pembrolizumab	pembrolizumab	NOUN
dpc-2582	91	26	and	and	CCONJ
dpc-2582	91	27	1	1	NUM
dpc-2582	91	28	to	to	ADP
dpc-2582	91	29	monotherapy	monotherapy	NOUN
dpc-2582	91	30	with	with	ADP
dpc-2582	91	31	dacarbazine	dacarbazine	NOUN
dpc-2582	91	32	.	.	PUNCT
dpc-2582	92	1	radiation	radiation	NOUN
dpc-2582	92	2	therapy	therapy	NOUN
dpc-2582	92	3	(	(	PUNCT
dpc-2582	92	4	rt	rt	PROPN
dpc-2582	92	5	):	):	PUNCT
dpc-2582	92	6	in	in	ADP
dpc-2582	92	7	our	our	PRON
dpc-2582	92	8	analysis	analysis	NOUN
dpc-2582	92	9	,	,	PUNCT
dpc-2582	92	10	rt	rt	PROPN
dpc-2582	92	11	on	on	ADP
dpc-2582	92	12	the	the	DET
dpc-2582	92	13	primary	primary	ADJ
dpc-2582	92	14	tumor	tumor	NOUN
dpc-2582	92	15	has	have	AUX
dpc-2582	92	16	always	always	ADV
dpc-2582	92	17	been	be	AUX
dpc-2582	92	18	proposed	propose	VERB
dpc-2582	92	19	as	as	ADP
dpc-2582	92	20	a	a	DET
dpc-2582	92	21	cytoreductive	cytoreductive	ADJ
dpc-2582	92	22	-	-	PUNCT
dpc-2582	92	23	palliative	palliative	NOUN
dpc-2582	92	24	treatment	treatment	NOUN
dpc-2582	92	25	;	;	PUNCT
dpc-2582	92	26	it	it	PRON
dpc-2582	92	27	was	be	AUX
dpc-2582	92	28	performed	perform	VERB
dpc-2582	92	29	in	in	ADP
dpc-2582	92	30	all	all	DET
dpc-2582	92	31	cases	case	NOUN
dpc-2582	92	32	of	of	ADP
dpc-2582	92	33	sinonasal	sinonasal	ADJ
dpc-2582	92	34	melanoma	melanoma	NOUN
dpc-2582	92	35	(	(	PUNCT
dpc-2582	92	36	p<0.05	p<0.05	NOUN
dpc-2582	92	37	)	)	PUNCT
dpc-2582	92	38	.	.	PUNCT
dpc-2582	93	1	anorectal	anorectal	ADJ
dpc-2582	93	2	melanomas	melanoma	NOUN
dpc-2582	93	3	were	be	AUX
dpc-2582	93	4	treated	treat	VERB
dpc-2582	93	5	with	with	ADP
dpc-2582	93	6	rt	rt	PROPN
dpc-2582	93	7	4	4	NUM
dpc-2582	93	8	original	original	ADJ
dpc-2582	93	9	article	article	NOUN
dpc-2582	93	10	|	|	ADV
dpc-2582	93	11	dermatol	dermatol	ADJ
dpc-2582	93	12	pract	pract	NOUN
dpc-2582	93	13	concept	concept	NOUN
dpc-2582	93	14	.	.	PUNCT
dpc-2582	94	1	2023;13(1):e2023057	2023;13(1):e2023057	NUM
dpc-2582	94	2	table	table	NOUN
dpc-2582	94	3	1	1	NUM
dpc-2582	94	4	.	.	PUNCT
dpc-2582	94	5	comparison	comparison	NOUN
dpc-2582	94	6	of	of	ADP
dpc-2582	94	7	demographic	demographic	ADJ
dpc-2582	94	8	,	,	PUNCT
dpc-2582	94	9	clinical	clinical	ADJ
dpc-2582	94	10	,	,	PUNCT
dpc-2582	94	11	and	and	CCONJ
dpc-2582	94	12	survival	survival	NOUN
dpc-2582	94	13	data	datum	NOUN
dpc-2582	94	14	in	in	ADP
dpc-2582	94	15	patients	patient	NOUN
dpc-2582	94	16	with	with	ADP
dpc-2582	94	17	mucosal	mucosal	NOUN
dpc-2582	94	18	melanomas	melanoma	NOUN
dpc-2582	94	19	and	and	CCONJ
dpc-2582	94	20	stratification	stratification	NOUN
dpc-2582	94	21	by	by	ADP
dpc-2582	94	22	the	the	DET
dpc-2582	94	23	site	site	NOUN
dpc-2582	94	24	of	of	ADP
dpc-2582	94	25	origin	origin	NOUN
dpc-2582	94	26	.	.	PUNCT
dpc-2582	95	1	mucosal	mucosal	ADJ
dpc-2582	95	2	melanomas	melanomas	NOUN
dpc-2582	95	3	(	(	PUNCT
dpc-2582	95	4	n=33	n=33	NOUN
dpc-2582	95	5	,	,	PUNCT
dpc-2582	95	6	100	100	NUM
dpc-2582	95	7	%	%	NOUN
dpc-2582	95	8	)	)	PUNCT
dpc-2582	95	9	sinunasal	sinunasal	NOUN
dpc-2582	95	10	(	(	PUNCT
dpc-2582	95	11	n=9	n=9	PROPN
dpc-2582	95	12	,	,	PUNCT
dpc-2582	95	13	27.3	27.3	NUM
dpc-2582	95	14	)	)	PUNCT
dpc-2582	95	15	anorectal	anorectal	ADJ
dpc-2582	95	16	(	(	PUNCT
dpc-2582	95	17	n=13	n=13	PROPN
dpc-2582	95	18	,	,	PUNCT
dpc-2582	95	19	39.4	39.4	NUM
dpc-2582	95	20	%	%	NOUN
dpc-2582	95	21	)	)	PUNCT
dpc-2582	96	1	urogenital	urogenital	PROPN
dpc-2582	96	2	(	(	PUNCT
dpc-2582	96	3	n=11	n=11	ADJ
dpc-2582	96	4	,	,	PUNCT
dpc-2582	96	5	33.3	33.3	NUM
dpc-2582	96	6	%	%	NOUN
dpc-2582	96	7	)	)	PUNCT
dpc-2582	96	8	p	p	X
dpc-2582	96	9	-	-	PUNCT
dpc-2582	96	10	value	value	NOUN
dpc-2582	96	11	age	age	NOUN
dpc-2582	96	12	at	at	ADP
dpc-2582	96	13	diagnosis	diagnosis	NOUN
dpc-2582	96	14	,	,	PUNCT
dpc-2582	96	15	median	median	NOUN
dpc-2582	96	16	(	(	PUNCT
dpc-2582	96	17	iqr	iqr	NOUN
dpc-2582	96	18	)	)	PUNCT
dpc-2582	96	19	82	82	NUM
dpc-2582	96	20	(	(	PUNCT
dpc-2582	96	21	75	75	NUM
dpc-2582	96	22	-	-	SYM
dpc-2582	96	23	85	85	NUM
dpc-2582	96	24	)	)	PUNCT
dpc-2582	96	25	82	82	NUM
dpc-2582	96	26	(	(	PUNCT
dpc-2582	96	27	75	75	NUM
dpc-2582	96	28	-	-	SYM
dpc-2582	96	29	83	83	NUM
dpc-2582	96	30	)	)	PUNCT
dpc-2582	96	31	80	80	NUM
dpc-2582	96	32	(	(	PUNCT
dpc-2582	96	33	72	72	NUM
dpc-2582	96	34	-	-	SYM
dpc-2582	96	35	87	87	NUM
dpc-2582	96	36	)	)	PUNCT
dpc-2582	96	37	83	83	NUM
dpc-2582	96	38	(	(	PUNCT
dpc-2582	96	39	80	80	NUM
dpc-2582	96	40	-	-	SYM
dpc-2582	96	41	85	85	NUM
dpc-2582	96	42	)	)	PUNCT
dpc-2582	96	43	0.977	0.977	NUM
dpc-2582	96	44	female	female	ADJ
dpc-2582	96	45	22	22	NUM
dpc-2582	96	46	(	(	PUNCT
dpc-2582	96	47	66.7	66.7	NUM
dpc-2582	96	48	)	)	PUNCT
dpc-2582	96	49	5	5	NUM
dpc-2582	96	50	(	(	PUNCT
dpc-2582	96	51	55,6	55,6	NUM
dpc-2582	96	52	)	)	PUNCT
dpc-2582	96	53	6	6	NUM
dpc-2582	96	54	(	(	PUNCT
dpc-2582	96	55	46,2	46,2	NUM
dpc-2582	96	56	)	)	PUNCT
dpc-2582	96	57	11	11	NUM
dpc-2582	96	58	(	(	PUNCT
dpc-2582	96	59	100	100	NUM
dpc-2582	96	60	)	)	PUNCT
dpc-2582	96	61	0.015	0.015	NUM
dpc-2582	96	62	metastasis	metastasis	NOUN
dpc-2582	96	63	at	at	ADP
dpc-2582	96	64	diagnosis	diagnosis	NOUN
dpc-2582	96	65	18	18	NUM
dpc-2582	96	66	(	(	PUNCT
dpc-2582	96	67	54.5	54.5	NUM
dpc-2582	96	68	)	)	PUNCT
dpc-2582	96	69	4	4	NUM
dpc-2582	96	70	(	(	PUNCT
dpc-2582	96	71	44,4	44,4	NUM
dpc-2582	96	72	)	)	PUNCT
dpc-2582	96	73	10	10	NUM
dpc-2582	96	74	(	(	PUNCT
dpc-2582	96	75	76.9	76.9	NUM
dpc-2582	96	76	)	)	PUNCT
dpc-2582	96	77	4	4	NUM
dpc-2582	96	78	(	(	PUNCT
dpc-2582	96	79	36.4	36.4	NUM
dpc-2582	96	80	)	)	PUNCT
dpc-2582	96	81	0.021	0.021	NUM
dpc-2582	96	82	regional	regional	ADJ
dpc-2582	96	83	lymph	lymph	NOUN
dpc-2582	96	84	nodes	nod	VERB
dpc-2582	96	85	8	8	NUM
dpc-2582	96	86	(	(	PUNCT
dpc-2582	96	87	24.2	24.2	NUM
dpc-2582	96	88	)	)	PUNCT
dpc-2582	96	89	0	0	NUM
dpc-2582	97	1	(	(	PUNCT
dpc-2582	97	2	0.0	0.0	NUM
dpc-2582	97	3	)	)	PUNCT
dpc-2582	97	4	4	4	NUM
dpc-2582	97	5	(	(	PUNCT
dpc-2582	97	6	30.8	30.8	NUM
dpc-2582	97	7	)	)	PUNCT
dpc-2582	97	8	4	4	NUM
dpc-2582	97	9	(	(	PUNCT
dpc-2582	97	10	36.4	36.4	NUM
dpc-2582	97	11	)	)	PUNCT
dpc-2582	97	12	visceral	visceral	ADJ
dpc-2582	97	13	4	4	NUM
dpc-2582	97	14	(	(	PUNCT
dpc-2582	97	15	12.1	12.1	NUM
dpc-2582	97	16	)	)	PUNCT
dpc-2582	97	17	3	3	NUM
dpc-2582	97	18	(	(	PUNCT
dpc-2582	97	19	33.3	33.3	NUM
dpc-2582	97	20	)	)	SYM
dpc-2582	97	21	1	1	NUM
dpc-2582	97	22	(	(	PUNCT
dpc-2582	97	23	7.7	7.7	NUM
dpc-2582	97	24	)	)	PUNCT
dpc-2582	97	25	0	0	NUM
dpc-2582	98	1	(	(	PUNCT
dpc-2582	98	2	0.0	0.0	NUM
dpc-2582	98	3	)	)	PUNCT
dpc-2582	98	4	cerebral	cerebral	ADJ
dpc-2582	98	5	2	2	NUM
dpc-2582	98	6	(	(	PUNCT
dpc-2582	98	7	6.1	6.1	NUM
dpc-2582	98	8	)	)	PUNCT
dpc-2582	98	9	0	0	NUM
dpc-2582	99	1	(	(	PUNCT
dpc-2582	99	2	0.0	0.0	NUM
dpc-2582	99	3	)	)	PUNCT
dpc-2582	99	4	2	2	NUM
dpc-2582	99	5	(	(	PUNCT
dpc-2582	99	6	15.4	15.4	NUM
dpc-2582	99	7	)	)	PUNCT
dpc-2582	99	8	0	0	NUM
dpc-2582	100	1	(	(	PUNCT
dpc-2582	100	2	0.0	0.0	NUM
dpc-2582	100	3	)	)	PUNCT
dpc-2582	100	4	≥2	≥2	PROPN
dpc-2582	100	5	sites	site	NOUN
dpc-2582	100	6	4	4	NUM
dpc-2582	100	7	(	(	PUNCT
dpc-2582	100	8	12.1	12.1	NUM
dpc-2582	100	9	)	)	PUNCT
dpc-2582	100	10	1	1	NUM
dpc-2582	100	11	(	(	PUNCT
dpc-2582	100	12	11,1	11,1	NUM
dpc-2582	100	13	)	)	PUNCT
dpc-2582	100	14	3	3	NUM
dpc-2582	100	15	(	(	PUNCT
dpc-2582	100	16	23.1	23.1	NUM
dpc-2582	100	17	)	)	PUNCT
dpc-2582	100	18	0	0	NUM
dpc-2582	101	1	(	(	PUNCT
dpc-2582	101	2	0.0	0.0	NUM
dpc-2582	101	3	)	)	PUNCT
dpc-2582	101	4	surgical	surgical	ADJ
dpc-2582	101	5	treatment	treatment	NOUN
dpc-2582	101	6	13	13	NUM
dpc-2582	101	7	(	(	PUNCT
dpc-2582	101	8	39.4	39.4	NUM
dpc-2582	101	9	)	)	PUNCT
dpc-2582	101	10	4	4	NUM
dpc-2582	101	11	(	(	PUNCT
dpc-2582	101	12	44.4	44.4	NUM
dpc-2582	101	13	)	)	PUNCT
dpc-2582	101	14	4	4	NUM
dpc-2582	101	15	(	(	PUNCT
dpc-2582	101	16	30.8	30.8	NUM
dpc-2582	101	17	)	)	SYM
dpc-2582	101	18	5	5	NUM
dpc-2582	101	19	(	(	PUNCT
dpc-2582	101	20	45.5	45.5	NUM
dpc-2582	101	21	)	)	PUNCT
dpc-2582	101	22	0.015debulking	0.015debulking	NOUN
dpc-2582	101	23	4	4	NUM
dpc-2582	101	24	(	(	PUNCT
dpc-2582	101	25	12.1	12.1	NUM
dpc-2582	101	26	)	)	PUNCT
dpc-2582	101	27	4	4	NUM
dpc-2582	101	28	(	(	PUNCT
dpc-2582	101	29	44.4	44.4	NUM
dpc-2582	101	30	)	)	PUNCT
dpc-2582	101	31	0	0	NUM
dpc-2582	101	32	(	(	PUNCT
dpc-2582	101	33	0.0	0.0	NUM
dpc-2582	101	34	)	)	PUNCT
dpc-2582	101	35	0	0	NUM
dpc-2582	102	1	(	(	PUNCT
dpc-2582	102	2	0.0	0.0	NUM
dpc-2582	102	3	)	)	PUNCT
dpc-2582	102	4	radical	radical	ADJ
dpc-2582	102	5	excision	excision	NOUN
dpc-2582	102	6	9	9	NUM
dpc-2582	102	7	(	(	PUNCT
dpc-2582	102	8	27.3	27.3	NUM
dpc-2582	102	9	)	)	PUNCT
dpc-2582	102	10	0	0	NUM
dpc-2582	102	11	(	(	PUNCT
dpc-2582	102	12	0.0	0.0	NUM
dpc-2582	102	13	)	)	PUNCT
dpc-2582	102	14	4	4	NUM
dpc-2582	102	15	(	(	PUNCT
dpc-2582	102	16	30.8	30.8	NUM
dpc-2582	102	17	)	)	SYM
dpc-2582	102	18	5	5	NUM
dpc-2582	102	19	(	(	PUNCT
dpc-2582	102	20	45.5	45.5	NUM
dpc-2582	102	21	)	)	PUNCT
dpc-2582	102	22	first	first	ADJ
dpc-2582	102	23	-	-	PUNCT
dpc-2582	102	24	line	line	NOUN
dpc-2582	102	25	biological	biological	ADJ
dpc-2582	102	26	therapy	therapy	NOUN
dpc-2582	102	27	17	17	NUM
dpc-2582	102	28	(	(	PUNCT
dpc-2582	102	29	51.5	51.5	NUM
dpc-2582	102	30	)	)	PUNCT
dpc-2582	102	31	5	5	NUM
dpc-2582	102	32	(	(	PUNCT
dpc-2582	102	33	55.5	55.5	NUM
dpc-2582	102	34	)	)	PUNCT
dpc-2582	102	35	6	6	NUM
dpc-2582	102	36	(	(	PUNCT
dpc-2582	102	37	46.2	46.2	NUM
dpc-2582	102	38	)	)	SYM
dpc-2582	102	39	5	5	NUM
dpc-2582	102	40	(	(	PUNCT
dpc-2582	102	41	45.5	45.5	NUM
dpc-2582	102	42	)	)	PUNCT
dpc-2582	102	43	0.005	0.005	NUM
dpc-2582	102	44	nivolumab	nivolumab	ADP
dpc-2582	102	45	13	13	NUM
dpc-2582	102	46	(	(	PUNCT
dpc-2582	102	47	39.4	39.4	NUM
dpc-2582	102	48	)	)	PUNCT
dpc-2582	102	49	4	4	NUM
dpc-2582	102	50	(	(	PUNCT
dpc-2582	102	51	44.4	44.4	NUM
dpc-2582	102	52	)	)	PUNCT
dpc-2582	102	53	4	4	NUM
dpc-2582	102	54	(	(	PUNCT
dpc-2582	102	55	30.8	30.8	NUM
dpc-2582	102	56	)	)	SYM
dpc-2582	102	57	5	5	NUM
dpc-2582	102	58	(	(	PUNCT
dpc-2582	102	59	45.5	45.5	NUM
dpc-2582	102	60	)	)	PUNCT
dpc-2582	102	61	pembrolizumab	pembrolizumab	NOUN
dpc-2582	102	62	2	2	NUM
dpc-2582	102	63	(	(	PUNCT
dpc-2582	102	64	6.1	6.1	NUM
dpc-2582	102	65	)	)	PUNCT
dpc-2582	102	66	1	1	NUM
dpc-2582	102	67	(	(	PUNCT
dpc-2582	102	68	11.1	11.1	NUM
dpc-2582	102	69	)	)	SYM
dpc-2582	102	70	1	1	NUM
dpc-2582	102	71	(	(	PUNCT
dpc-2582	102	72	7.7	7.7	NUM
dpc-2582	102	73	)	)	PUNCT
dpc-2582	102	74	0	0	NUM
dpc-2582	103	1	(	(	PUNCT
dpc-2582	103	2	0.0	0.0	NUM
dpc-2582	103	3	)	)	PUNCT
dpc-2582	103	4	imatinib	imatinib	NOUN
dpc-2582	103	5	1	1	NUM
dpc-2582	103	6	(	(	PUNCT
dpc-2582	103	7	3.0	3.0	NUM
dpc-2582	103	8	)	)	PUNCT
dpc-2582	103	9	0	0	NUM
dpc-2582	104	1	(	(	PUNCT
dpc-2582	104	2	0.0	0.0	NUM
dpc-2582	104	3	)	)	PUNCT
dpc-2582	104	4	1	1	NUM
dpc-2582	104	5	(	(	PUNCT
dpc-2582	104	6	7.7	7.7	NUM
dpc-2582	104	7	)	)	PUNCT
dpc-2582	104	8	0	0	NUM
dpc-2582	105	1	(	(	PUNCT
dpc-2582	105	2	0.0	0.0	NUM
dpc-2582	105	3	)	)	PUNCT
dpc-2582	105	4	first	first	ADJ
dpc-2582	105	5	-	-	PUNCT
dpc-2582	105	6	line	line	NOUN
dpc-2582	105	7	chemotherapy	chemotherapy	NOUN
dpc-2582	105	8	1	1	NUM
dpc-2582	105	9	(	(	PUNCT
dpc-2582	105	10	3.0	3.0	NUM
dpc-2582	105	11	)	)	SYM
dpc-2582	105	12	1	1	NUM
dpc-2582	105	13	(	(	PUNCT
dpc-2582	105	14	11.1	11.1	NUM
dpc-2582	105	15	)	)	PUNCT
dpc-2582	105	16	0	0	NUM
dpc-2582	105	17	(	(	PUNCT
dpc-2582	105	18	0.0	0.0	NUM
dpc-2582	105	19	)	)	PUNCT
dpc-2582	105	20	0	0	NUM
dpc-2582	105	21	(	(	PUNCT
dpc-2582	105	22	0.0	0.0	NUM
dpc-2582	105	23	)	)	PUNCT
dpc-2582	105	24	0.253	0.253	NUM
dpc-2582	105	25	second	second	ADJ
dpc-2582	105	26	-	-	PUNCT
dpc-2582	105	27	line	line	NOUN
dpc-2582	105	28	systemic	systemic	ADJ
dpc-2582	105	29	therapy	therapy	NOUN
dpc-2582	105	30	5	5	NUM
dpc-2582	105	31	(	(	PUNCT
dpc-2582	105	32	15.1	15.1	NUM
dpc-2582	105	33	)	)	PUNCT
dpc-2582	105	34	2	2	NUM
dpc-2582	105	35	(	(	PUNCT
dpc-2582	105	36	22.2	22.2	NUM
dpc-2582	105	37	)	)	SYM
dpc-2582	105	38	2	2	NUM
dpc-2582	105	39	(	(	PUNCT
dpc-2582	105	40	15.4	15.4	NUM
dpc-2582	105	41	)	)	PUNCT
dpc-2582	105	42	1	1	NUM
dpc-2582	105	43	(	(	PUNCT
dpc-2582	105	44	9.1	9.1	NUM
dpc-2582	105	45	)	)	PUNCT
dpc-2582	105	46	0.383	0.383	NUM
dpc-2582	105	47	ipilimumab	ipilimumab	VERB
dpc-2582	105	48	3	3	NUM
dpc-2582	105	49	(	(	PUNCT
dpc-2582	105	50	9.1	9.1	NUM
dpc-2582	105	51	)	)	SYM
dpc-2582	105	52	2	2	NUM
dpc-2582	105	53	(	(	PUNCT
dpc-2582	105	54	22.2	22.2	NUM
dpc-2582	105	55	)	)	PUNCT
dpc-2582	105	56	1	1	NUM
dpc-2582	105	57	(	(	PUNCT
dpc-2582	105	58	7.7	7.7	NUM
dpc-2582	105	59	)	)	PUNCT
dpc-2582	105	60	0	0	NUM
dpc-2582	106	1	(	(	PUNCT
dpc-2582	106	2	0.0	0.0	NUM
dpc-2582	106	3	)	)	PUNCT
dpc-2582	106	4	pembrolizumab	pembrolizumab	NOUN
dpc-2582	106	5	1	1	NUM
dpc-2582	106	6	(	(	PUNCT
dpc-2582	106	7	3.0	3.0	NUM
dpc-2582	106	8	)	)	PUNCT
dpc-2582	106	9	0	0	NUM
dpc-2582	107	1	(	(	PUNCT
dpc-2582	107	2	0.0	0.0	NUM
dpc-2582	107	3	)	)	PUNCT
dpc-2582	107	4	1	1	NUM
dpc-2582	107	5	(	(	PUNCT
dpc-2582	107	6	7.7	7.7	NUM
dpc-2582	107	7	)	)	PUNCT
dpc-2582	107	8	0	0	NUM
dpc-2582	108	1	(	(	PUNCT
dpc-2582	108	2	0.0	0.0	NUM
dpc-2582	108	3	)	)	PUNCT
dpc-2582	108	4	dacarbazine	dacarbazine	NOUN
dpc-2582	108	5	1	1	NUM
dpc-2582	108	6	(	(	PUNCT
dpc-2582	108	7	3.0	3.0	NUM
dpc-2582	108	8	)	)	PUNCT
dpc-2582	108	9	0	0	NUM
dpc-2582	108	10	(	(	PUNCT
dpc-2582	108	11	0.0	0.0	NUM
dpc-2582	108	12	)	)	PUNCT
dpc-2582	108	13	0	0	NUM
dpc-2582	109	1	(	(	PUNCT
dpc-2582	109	2	0.0	0.0	NUM
dpc-2582	109	3	)	)	PUNCT
dpc-2582	109	4	1	1	NUM
dpc-2582	109	5	(	(	PUNCT
dpc-2582	109	6	9.1	9.1	NUM
dpc-2582	109	7	)	)	PUNCT
dpc-2582	109	8	radiation	radiation	NOUN
dpc-2582	109	9	therapy	therapy	NOUN
dpc-2582	109	10	on	on	ADP
dpc-2582	109	11	the	the	DET
dpc-2582	109	12	primary	primary	ADJ
dpc-2582	109	13	tumor	tumor	NOUN
dpc-2582	109	14	17	17	NUM
dpc-2582	109	15	(	(	PUNCT
dpc-2582	109	16	51.5	51.5	NUM
dpc-2582	109	17	)	)	PUNCT
dpc-2582	109	18	9	9	NUM
dpc-2582	109	19	(	(	PUNCT
dpc-2582	109	20	100	100	NUM
dpc-2582	109	21	)	)	PUNCT
dpc-2582	109	22	6	6	NUM
dpc-2582	109	23	(	(	PUNCT
dpc-2582	109	24	46.2	46.2	NUM
dpc-2582	109	25	)	)	SYM
dpc-2582	109	26	2	2	NUM
dpc-2582	109	27	(	(	PUNCT
dpc-2582	109	28	18.2	18.2	NUM
dpc-2582	109	29	)	)	PUNCT
dpc-2582	109	30	0.004	0.004	NUM
dpc-2582	109	31	overall	overall	ADJ
dpc-2582	109	32	survival	survival	NOUN
dpc-2582	109	33	,	,	PUNCT
dpc-2582	109	34	median	median	PROPN
dpc-2582	109	35	(	(	PUNCT
dpc-2582	109	36	iqr	iqr	NOUN
dpc-2582	109	37	)	)	PUNCT
dpc-2582	109	38	months	month	NOUN
dpc-2582	109	39	11	11	NUM
dpc-2582	109	40	(	(	PUNCT
dpc-2582	109	41	6	6	NUM
dpc-2582	109	42	-	-	SYM
dpc-2582	109	43	25	25	NUM
dpc-2582	109	44	)	)	PUNCT
dpc-2582	109	45	14	14	NUM
dpc-2582	109	46	(	(	PUNCT
dpc-2582	109	47	6	6	NUM
dpc-2582	109	48	-	-	SYM
dpc-2582	109	49	22	22	NUM
dpc-2582	109	50	)	)	PUNCT
dpc-2582	109	51	6	6	NUM
dpc-2582	109	52	(	(	PUNCT
dpc-2582	109	53	2	2	NUM
dpc-2582	109	54	-	-	SYM
dpc-2582	109	55	11	11	NUM
dpc-2582	109	56	)	)	PUNCT
dpc-2582	109	57	26	26	NUM
dpc-2582	109	58	(	(	PUNCT
dpc-2582	109	59	11	11	NUM
dpc-2582	109	60	-	-	SYM
dpc-2582	109	61	34	34	NUM
dpc-2582	109	62	)	)	PUNCT
dpc-2582	109	63	0.021	0.021	NUM
dpc-2582	109	64	overall	overall	ADJ
dpc-2582	109	65	survival	survival	NOUN
dpc-2582	109	66	rate%	rate%	VERB
dpc-2582	109	67	,	,	PUNCT
dpc-2582	109	68	12	12	NUM
dpc-2582	109	69	months	month	NOUN
dpc-2582	109	70	71	71	NUM
dpc-2582	109	71	55	55	NUM
dpc-2582	109	72	54	54	NUM
dpc-2582	109	73	100	100	NUM
dpc-2582	109	74	overall	overall	ADJ
dpc-2582	109	75	survival	survival	NOUN
dpc-2582	109	76	rate%	rate%	VERB
dpc-2582	109	77	,	,	PUNCT
dpc-2582	109	78	12	12	NUM
dpc-2582	109	79	months	month	NOUN
dpc-2582	109	80	54	54	NUM
dpc-2582	109	81	37	37	NUM
dpc-2582	109	82	18	18	NUM
dpc-2582	109	83	100	100	NUM
dpc-2582	109	84	median	median	ADJ
dpc-2582	109	85	follow	follow	NOUN
dpc-2582	109	86	-	-	PUNCT
dpc-2582	109	87	up	up	NOUN
dpc-2582	109	88	period	period	NOUN
dpc-2582	109	89	(	(	PUNCT
dpc-2582	109	90	months	month	NOUN
dpc-2582	109	91	)	)	PUNCT
dpc-2582	109	92	11.5	11.5	NUM
dpc-2582	109	93	iqr	iqr	NOUN
dpc-2582	109	94	:	:	PUNCT
dpc-2582	109	95	interquartile	interquartile	NOUN
dpc-2582	109	96	range	range	NOUN
dpc-2582	109	97	mucosal	mucosal	ADJ
dpc-2582	109	98	melanoma	melanoma	NOUN
dpc-2582	109	99	n=33	n=33	NOUN
dpc-2582	109	100	sinonasal	sinonasal	VERB
dpc-2582	109	101	melanoma	melanoma	NOUN
dpc-2582	109	102	n=9	n=9	NOUN
dpc-2582	109	103	(	(	PUNCT
dpc-2582	109	104	27.3	27.3	NUM
dpc-2582	109	105	%	%	NOUN
dpc-2582	109	106	)	)	PUNCT
dpc-2582	109	107	anorectal	anorectal	ADJ
dpc-2582	109	108	melanoma	melanoma	NOUN
dpc-2582	109	109	n=13	n=13	X
dpc-2582	109	110	(	(	PUNCT
dpc-2582	109	111	39.4	39.4	NUM
dpc-2582	109	112	%	%	NOUN
dpc-2582	109	113	)	)	PUNCT
dpc-2582	109	114	urogenital	urogenital	ADJ
dpc-2582	109	115	melanoma	melanoma	NOUN
dpc-2582	109	116	n=11	n=11	NOUN
dpc-2582	109	117	(	(	PUNCT
dpc-2582	109	118	33.3	33.3	NUM
dpc-2582	109	119	%	%	NOUN
dpc-2582	109	120	)	)	PUNCT
dpc-2582	109	121	figure	figure	NOUN
dpc-2582	109	122	1	1	NUM
dpc-2582	109	123	.	.	PUNCT
dpc-2582	110	1	flow	flow	NOUN
dpc-2582	110	2	diagram	diagram	NOUN
dpc-2582	110	3	showing	show	VERB
dpc-2582	110	4	mucosal	mucosal	ADJ
dpc-2582	110	5	melanoma	melanoma	NOUN
dpc-2582	110	6	subdivided	subdivide	VERB
dpc-2582	110	7	by	by	ADP
dpc-2582	110	8	anatomical	anatomical	ADJ
dpc-2582	110	9	site	site	NOUN
dpc-2582	110	10	of	of	ADP
dpc-2582	110	11	origin	origin	NOUN
dpc-2582	110	12	.	.	PUNCT
dpc-2582	111	1	table	table	NOUN
dpc-2582	111	2	2	2	NUM
dpc-2582	111	3	.	.	PUNCT
dpc-2582	111	4	presenting	present	VERB
dpc-2582	111	5	symptoms	symptom	NOUN
dpc-2582	111	6	of	of	ADP
dpc-2582	111	7	mucosal	mucosal	ADJ
dpc-2582	111	8	melanoma	melanoma	NOUN
dpc-2582	111	9	by	by	ADP
dpc-2582	111	10	anatomical	anatomical	ADJ
dpc-2582	111	11	region	region	NOUN
dpc-2582	111	12	.	.	PUNCT
dpc-2582	112	1	presenting	present	VERB
dpc-2582	112	2	symptoms	symptom	NOUN
dpc-2582	112	3	(	(	PUNCT
dpc-2582	112	4	n	n	CCONJ
dpc-2582	112	5	)	)	PUNCT
dpc-2582	112	6	site	site	NOUN
dpc-2582	112	7	of	of	ADP
dpc-2582	112	8	primary	primary	ADJ
dpc-2582	112	9	melanoma	melanoma	NOUN
dpc-2582	112	10	sinonasal	sinonasal	ADJ
dpc-2582	112	11	epistaxis	epistaxis	ADJ
dpc-2582	112	12	(	(	PUNCT
dpc-2582	112	13	2	2	NUM
dpc-2582	112	14	)	)	PUNCT
dpc-2582	112	15	,	,	PUNCT
dpc-2582	112	16	nasal	nasal	NOUN
dpc-2582	112	17	obstruction	obstruction	NOUN
dpc-2582	112	18	(	(	PUNCT
dpc-2582	112	19	2	2	NUM
dpc-2582	112	20	)	)	PUNCT
dpc-2582	112	21	,	,	PUNCT
dpc-2582	112	22	eyelid	eyelid	NOUN
dpc-2582	112	23	ptosis	ptosis	NOUN
dpc-2582	112	24	(	(	PUNCT
dpc-2582	112	25	1	1	X
dpc-2582	112	26	)	)	PUNCT
dpc-2582	112	27	anorectal	anorectal	ADJ
dpc-2582	112	28	rectorrhagia	rectorrhagia	NOUN
dpc-2582	112	29	(	(	PUNCT
dpc-2582	112	30	4	4	NUM
dpc-2582	112	31	)	)	PUNCT
dpc-2582	112	32	,	,	PUNCT
dpc-2582	112	33	tumor	tumor	NOUN
dpc-2582	112	34	mass	mass	NOUN
dpc-2582	112	35	prolapse	prolapse	NOUN
dpc-2582	112	36	(	(	PUNCT
dpc-2582	112	37	2	2	NUM
dpc-2582	112	38	)	)	PUNCT
dpc-2582	112	39	,	,	PUNCT
dpc-2582	112	40	anemia	anemia	NOUN
dpc-2582	112	41	(	(	PUNCT
dpc-2582	112	42	2	2	NUM
dpc-2582	112	43	)	)	PUNCT
dpc-2582	112	44	urogenital	urogenital	ADJ
dpc-2582	112	45	tumor	tumor	NOUN
dpc-2582	112	46	mass	mass	NOUN
dpc-2582	112	47	(	(	PUNCT
dpc-2582	112	48	6	6	NUM
dpc-2582	112	49	)	)	PUNCT
dpc-2582	112	50	,	,	PUNCT
dpc-2582	112	51	pigmentation	pigmentation	NOUN
dpc-2582	112	52	of	of	ADP
dpc-2582	112	53	external	external	ADJ
dpc-2582	112	54	genitalia	genitalia	NOUN
dpc-2582	112	55	(	(	PUNCT
dpc-2582	112	56	1	1	NUM
dpc-2582	112	57	)	)	PUNCT
dpc-2582	112	58	,	,	PUNCT
dpc-2582	112	59	vaginal	vaginal	ADJ
dpc-2582	112	60	bleeding	bleeding	NOUN
dpc-2582	112	61	(	(	PUNCT
dpc-2582	112	62	1	1	NUM
dpc-2582	112	63	)	)	PUNCT
dpc-2582	112	64	n=	n=	ADJ
dpc-2582	112	65	number(s	number(s	ADJ
dpc-2582	112	66	)	)	PUNCT
dpc-2582	112	67	original	original	ADJ
dpc-2582	112	68	article	article	NOUN
dpc-2582	112	69	|	|	ADV
dpc-2582	112	70	dermatol	dermatol	ADJ
dpc-2582	112	71	pract	pract	NOUN
dpc-2582	112	72	concept	concept	NOUN
dpc-2582	112	73	.	.	PUNCT
dpc-2582	113	1	2023;13(1):e2023057	2023;13(1):e2023057	NUM
dpc-2582	113	2	5	5	NUM
dpc-2582	113	3	cavities	cavity	NOUN
dpc-2582	113	4	,	,	PUNCT
dpc-2582	113	5	melanocytes	melanocyte	NOUN
dpc-2582	113	6	can	can	AUX
dpc-2582	113	7	be	be	AUX
dpc-2582	113	8	found	find	VERB
dpc-2582	113	9	both	both	PRON
dpc-2582	113	10	in	in	ADP
dpc-2582	113	11	the	the	DET
dpc-2582	113	12	epithelium	epithelium	NOUN
dpc-2582	113	13	and	and	CCONJ
dpc-2582	113	14	in	in	ADP
dpc-2582	113	15	the	the	DET
dpc-2582	113	16	stroma	stroma	NOUN
dpc-2582	113	17	,	,	PUNCT
dpc-2582	113	18	mainly	mainly	ADV
dpc-2582	113	19	in	in	ADP
dpc-2582	113	20	the	the	DET
dpc-2582	113	21	dark	dark	ADJ
dpc-2582	113	22	-	-	PUNCT
dpc-2582	113	23	skinned	skinned	ADJ
dpc-2582	113	24	population	population	NOUN
dpc-2582	113	25	.	.	PUNCT
dpc-2582	114	1	delayed	delay	VERB
dpc-2582	114	2	site	site	NOUN
dpc-2582	114	3	-	-	PUNCT
dpc-2582	114	4	related	relate	VERB
dpc-2582	114	5	detection	detection	NOUN
dpc-2582	114	6	of	of	ADP
dpc-2582	114	7	these	these	DET
dpc-2582	114	8	melanomas	melanomas	NOUN
dpc-2582	114	9	can	can	AUX
dpc-2582	114	10	explain	explain	VERB
dpc-2582	114	11	their	their	PRON
dpc-2582	114	12	architecture	architecture	NOUN
dpc-2582	114	13	,	,	PUNCT
dpc-2582	114	14	which	which	PRON
dpc-2582	114	15	is	be	AUX
dpc-2582	114	16	often	often	ADV
dpc-2582	114	17	nodular	nodular	ADJ
dpc-2582	114	18	or	or	CCONJ
dpc-2582	114	19	polypoid	polypoid	ADJ
dpc-2582	114	20	,	,	PUNCT
dpc-2582	114	21	and	and	CCONJ
dpc-2582	114	22	,	,	PUNCT
dpc-2582	114	23	at	at	ADP
dpc-2582	114	24	the	the	DET
dpc-2582	114	25	same	same	ADJ
dpc-2582	114	26	time	time	NOUN
dpc-2582	114	27	,	,	PUNCT
dpc-2582	114	28	their	their	PRON
dpc-2582	114	29	thickness	thickness	NOUN
dpc-2582	114	30	,	,	PUNCT
dpc-2582	114	31	which	which	PRON
dpc-2582	114	32	is	be	AUX
dpc-2582	114	33	usually	usually	ADV
dpc-2582	114	34	higher	high	ADJ
dpc-2582	114	35	than	than	ADP
dpc-2582	114	36	most	most	ADJ
dpc-2582	114	37	cutaneous	cutaneous	ADJ
dpc-2582	114	38	melanomas	melanoma	NOUN
dpc-2582	114	39	.	.	PUNCT
dpc-2582	115	1	most	most	ADJ
dpc-2582	115	2	mucosal	mucosal	ADJ
dpc-2582	115	3	melanomas	melanoma	NOUN
dpc-2582	115	4	are	be	AUX
dpc-2582	115	5	often	often	ADV
dpc-2582	115	6	associated	associate	VERB
dpc-2582	115	7	with	with	ADP
dpc-2582	115	8	an	an	DET
dpc-2582	115	9	in	in	ADP
dpc-2582	115	10	situ	situ	ADJ
dpc-2582	115	11	lateral	lateral	ADJ
dpc-2582	115	12	spread	spread	NOUN
dpc-2582	115	13	on	on	ADP
dpc-2582	115	14	the	the	DET
dpc-2582	115	15	mucosal	mucosal	NOUN
dpc-2582	115	16	surface	surface	NOUN
dpc-2582	115	17	(	(	PUNCT
dpc-2582	115	18	figure	figure	NOUN
dpc-2582	115	19	3	3	NUM
dpc-2582	115	20	)	)	PUNCT
dpc-2582	115	21	,	,	PUNCT
dpc-2582	115	22	which	which	PRON
dpc-2582	115	23	is	be	AUX
dpc-2582	115	24	a	a	DET
dpc-2582	115	25	supportive	supportive	ADJ
dpc-2582	115	26	feature	feature	NOUN
dpc-2582	115	27	that	that	PRON
dpc-2582	115	28	the	the	DET
dpc-2582	115	29	tumor	tumor	NOUN
dpc-2582	115	30	is	be	AUX
dpc-2582	115	31	primitive	primitive	ADJ
dpc-2582	115	32	.	.	PUNCT
dpc-2582	116	1	cytologically	cytologically	ADV
dpc-2582	116	2	,	,	PUNCT
dpc-2582	116	3	mucosal	mucosal	ADJ
dpc-2582	116	4	melanomas	melanoma	NOUN
dpc-2582	116	5	are	be	AUX
dpc-2582	116	6	remarkably	remarkably	ADV
dpc-2582	116	7	variable	variable	ADJ
dpc-2582	116	8	;	;	PUNCT
dpc-2582	116	9	neoplastic	neoplastic	ADJ
dpc-2582	116	10	cells	cell	NOUN
dpc-2582	116	11	can	can	AUX
dpc-2582	116	12	be	be	AUX
dpc-2582	116	13	spindle	spindle	NOUN
dpc-2582	116	14	,	,	PUNCT
dpc-2582	116	15	rhabdoid	rhabdoid	NOUN
dpc-2582	116	16	,	,	PUNCT
dpc-2582	116	17	epithelioid	epithelioid	NOUN
dpc-2582	116	18	,	,	PUNCT
dpc-2582	116	19	small	small	ADJ
dpc-2582	116	20	,	,	PUNCT
dpc-2582	116	21	or	or	CCONJ
dpc-2582	116	22	giant	giant	ADJ
dpc-2582	116	23	pleomorphic	pleomorphic	ADJ
dpc-2582	116	24	(	(	PUNCT
dpc-2582	116	25	often	often	ADV
dpc-2582	116	26	multinucleated	multinucleate	VERB
dpc-2582	116	27	)	)	PUNCT
dpc-2582	116	28	,	,	PUNCT
dpc-2582	116	29	thus	thus	ADV
dpc-2582	116	30	causing	cause	VERB
dpc-2582	116	31	challenging	challenging	ADJ
dpc-2582	116	32	diagnostic	diagnostic	ADJ
dpc-2582	116	33	problems	problem	NOUN
dpc-2582	116	34	in	in	ADP
dpc-2582	116	35	differentiating	differentiate	VERB
dpc-2582	116	36	them	they	PRON
dpc-2582	116	37	from	from	ADP
dpc-2582	116	38	lymphomas	lymphoma	NOUN
dpc-2582	116	39	,	,	PUNCT
dpc-2582	116	40	carcinomas	carcinoma	NOUN
dpc-2582	116	41	or	or	CCONJ
dpc-2582	116	42	sarcomas	sarcoma	NOUN
dpc-2582	116	43	.	.	PUNCT
dpc-2582	117	1	necrotic	necrotic	ADJ
dpc-2582	117	2	areas	area	NOUN
dpc-2582	117	3	are	be	AUX
dpc-2582	117	4	frequent	frequent	ADJ
dpc-2582	117	5	and	and	CCONJ
dpc-2582	117	6	mitotic	mitotic	ADJ
dpc-2582	117	7	activity	activity	NOUN
dpc-2582	117	8	is	be	AUX
dpc-2582	117	9	usually	usually	ADV
dpc-2582	117	10	high	high	ADJ
dpc-2582	117	11	(	(	PUNCT
dpc-2582	117	12	figure	figure	NOUN
dpc-2582	117	13	4	4	NUM
dpc-2582	117	14	)	)	PUNCT
dpc-2582	117	15	.	.	PUNCT
dpc-2582	118	1	due	due	ADP
dpc-2582	118	2	to	to	ADP
dpc-2582	118	3	their	their	PRON
dpc-2582	118	4	heterogeneous	heterogeneous	ADJ
dpc-2582	118	5	appearance	appearance	NOUN
dpc-2582	118	6	,	,	PUNCT
dpc-2582	118	7	immunohistochemical	immunohistochemical	ADJ
dpc-2582	118	8	staining	stain	VERB
dpc-2582	118	9	(	(	PUNCT
dpc-2582	118	10	s100	s100	PROPN
dpc-2582	118	11	,	,	PUNCT
dpc-2582	118	12	mart-1	mart-1	PROPN
dpc-2582	118	13	,	,	PUNCT
dpc-2582	118	14	hmb45	hmb45	PROPN
dpc-2582	118	15	or	or	CCONJ
dpc-2582	118	16	sox10	sox10	NOUN
dpc-2582	118	17	)	)	PUNCT
dpc-2582	118	18	is	be	AUX
dpc-2582	118	19	often	often	ADV
dpc-2582	118	20	required	require	VERB
dpc-2582	118	21	to	to	PART
dpc-2582	118	22	demonstrate	demonstrate	VERB
dpc-2582	118	23	the	the	DET
dpc-2582	118	24	melanocytic	melanocytic	ADJ
dpc-2582	118	25	origin	origin	NOUN
dpc-2582	118	26	of	of	ADP
dpc-2582	118	27	the	the	DET
dpc-2582	118	28	neoplasm	neoplasm	NOUN
dpc-2582	118	29	.	.	PUNCT
dpc-2582	119	1	in	in	ADP
dpc-2582	119	2	our	our	PRON
dpc-2582	119	3	series	series	NOUN
dpc-2582	119	4	,	,	PUNCT
dpc-2582	119	5	epithelioid	epithelioid	PROPN
dpc-2582	119	6	features	feature	NOUN
dpc-2582	119	7	were	be	AUX
dpc-2582	119	8	prevalent	prevalent	ADJ
dpc-2582	119	9	(	(	PUNCT
dpc-2582	119	10	25	25	NUM
dpc-2582	119	11	out	out	ADP
dpc-2582	119	12	of	of	ADP
dpc-2582	119	13	33	33	NUM
dpc-2582	119	14	cases	case	NOUN
dpc-2582	119	15	)	)	PUNCT
dpc-2582	119	16	.	.	PUNCT
dpc-2582	120	1	two	two	NUM
dpc-2582	120	2	cases	case	NOUN
dpc-2582	120	3	were	be	AUX
dpc-2582	120	4	composed	compose	VERB
dpc-2582	120	5	of	of	ADP
dpc-2582	120	6	spindle	spindle	NOUN
dpc-2582	120	7	hyperpigmented	hyperpigmente	VERB
dpc-2582	120	8	cells	cell	NOUN
dpc-2582	120	9	,	,	PUNCT
dpc-2582	120	10	two	two	NUM
dpc-2582	120	11	cases	case	NOUN
dpc-2582	120	12	had	have	VERB
dpc-2582	120	13	a	a	DET
dpc-2582	120	14	lymphocytic	lymphocytic	ADJ
dpc-2582	120	15	-	-	PUNCT
dpc-2582	120	16	like	like	ADJ
dpc-2582	120	17	appearance	appearance	NOUN
dpc-2582	120	18	,	,	PUNCT
dpc-2582	120	19	one	one	NUM
dpc-2582	120	20	was	be	AUX
dpc-2582	120	21	rhabdoid	rhabdoid	NOUN
dpc-2582	120	22	and	and	CCONJ
dpc-2582	120	23	,	,	PUNCT
dpc-2582	120	24	in	in	ADP
dpc-2582	120	25	three	three	NUM
dpc-2582	120	26	cases	case	NOUN
dpc-2582	120	27	,	,	PUNCT
dpc-2582	120	28	the	the	DET
dpc-2582	120	29	cytological	cytological	ADJ
dpc-2582	120	30	pattern	pattern	NOUN
dpc-2582	120	31	of	of	ADP
dpc-2582	120	32	growth	growth	NOUN
dpc-2582	120	33	was	be	AUX
dpc-2582	120	34	mixed	mixed	ADJ
dpc-2582	120	35	(	(	PUNCT
dpc-2582	120	36	figure	figure	NOUN
dpc-2582	120	37	5	5	NUM
dpc-2582	120	38	)	)	PUNCT
dpc-2582	120	39	.	.	PUNCT
dpc-2582	121	1	mean	mean	VERB
dpc-2582	121	2	breslow	breslow	ADJ
dpc-2582	121	3	thickness	thickness	NOUN
dpc-2582	121	4	in	in	ADP
dpc-2582	121	5	mucosal	mucosal	ADJ
dpc-2582	121	6	melanoma	melanoma	NOUN
dpc-2582	121	7	was	be	AUX
dpc-2582	121	8	6.7	6.7	NUM
dpc-2582	121	9	with	with	ADP
dpc-2582	121	10	no	no	DET
dpc-2582	121	11	appreciable	appreciable	ADJ
dpc-2582	121	12	difference	difference	NOUN
dpc-2582	121	13	between	between	ADP
dpc-2582	121	14	different	different	ADJ
dpc-2582	121	15	anatomical	anatomical	ADJ
dpc-2582	121	16	sites	site	NOUN
dpc-2582	121	17	;	;	PUNCT
dpc-2582	121	18	no	no	DET
dpc-2582	121	19	breslow	breslow	ADJ
dpc-2582	121	20	thickness	thickness	NOUN
dpc-2582	121	21	was	be	AUX
dpc-2582	121	22	reported	report	VERB
dpc-2582	121	23	in	in	ADP
dpc-2582	121	24	sinonasal	sinonasal	ADJ
dpc-2582	121	25	melanomas	melanoma	NOUN
dpc-2582	121	26	due	due	ADP
dpc-2582	121	27	to	to	ADP
dpc-2582	121	28	the	the	DET
dpc-2582	121	29	sparse	sparse	ADJ
dpc-2582	121	30	and	and	CCONJ
dpc-2582	121	31	fragmented	fragmented	ADJ
dpc-2582	121	32	nature	nature	NOUN
dpc-2582	121	33	of	of	ADP
dpc-2582	121	34	biopsy	biopsy	NOUN
dpc-2582	121	35	specimens	specimen	NOUN
dpc-2582	121	36	.	.	PUNCT
dpc-2582	122	1	tumor	tumor	PROPN
dpc-2582	122	2	ulceration	ulceration	NOUN
dpc-2582	122	3	was	be	AUX
dpc-2582	122	4	noted	note	VERB
dpc-2582	122	5	in	in	ADP
dpc-2582	122	6	11	11	NUM
dpc-2582	122	7	samples	sample	NOUN
dpc-2582	122	8	.	.	PUNCT
dpc-2582	123	1	in	in	ADP
dpc-2582	123	2	one	one	NUM
dpc-2582	123	3	case	case	NOUN
dpc-2582	123	4	of	of	ADP
dpc-2582	123	5	vulvar	vulvar	NOUN
dpc-2582	123	6	melanoma	melanoma	NOUN
dpc-2582	123	7	,	,	PUNCT
dpc-2582	123	8	a	a	DET
dpc-2582	123	9	residual	residual	ADJ
dpc-2582	123	10	melanocytic	melanocytic	ADJ
dpc-2582	123	11	nevus	nevus	NOUN
dpc-2582	123	12	was	be	AUX
dpc-2582	123	13	found	find	VERB
dpc-2582	123	14	at	at	ADP
dpc-2582	123	15	the	the	DET
dpc-2582	123	16	periphery	periphery	NOUN
dpc-2582	123	17	of	of	ADP
dpc-2582	123	18	the	the	DET
dpc-2582	123	19	tumor	tumor	NOUN
dpc-2582	123	20	.	.	PUNCT
dpc-2582	124	1	no	no	DET
dpc-2582	124	2	samples	sample	NOUN
dpc-2582	124	3	undergoing	undergo	VERB
dpc-2582	124	4	biomolecular	biomolecular	ADJ
dpc-2582	124	5	analysis	analysis	NOUN
dpc-2582	124	6	had	have	VERB
dpc-2582	124	7	braf	braf	NOUN
dpc-2582	124	8	or	or	CCONJ
dpc-2582	124	9	nras	nras	PROPN
dpc-2582	124	10	mutation	mutation	NOUN
dpc-2582	124	11	,	,	PUNCT
dpc-2582	124	12	while	while	SCONJ
dpc-2582	124	13	3	3	NUM
dpc-2582	124	14	cases	case	NOUN
dpc-2582	124	15	had	have	VERB
dpc-2582	124	16	c	c	NOUN
dpc-2582	124	17	-	-	PUNCT
dpc-2582	124	18	kit	kit	NOUN
dpc-2582	124	19	and	and	CCONJ
dpc-2582	124	20	3	3	NUM
dpc-2582	124	21	cases	case	NOUN
dpc-2582	124	22	kras	kra	NOUN
dpc-2582	124	23	mutations	mutation	NOUN
dpc-2582	124	24	.	.	PUNCT
dpc-2582	125	1	in	in	ADP
dpc-2582	125	2	46.3	46.3	NUM
dpc-2582	125	3	%	%	NOUN
dpc-2582	125	4	of	of	ADP
dpc-2582	125	5	cases	case	NOUN
dpc-2582	125	6	while	while	SCONJ
dpc-2582	125	7	only	only	ADV
dpc-2582	125	8	2	2	NUM
dpc-2582	125	9	patients	patient	NOUN
dpc-2582	125	10	with	with	ADP
dpc-2582	125	11	urogenital	urogenital	ADJ
dpc-2582	125	12	melanomas	melanoma	NOUN
dpc-2582	125	13	were	be	AUX
dpc-2582	125	14	treated	treat	VERB
dpc-2582	125	15	with	with	ADP
dpc-2582	125	16	rt	rt	PROPN
dpc-2582	125	17	.	.	PROPN
dpc-2582	125	18	survival	survival	PROPN
dpc-2582	125	19	data	data	PROPN
dpc-2582	125	20	:	:	PUNCT
dpc-2582	125	21	overall	overall	ADJ
dpc-2582	125	22	survival	survival	NOUN
dpc-2582	125	23	(	(	PUNCT
dpc-2582	125	24	os	os	NOUN
dpc-2582	125	25	)	)	PUNCT
dpc-2582	125	26	,	,	PUNCT
dpc-2582	125	27	expressed	express	VERB
dpc-2582	125	28	as	as	ADP
dpc-2582	125	29	a	a	DET
dpc-2582	125	30	median	median	ADJ
dpc-2582	125	31	value	value	NOUN
dpc-2582	125	32	,	,	PUNCT
dpc-2582	125	33	was	be	AUX
dpc-2582	125	34	longer	long	ADJ
dpc-2582	125	35	in	in	ADP
dpc-2582	125	36	urogenital	urogenital	ADJ
dpc-2582	125	37	melanomas	melanomas	NOUN
dpc-2582	125	38	(	(	PUNCT
dpc-2582	125	39	26	26	NUM
dpc-2582	125	40	months	month	NOUN
dpc-2582	125	41	)	)	PUNCT
dpc-2582	125	42	,	,	PUNCT
dpc-2582	125	43	than	than	ADP
dpc-2582	125	44	sinonasal	sinonasal	ADJ
dpc-2582	125	45	melanomas	melanomas	NOUN
dpc-2582	125	46	(	(	PUNCT
dpc-2582	125	47	14	14	NUM
dpc-2582	125	48	months	month	NOUN
dpc-2582	125	49	)	)	PUNCT
dpc-2582	125	50	and	and	CCONJ
dpc-2582	125	51	anorectal	anorectal	ADJ
dpc-2582	125	52	melanomas	melanomas	NOUN
dpc-2582	125	53	(	(	PUNCT
dpc-2582	125	54	6	6	NUM
dpc-2582	125	55	months	month	NOUN
dpc-2582	125	56	)	)	PUNCT
dpc-2582	125	57	.	.	PUNCT
dpc-2582	126	1	as	as	SCONJ
dpc-2582	126	2	reported	report	VERB
dpc-2582	126	3	in	in	ADP
dpc-2582	126	4	the	the	DET
dpc-2582	126	5	kaplan	kaplan	PROPN
dpc-2582	126	6	-	-	PUNCT
dpc-2582	126	7	meier	meier	PROPN
dpc-2582	126	8	estimate	estimate	NOUN
dpc-2582	126	9	(	(	PUNCT
dpc-2582	126	10	figure	figure	NOUN
dpc-2582	126	11	2	2	NUM
dpc-2582	126	12	)	)	PUNCT
dpc-2582	126	13	,	,	PUNCT
dpc-2582	126	14	sinonasal	sinonasal	ADJ
dpc-2582	126	15	and	and	CCONJ
dpc-2582	126	16	anorectal	anorectal	ADJ
dpc-2582	126	17	melanoma	melanoma	NOUN
dpc-2582	126	18	carried	carry	VERB
dpc-2582	126	19	higher	high	ADJ
dpc-2582	126	20	mortality	mortality	NOUN
dpc-2582	126	21	in	in	ADP
dpc-2582	126	22	the	the	DET
dpc-2582	126	23	first	first	ADJ
dpc-2582	126	24	two	two	NUM
dpc-2582	126	25	years	year	NOUN
dpc-2582	126	26	;	;	PUNCT
dpc-2582	126	27	anorectal	anorectal	ADJ
dpc-2582	126	28	melanoma	melanoma	NOUN
dpc-2582	126	29	had	have	VERB
dpc-2582	126	30	a	a	DET
dpc-2582	126	31	high	high	ADJ
dpc-2582	126	32	mortality	mortality	NOUN
dpc-2582	126	33	rate	rate	NOUN
dpc-2582	126	34	over	over	ADP
dpc-2582	126	35	time	time	NOUN
dpc-2582	126	36	while	while	SCONJ
dpc-2582	126	37	sinonasal	sinonasal	ADJ
dpc-2582	126	38	melanoma	melanoma	NOUN
dpc-2582	126	39	reached	reach	VERB
dpc-2582	126	40	a	a	DET
dpc-2582	126	41	plateau	plateau	NOUN
dpc-2582	126	42	.	.	PUNCT
dpc-2582	127	1	urogenital	urogenital	ADJ
dpc-2582	127	2	melanoma	melanoma	NOUN
dpc-2582	127	3	showed	show	VERB
dpc-2582	127	4	longer	long	ADJ
dpc-2582	127	5	survival	survival	NOUN
dpc-2582	127	6	in	in	ADP
dpc-2582	127	7	the	the	DET
dpc-2582	127	8	first	first	ADJ
dpc-2582	127	9	two	two	NUM
dpc-2582	127	10	years	year	NOUN
dpc-2582	127	11	from	from	ADP
dpc-2582	127	12	diagnosis	diagnosis	NOUN
dpc-2582	127	13	with	with	ADP
dpc-2582	127	14	delayed	delayed	ADJ
dpc-2582	127	15	mortality	mortality	NOUN
dpc-2582	127	16	.	.	PUNCT
dpc-2582	128	1	the	the	DET
dpc-2582	128	2	24	24	NUM
dpc-2582	128	3	-	-	PUNCT
dpc-2582	128	4	month	month	NOUN
dpc-2582	128	5	overall	overall	ADJ
dpc-2582	128	6	survival	survival	NOUN
dpc-2582	128	7	rate	rate	NOUN
dpc-2582	128	8	among	among	ADP
dpc-2582	128	9	mucosal	mucosal	ADJ
dpc-2582	128	10	melanoma	melanoma	NOUN
dpc-2582	128	11	patients	patient	NOUN
dpc-2582	128	12	was	be	AUX
dpc-2582	128	13	54	54	NUM
dpc-2582	128	14	%	%	NOUN
dpc-2582	128	15	.	.	PUNCT
dpc-2582	129	1	the	the	DET
dpc-2582	129	2	24	24	NUM
dpc-2582	129	3	-	-	PUNCT
dpc-2582	129	4	month	month	NOUN
dpc-2582	129	5	overall	overall	ADJ
dpc-2582	129	6	mortality	mortality	NOUN
dpc-2582	129	7	for	for	ADP
dpc-2582	129	8	the	the	DET
dpc-2582	129	9	location	location	NOUN
dpc-2582	129	10	was	be	AUX
dpc-2582	129	11	37	37	NUM
dpc-2582	129	12	%	%	NOUN
dpc-2582	129	13	in	in	ADP
dpc-2582	129	14	sinonasal	sinonasal	ADJ
dpc-2582	129	15	melanomas	melanomas	PROPN
dpc-2582	129	16	,	,	PUNCT
dpc-2582	129	17	18	18	NUM
dpc-2582	129	18	%	%	NOUN
dpc-2582	129	19	in	in	ADP
dpc-2582	129	20	anorectal	anorectal	ADJ
dpc-2582	129	21	melanoma	melanoma	NOUN
dpc-2582	129	22	and	and	CCONJ
dpc-2582	129	23	100	100	NUM
dpc-2582	129	24	%	%	NOUN
dpc-2582	129	25	in	in	ADP
dpc-2582	129	26	urogenital	urogenital	ADJ
dpc-2582	129	27	melanoma	melanoma	NOUN
dpc-2582	129	28	.	.	PUNCT
dpc-2582	130	1	the	the	DET
dpc-2582	130	2	last	last	ADJ
dpc-2582	130	3	observed	observed	ADJ
dpc-2582	130	4	exit	exit	NOUN
dpc-2582	130	5	from	from	ADP
dpc-2582	130	6	the	the	DET
dpc-2582	130	7	estimate	estimate	NOUN
dpc-2582	130	8	was	be	AUX
dpc-2582	130	9	58	58	NUM
dpc-2582	130	10	months	month	NOUN
dpc-2582	130	11	(	(	PUNCT
dpc-2582	130	12	figure	figure	NOUN
dpc-2582	130	13	2	2	NUM
dpc-2582	130	14	)	)	PUNCT
dpc-2582	130	15	.	.	PUNCT
dpc-2582	131	1	the	the	DET
dpc-2582	131	2	univariate	univariate	ADJ
dpc-2582	131	3	analysis	analysis	NOUN
dpc-2582	131	4	showed	show	VERB
dpc-2582	131	5	that	that	SCONJ
dpc-2582	131	6	metastasis	metastasis	NOUN
dpc-2582	131	7	at	at	ADP
dpc-2582	131	8	diagnosis	diagnosis	NOUN
dpc-2582	131	9	was	be	AUX
dpc-2582	131	10	significantly	significantly	ADV
dpc-2582	131	11	associated	associate	VERB
dpc-2582	131	12	with	with	ADP
dpc-2582	131	13	mortality	mortality	NOUN
dpc-2582	131	14	(	(	PUNCT
dpc-2582	131	15	table	table	NOUN
dpc-2582	131	16	 	 	SPACE
dpc-2582	131	17	2	2	NUM
dpc-2582	131	18	)	)	PUNCT
dpc-2582	131	19	.	.	PUNCT
dpc-2582	132	1	in	in	ADP
dpc-2582	132	2	the	the	DET
dpc-2582	132	3	multivariate	multivariate	NOUN
dpc-2582	132	4	analysis	analysis	NOUN
dpc-2582	132	5	,	,	PUNCT
dpc-2582	132	6	the	the	DET
dpc-2582	132	7	risk	risk	NOUN
dpc-2582	132	8	factor	factor	NOUN
dpc-2582	132	9	significantly	significantly	ADV
dpc-2582	132	10	associated	associate	VERB
dpc-2582	132	11	with	with	ADP
dpc-2582	132	12	mortality	mortality	NOUN
dpc-2582	132	13	was	be	AUX
dpc-2582	132	14	the	the	DET
dpc-2582	132	15	presence	presence	NOUN
dpc-2582	132	16	of	of	ADP
dpc-2582	132	17	metastasis	metastasis	NOUN
dpc-2582	132	18	at	at	ADP
dpc-2582	132	19	diagnosis	diagnosis	NOUN
dpc-2582	132	20	,	,	PUNCT
dpc-2582	132	21	while	while	SCONJ
dpc-2582	132	22	first	first	ADJ
dpc-2582	132	23	-	-	PUNCT
dpc-2582	132	24	line	line	NOUN
dpc-2582	132	25	immunotherapy	immunotherapy	NOUN
dpc-2582	132	26	demonstrated	demonstrate	VERB
dpc-2582	132	27	a	a	DET
dpc-2582	132	28	protective	protective	ADJ
dpc-2582	132	29	role	role	NOUN
dpc-2582	132	30	(	(	PUNCT
dpc-2582	132	31	table	table	NOUN
dpc-2582	132	32	4	4	NUM
dpc-2582	132	33	)	)	PUNCT
dpc-2582	132	34	.	.	PUNCT
dpc-2582	133	1	histopathologic	histopathologic	NOUN
dpc-2582	133	2	and	and	CCONJ
dpc-2582	133	3	molecular	molecular	ADJ
dpc-2582	133	4	data	datum	NOUN
dpc-2582	133	5	mucosal	mucosal	NOUN
dpc-2582	133	6	melanomas	melanoma	NOUN
dpc-2582	133	7	can	can	AUX
dpc-2582	133	8	occur	occur	VERB
dpc-2582	133	9	in	in	ADP
dpc-2582	133	10	all	all	DET
dpc-2582	133	11	sites	site	NOUN
dpc-2582	133	12	where	where	SCONJ
dpc-2582	133	13	mucosal	mucosal	NOUN
dpc-2582	133	14	melanocytes	melanocyte	NOUN
dpc-2582	133	15	are	be	AUX
dpc-2582	133	16	present	present	ADJ
dpc-2582	133	17	.	.	PUNCT
dpc-2582	134	1	while	while	SCONJ
dpc-2582	134	2	perianal	perianal	ADJ
dpc-2582	134	3	,	,	PUNCT
dpc-2582	134	4	genital	genital	ADJ
dpc-2582	134	5	,	,	PUNCT
dpc-2582	134	6	and	and	CCONJ
dpc-2582	134	7	perioral	perioral	ADJ
dpc-2582	134	8	skin	skin	NOUN
dpc-2582	134	9	normally	normally	ADV
dpc-2582	134	10	harbors	harbor	VERB
dpc-2582	134	11	melanocytes	melanocyte	NOUN
dpc-2582	134	12	(	(	PUNCT
dpc-2582	134	13	and	and	CCONJ
dpc-2582	134	14	,	,	PUNCT
dpc-2582	134	15	consequently	consequently	ADV
dpc-2582	134	16	,	,	PUNCT
dpc-2582	134	17	these	these	PRON
dpc-2582	134	18	are	be	AUX
dpc-2582	134	19	sites	site	NOUN
dpc-2582	134	20	of	of	ADP
dpc-2582	134	21	origin	origin	NOUN
dpc-2582	134	22	of	of	ADP
dpc-2582	134	23	benign	benign	ADJ
dpc-2582	134	24	and	and	CCONJ
dpc-2582	134	25	malignant	malignant	ADJ
dpc-2582	134	26	melanocytic	melanocytic	ADJ
dpc-2582	134	27	tumors	tumor	NOUN
dpc-2582	134	28	,	,	PUNCT
dpc-2582	134	29	albeit	albeit	SCONJ
dpc-2582	134	30	rare	rare	ADJ
dpc-2582	134	31	)	)	PUNCT
dpc-2582	134	32	,	,	PUNCT
dpc-2582	134	33	melanocytes	melanocyte	NOUN
dpc-2582	134	34	are	be	AUX
dpc-2582	134	35	usually	usually	ADV
dpc-2582	134	36	absent	absent	ADJ
dpc-2582	134	37	in	in	ADP
dpc-2582	134	38	the	the	DET
dpc-2582	134	39	bladder	bladder	NOUN
dpc-2582	134	40	mucosa	mucosa	NOUN
dpc-2582	134	41	.	.	PUNCT
dpc-2582	135	1	in	in	ADP
dpc-2582	135	2	the	the	DET
dpc-2582	135	3	rare	rare	ADJ
dpc-2582	135	4	case	case	NOUN
dpc-2582	135	5	of	of	ADP
dpc-2582	135	6	bladder	bladder	NOUN
dpc-2582	135	7	melanoma	melanoma	NOUN
dpc-2582	135	8	,	,	PUNCT
dpc-2582	135	9	a	a	DET
dpc-2582	135	10	spread	spread	NOUN
dpc-2582	135	11	of	of	ADP
dpc-2582	135	12	melanocytes	melanocyte	NOUN
dpc-2582	135	13	from	from	ADP
dpc-2582	135	14	the	the	DET
dpc-2582	135	15	urethra	urethra	NOUN
dpc-2582	135	16	could	could	AUX
dpc-2582	135	17	explain	explain	VERB
dpc-2582	135	18	its	its	PRON
dpc-2582	135	19	etiopathogenesis	etiopathogenesis	NOUN
dpc-2582	135	20	.	.	PUNCT
dpc-2582	136	1	in	in	ADP
dpc-2582	136	2	the	the	DET
dpc-2582	136	3	nasal	nasal	NOUN
dpc-2582	136	4	and	and	CCONJ
dpc-2582	136	5	paranasal	paranasal	ADJ
dpc-2582	136	6	analysis	analysis	NOUN
dpc-2582	136	7	time	time	NOUN
dpc-2582	136	8	number	number	NOUN
dpc-2582	136	9	at	at	ADP
dpc-2582	136	10	risk	risk	NOUN
dpc-2582	136	11	33	33	NUM
dpc-2582	136	12	12	12	NUM
dpc-2582	136	13	3	3	NUM
dpc-2582	136	14	0	0	NUM
dpc-2582	136	15	6040200	6040200	NUM
dpc-2582	136	16	0	0	NUM
dpc-2582	136	17	.	.	PUNCT
dpc-2582	136	18	00	00	NUM
dpc-2582	136	19	0	0	NUM
dpc-2582	136	20	.	.	PUNCT
dpc-2582	136	21	25	25	NUM
dpc-2582	136	22	0	0	NUM
dpc-2582	136	23	.	.	PUNCT
dpc-2582	136	24	50	50	NUM
dpc-2582	136	25	0	0	NUM
dpc-2582	136	26	.	.	PUNCT
dpc-2582	136	27	75	75	NUM
dpc-2582	136	28	1	1	NUM
dpc-2582	136	29	.	.	PUNCT
dpc-2582	136	30	00	00	PUNCT
dpc-2582	137	1	kaplan	kaplan	PROPN
dpc-2582	137	2	–	–	PUNCT
dpc-2582	137	3	meier	meier	PROPN
dpc-2582	137	4	survival	survival	PROPN
dpc-2582	137	5	estimatea	estimatea	PROPN
dpc-2582	137	6	)	)	PUNCT
dpc-2582	137	7	sinonasal	sinonasal	ADJ
dpc-2582	137	8	melanoma	melanoma	NOUN
dpc-2582	137	9	number	number	NOUN
dpc-2582	137	10	at	at	ADP
dpc-2582	137	11	risk	risk	NOUN
dpc-2582	137	12	sinonasal	sinonasal	ADJ
dpc-2582	137	13	melanoma	melanoma	NOUN
dpc-2582	137	14	anorectal	anorectal	ADJ
dpc-2582	137	15	melanoma	melanoma	NOUN
dpc-2582	137	16	urogeital	urogeital	ADJ
dpc-2582	137	17	melanoma	melanoma	NOUN
dpc-2582	137	18	9	9	NUM
dpc-2582	137	19	13	13	NUM
dpc-2582	137	20	11	11	NUM
dpc-2582	137	21	3	3	NUM
dpc-2582	137	22	2	2	NUM
dpc-2582	137	23	7	7	NUM
dpc-2582	137	24	1	1	NUM
dpc-2582	137	25	0	0	NUM
dpc-2582	137	26	2	2	NUM
dpc-2582	137	27	0	0	NUM
dpc-2582	137	28	604020	604020	NUM
dpc-2582	137	29	analysis	analysis	NOUN
dpc-2582	137	30	time	time	NOUN
dpc-2582	137	31	kaplan	kaplan	PROPN
dpc-2582	137	32	–	–	PUNCT
dpc-2582	137	33	meier	meier	PROPN
dpc-2582	137	34	survival	survival	PROPN
dpc-2582	137	35	estimatesb	estimatesb	PROPN
dpc-2582	137	36	)	)	PUNCT
dpc-2582	137	37	0	0	NUM
dpc-2582	138	1	0	0	NUM
dpc-2582	138	2	.	.	PUNCT
dpc-2582	138	3	00	00	NUM
dpc-2582	139	1	0	0	NUM
dpc-2582	139	2	.	.	PUNCT
dpc-2582	140	1	25	25	NUM
dpc-2582	140	2	0	0	NUM
dpc-2582	140	3	.	.	PUNCT
dpc-2582	141	1	50	50	NUM
dpc-2582	141	2	0	0	NUM
dpc-2582	141	3	.	.	PUNCT
dpc-2582	142	1	75	75	NUM
dpc-2582	142	2	1	1	NUM
dpc-2582	142	3	.	.	PUNCT
dpc-2582	142	4	00	00	NUM
dpc-2582	143	1	0	0	NUM
dpc-2582	143	2	0	0	NUM
dpc-2582	143	3	anorectal	anorectal	ADJ
dpc-2582	143	4	melanoma	melanoma	NOUN
dpc-2582	143	5	urogintal	urogintal	ADJ
dpc-2582	143	6	melanoma	melanoma	NOUN
dpc-2582	143	7	figure	figure	NOUN
dpc-2582	143	8	2	2	NUM
dpc-2582	143	9	.	.	PUNCT
dpc-2582	144	1	kaplan	kaplan	PROPN
dpc-2582	144	2	meier	meier	PROPN
dpc-2582	144	3	estimates	estimate	VERB
dpc-2582	144	4	for	for	ADP
dpc-2582	144	5	overall	overall	ADJ
dpc-2582	144	6	survival	survival	NOUN
dpc-2582	144	7	.	.	PUNCT
dpc-2582	145	1	(	(	PUNCT
dpc-2582	145	2	a	a	X
dpc-2582	145	3	)	)	PUNCT
dpc-2582	145	4	os	os	NOUN
dpc-2582	145	5	in	in	ADP
dpc-2582	145	6	mucosal	mucosal	ADJ
dpc-2582	145	7	melanomas	melanoma	NOUN
dpc-2582	145	8	.	.	PUNCT
dpc-2582	146	1	(	(	PUNCT
dpc-2582	146	2	b	b	X
dpc-2582	146	3	)	)	PUNCT
dpc-2582	146	4	stratification	stratification	NOUN
dpc-2582	146	5	of	of	ADP
dpc-2582	146	6	the	the	DET
dpc-2582	146	7	cohort	cohort	NOUN
dpc-2582	146	8	by	by	ADP
dpc-2582	146	9	the	the	DET
dpc-2582	146	10	site	site	NOUN
dpc-2582	146	11	of	of	ADP
dpc-2582	146	12	the	the	DET
dpc-2582	146	13	primary	primary	ADJ
dpc-2582	146	14	tumor	tumor	NOUN
dpc-2582	146	15	.	.	PUNCT
dpc-2582	147	1	6	6	NUM
dpc-2582	147	2	original	original	ADJ
dpc-2582	147	3	article	article	NOUN
dpc-2582	147	4	|	|	ADV
dpc-2582	147	5	dermatol	dermatol	ADJ
dpc-2582	147	6	pract	pract	NOUN
dpc-2582	147	7	concept	concept	NOUN
dpc-2582	147	8	.	.	PUNCT
dpc-2582	148	1	2023;13(1):e2023057	2023;13(1):e2023057	NUM
dpc-2582	148	2	table	table	NOUN
dpc-2582	148	3	3	3	NUM
dpc-2582	148	4	.	.	PUNCT
dpc-2582	148	5	univariable	univariable	ADJ
dpc-2582	148	6	model	model	NOUN
dpc-2582	148	7	of	of	ADP
dpc-2582	148	8	risk	risk	NOUN
dpc-2582	148	9	factors	factor	NOUN
dpc-2582	148	10	for	for	ADP
dpc-2582	148	11	mortality	mortality	NOUN
dpc-2582	148	12	in	in	ADP
dpc-2582	148	13	mucosal	mucosal	ADJ
dpc-2582	148	14	melanomas	melanoma	NOUN
dpc-2582	148	15	.	.	PUNCT
dpc-2582	149	1	hr	hr	NOUN
dpc-2582	149	2	95	95	NUM
dpc-2582	149	3	%	%	NOUN
dpc-2582	149	4	ci	ci	NOUN
dpc-2582	149	5	p	p	ADJ
dpc-2582	149	6	-	-	PUNCT
dpc-2582	149	7	value	value	NOUN
dpc-2582	149	8	age	age	NOUN
dpc-2582	149	9	at	at	ADP
dpc-2582	149	10	diagnosis	diagnosis	NOUN
dpc-2582	149	11	1.02	1.02	NUM
dpc-2582	149	12	(	(	PUNCT
dpc-2582	149	13	0.97	0.97	NUM
dpc-2582	149	14	-	-	SYM
dpc-2582	149	15	1.07	1.07	NUM
dpc-2582	149	16	)	)	PUNCT
dpc-2582	149	17	0.292	0.292	NUM
dpc-2582	149	18	gender	gender	NOUN
dpc-2582	149	19	female	female	ADJ
dpc-2582	149	20	ref	ref	NOUN
dpc-2582	149	21	.	.	PUNCT
dpc-2582	150	1	male	male	NOUN
dpc-2582	150	2	1.93	1.93	NUM
dpc-2582	150	3	(	(	PUNCT
dpc-2582	150	4	0.67	0.67	NUM
dpc-2582	150	5	-	-	SYM
dpc-2582	150	6	5.45	5.45	NUM
dpc-2582	150	7	)	)	PUNCT
dpc-2582	150	8	0.216	0.216	NUM
dpc-2582	150	9	location	location	NOUN
dpc-2582	150	10	sinonasal	sinonasal	NOUN
dpc-2582	150	11	ref	ref	NOUN
dpc-2582	150	12	.	.	PUNCT
dpc-2582	151	1	1.90	1.90	NUM
dpc-2582	151	2	(	(	PUNCT
dpc-2582	151	3	0.57	0.57	NUM
dpc-2582	151	4	-	-	SYM
dpc-2582	151	5	6.29	6.29	NUM
dpc-2582	151	6	)	)	PUNCT
dpc-2582	151	7	0.291	0.291	NUM
dpc-2582	151	8	urogenital	urogenital	ADJ
dpc-2582	151	9	0.25	0.25	NUM
dpc-2582	151	10	(	(	PUNCT
dpc-2582	151	11	0.05	0.05	NUM
dpc-2582	151	12	-	-	SYM
dpc-2582	151	13	1.09	1.09	NUM
dpc-2582	151	14	)	)	PUNCT
dpc-2582	151	15	0.066	0.066	NUM
dpc-2582	151	16	metastasis	metastasis	NOUN
dpc-2582	151	17	at	at	ADP
dpc-2582	151	18	diagnosis	diagnosis	NOUN
dpc-2582	151	19	no	no	DET
dpc-2582	151	20	ref	ref	NOUN
dpc-2582	151	21	.	.	PUNCT
dpc-2582	152	1	yes	yes	INTJ
dpc-2582	152	2	8.75	8.75	NUM
dpc-2582	152	3	(	(	PUNCT
dpc-2582	152	4	1.79	1.79	NUM
dpc-2582	152	5	-	-	SYM
dpc-2582	152	6	42.76	42.76	NUM
dpc-2582	152	7	)	)	PUNCT
dpc-2582	152	8	0.007	0.007	NUM
dpc-2582	152	9	site	site	NOUN
dpc-2582	152	10	of	of	ADP
dpc-2582	152	11	metastasis	metastasis	NOUN
dpc-2582	152	12	at	at	ADP
dpc-2582	152	13	diagnosis	diagnosis	NOUN
dpc-2582	152	14	skin	skin	NOUN
dpc-2582	152	15	/	/	SYM
dpc-2582	152	16	regional	regional	ADJ
dpc-2582	152	17	lymph	lymph	NOUN
dpc-2582	152	18	node	node	NOUN
dpc-2582	152	19	ref	ref	NOUN
dpc-2582	152	20	.	.	PUNCT
dpc-2582	153	1	visceral	visceral	ADJ
dpc-2582	153	2	3.30	3.30	NUM
dpc-2582	153	3	(	(	PUNCT
dpc-2582	153	4	0.34	0.34	NUM
dpc-2582	153	5	-	-	SYM
dpc-2582	153	6	31.96	31.96	NUM
dpc-2582	153	7	)	)	PUNCT
dpc-2582	153	8	0.302	0.302	NUM
dpc-2582	153	9	cerebral	cerebral	ADJ
dpc-2582	153	10	6.21	6.21	NUM
dpc-2582	153	11	(	(	PUNCT
dpc-2582	153	12	0.53	0.53	NUM
dpc-2582	153	13	-	-	SYM
dpc-2582	153	14	72.00	72.00	NUM
dpc-2582	153	15	)	)	PUNCT
dpc-2582	153	16	0.144	0.144	NUM
dpc-2582	153	17	≥2	≥2	PROPN
dpc-2582	153	18	sites	site	NOUN
dpc-2582	153	19	2.50	2.50	NUM
dpc-2582	153	20	(	(	PUNCT
dpc-2582	153	21	0.22	0.22	NUM
dpc-2582	153	22	-	-	SYM
dpc-2582	153	23	27.95	27.95	NUM
dpc-2582	153	24	)	)	PUNCT
dpc-2582	153	25	0.456	0.456	NUM
dpc-2582	153	26	surgery	surgery	NOUN
dpc-2582	153	27	no	no	DET
dpc-2582	153	28	ref	ref	NOUN
dpc-2582	153	29	.	.	PUNCT
dpc-2582	154	1	debulking	debulke	VERB
dpc-2582	154	2	0.19	0.19	NUM
dpc-2582	154	3	(	(	PUNCT
dpc-2582	154	4	0.02	0.02	NUM
dpc-2582	154	5	-	-	SYM
dpc-2582	154	6	1.59	1.59	NUM
dpc-2582	154	7	)	)	PUNCT
dpc-2582	154	8	0.129	0.129	NUM
dpc-2582	154	9	radical	radical	ADJ
dpc-2582	154	10	0.33	0.33	NUM
dpc-2582	154	11	(	(	PUNCT
dpc-2582	154	12	0.09	0.09	NUM
dpc-2582	154	13	-	-	PUNCT
dpc-2582	154	14	1.16	1.16	NUM
dpc-2582	154	15	)	)	PUNCT
dpc-2582	154	16	0.085	0.085	NUM
dpc-2582	154	17	first	first	ADJ
dpc-2582	154	18	-	-	PUNCT
dpc-2582	154	19	line	line	NOUN
dpc-2582	154	20	biological	biological	ADJ
dpc-2582	154	21	therapy	therapy	NOUN
dpc-2582	154	22	no	no	DET
dpc-2582	154	23	ref	ref	NOUN
dpc-2582	154	24	.	.	PUNCT
dpc-2582	155	1	nivolumab	nivolumab	ADP
dpc-2582	155	2	0.88	0.88	NUM
dpc-2582	155	3	(	(	PUNCT
dpc-2582	155	4	0.26	0.26	NUM
dpc-2582	155	5	-	-	NUM
dpc-2582	155	6	2.95	2.95	NUM
dpc-2582	155	7	)	)	PUNCT
dpc-2582	155	8	0.840	0.840	NUM
dpc-2582	155	9	pembrolizumab	pembrolizumab	NOUN
dpc-2582	155	10	1.16	1.16	NUM
dpc-2582	155	11	(	(	PUNCT
dpc-2582	155	12	0.13	0.13	NUM
dpc-2582	155	13	-	-	SYM
dpc-2582	155	14	9.63	9.63	NUM
dpc-2582	155	15	)	)	PUNCT
dpc-2582	155	16	0.890	0.890	NUM
dpc-2582	155	17	imatinib	imatinib	NOUN
dpc-2582	155	18	2.71	2.71	NUM
dpc-2582	155	19	(	(	PUNCT
dpc-2582	155	20	0.31	0.31	NUM
dpc-2582	155	21	-	-	SYM
dpc-2582	155	22	23.21	23.21	NUM
dpc-2582	155	23	)	)	PUNCT
dpc-2582	155	24	0.362	0.362	NUM
dpc-2582	155	25	first	first	ADJ
dpc-2582	155	26	-	-	PUNCT
dpc-2582	155	27	line	line	NOUN
dpc-2582	155	28	chemotherapy	chemotherapy	NOUN
dpc-2582	155	29	no	no	DET
dpc-2582	155	30	ref	ref	NOUN
dpc-2582	155	31	.	.	PUNCT
dpc-2582	156	1	yes	yes	INTJ
dpc-2582	156	2	1.84	1.84	NUM
dpc-2582	156	3	(	(	PUNCT
dpc-2582	156	4	0.23	0.23	NUM
dpc-2582	156	5	-	-	SYM
dpc-2582	156	6	14.66	14.66	NUM
dpc-2582	156	7	)	)	PUNCT
dpc-2582	156	8	0.561	0.561	NUM
dpc-2582	156	9	second	second	ADJ
dpc-2582	156	10	-	-	PUNCT
dpc-2582	156	11	line	line	NOUN
dpc-2582	156	12	systemic	systemic	ADJ
dpc-2582	156	13	therapy	therapy	NOUN
dpc-2582	157	1	no	no	DET
dpc-2582	157	2	ref	ref	NOUN
dpc-2582	157	3	.	.	PUNCT
dpc-2582	158	1	ipilimumab	ipilimumab	ADJ
dpc-2582	158	2	0.71	0.71	NUM
dpc-2582	158	3	(	(	PUNCT
dpc-2582	158	4	0.09	0.09	NUM
dpc-2582	158	5	-	-	PUNCT
dpc-2582	158	6	5.68	5.68	NUM
dpc-2582	158	7	)	)	PUNCT
dpc-2582	158	8	0.752	0.752	NUM
dpc-2582	158	9	pembrolizumab	pembrolizumab	NOUN
dpc-2582	158	10	-	-	PUNCT
dpc-2582	158	11	dacarbazine	dacarbazine	NOUN
dpc-2582	158	12	1.42	1.42	NUM
dpc-2582	158	13	(	(	PUNCT
dpc-2582	158	14	0.17	0.17	NUM
dpc-2582	158	15	-	-	SYM
dpc-2582	158	16	11.30	11.30	NUM
dpc-2582	158	17	)	)	PUNCT
dpc-2582	158	18	0.740	0.740	NUM
dpc-2582	158	19	cytoreductive	cytoreductive	ADJ
dpc-2582	158	20	-	-	PUNCT
dpc-2582	158	21	palliative	palliative	NOUN
dpc-2582	158	22	radiation	radiation	NOUN
dpc-2582	158	23	therapy	therapy	NOUN
dpc-2582	158	24	no	no	DET
dpc-2582	158	25	ref	ref	NOUN
dpc-2582	158	26	.	.	PUNCT
dpc-2582	159	1	yes	yes	INTJ
dpc-2582	159	2	1.65	1.65	NUM
dpc-2582	159	3	(	(	PUNCT
dpc-2582	159	4	0.56	0.56	NUM
dpc-2582	159	5	-	-	SYM
dpc-2582	159	6	4.90	4.90	NUM
dpc-2582	159	7	)	)	PUNCT
dpc-2582	159	8	0.360	0.360	NUM
dpc-2582	159	9	hr	hr	NOUN
dpc-2582	159	10	:	:	PUNCT
dpc-2582	159	11	hazard	hazard	NOUN
dpc-2582	159	12	ratio	ratio	PROPN
dpc-2582	159	13	ci	ci	PROPN
dpc-2582	159	14	:	:	PUNCT
dpc-2582	159	15	confidence	confidence	NOUN
dpc-2582	159	16	interval	interval	NOUN
dpc-2582	159	17	detailed	detail	VERB
dpc-2582	159	18	descriptive	descriptive	ADJ
dpc-2582	159	19	data	datum	NOUN
dpc-2582	159	20	from	from	ADP
dpc-2582	159	21	histopathologic	histopathologic	ADJ
dpc-2582	159	22	and	and	CCONJ
dpc-2582	159	23	molecular	molecular	ADJ
dpc-2582	159	24	data	datum	NOUN
dpc-2582	159	25	are	be	AUX
dpc-2582	159	26	reported	report	VERB
dpc-2582	159	27	in	in	ADP
dpc-2582	159	28	table	table	NOUN
dpc-2582	159	29	5	5	NUM
dpc-2582	159	30	.	.	PUNCT
dpc-2582	160	1	discussion	discussion	NOUN
dpc-2582	160	2	this	this	DET
dpc-2582	160	3	11	11	NUM
dpc-2582	160	4	-	-	PUNCT
dpc-2582	160	5	year	year	NOUN
dpc-2582	160	6	retrospective	retrospective	ADJ
dpc-2582	160	7	study	study	NOUN
dpc-2582	160	8	shows	show	VERB
dpc-2582	160	9	that	that	SCONJ
dpc-2582	160	10	mucosal	mucosal	ADJ
dpc-2582	160	11	melanoma	melanoma	NOUN
dpc-2582	160	12	is	be	AUX
dpc-2582	160	13	a	a	DET
dpc-2582	160	14	tumor	tumor	NOUN
dpc-2582	160	15	typically	typically	ADV
dpc-2582	160	16	arising	arise	VERB
dpc-2582	160	17	in	in	ADP
dpc-2582	160	18	the	the	DET
dpc-2582	160	19	older	old	ADJ
dpc-2582	160	20	population	population	NOUN
dpc-2582	160	21	,	,	PUNCT
dpc-2582	160	22	with	with	ADP
dpc-2582	160	23	a	a	DET
dpc-2582	160	24	median	median	ADJ
dpc-2582	160	25	age	age	NOUN
dpc-2582	160	26	of	of	ADP
dpc-2582	160	27	82	82	NUM
dpc-2582	160	28	,	,	PUNCT
dpc-2582	160	29	not	not	PART
dpc-2582	160	30	significantly	significantly	ADV
dpc-2582	160	31	influenced	influence	VERB
dpc-2582	160	32	by	by	ADP
dpc-2582	160	33	site	site	NOUN
dpc-2582	160	34	of	of	ADP
dpc-2582	160	35	origin	origin	NOUN
dpc-2582	160	36	[	[	X
dpc-2582	160	37	13	13	NUM
dpc-2582	160	38	]	]	PUNCT
dpc-2582	160	39	.	.	PUNCT
dpc-2582	161	1	demographic	demographic	ADJ
dpc-2582	161	2	data	datum	NOUN
dpc-2582	161	3	also	also	ADV
dpc-2582	161	4	confirm	confirm	VERB
dpc-2582	161	5	that	that	SCONJ
dpc-2582	161	6	mucosal	mucosal	ADJ
dpc-2582	161	7	melanoma	melanoma	NOUN
dpc-2582	161	8	has	have	VERB
dpc-2582	161	9	a	a	DET
dpc-2582	161	10	higher	high	ADJ
dpc-2582	161	11	prevalence	prevalence	NOUN
dpc-2582	161	12	in	in	ADP
dpc-2582	161	13	females	female	NOUN
dpc-2582	161	14	[	[	X
dpc-2582	161	15	9	9	NUM
dpc-2582	161	16	]	]	PUNCT
dpc-2582	161	17	;	;	PUNCT
dpc-2582	161	18	this	this	DET
dpc-2582	161	19	result	result	NOUN
dpc-2582	161	20	is	be	AUX
dpc-2582	161	21	largely	largely	ADV
dpc-2582	161	22	driven	drive	VERB
dpc-2582	161	23	by	by	ADP
dpc-2582	161	24	cases	case	NOUN
dpc-2582	161	25	of	of	ADP
dpc-2582	161	26	vulvovaginal	vulvovaginal	ADJ
dpc-2582	161	27	melanoma	melanoma	NOUN
dpc-2582	161	28	in	in	ADP
dpc-2582	161	29	the	the	DET
dpc-2582	161	30	urogenital	urogenital	ADJ
dpc-2582	161	31	melanoma	melanoma	NOUN
dpc-2582	161	32	subgroup	subgroup	NOUN
dpc-2582	161	33	.	.	PUNCT
dpc-2582	162	1	surprisingly	surprisingly	ADV
dpc-2582	162	2	,	,	PUNCT
dpc-2582	162	3	we	we	PRON
dpc-2582	162	4	have	have	VERB
dpc-2582	162	5	no	no	DET
dpc-2582	162	6	records	record	NOUN
dpc-2582	162	7	of	of	ADP
dpc-2582	162	8	oral	oral	ADJ
dpc-2582	162	9	cavity	cavity	NOUN
dpc-2582	162	10	mucosal	mucosal	NOUN
dpc-2582	162	11	melanomas	melanoma	NOUN
dpc-2582	162	12	,	,	PUNCT
dpc-2582	162	13	which	which	PRON
dpc-2582	162	14	alone	alone	ADV
dpc-2582	162	15	have	have	AUX
dpc-2582	162	16	been	be	AUX
dpc-2582	162	17	described	describe	VERB
dpc-2582	162	18	as	as	ADP
dpc-2582	162	19	the	the	DET
dpc-2582	162	20	second	second	ADJ
dpc-2582	162	21	most	most	ADV
dpc-2582	162	22	frequent	frequent	ADJ
dpc-2582	162	23	location	location	NOUN
dpc-2582	162	24	in	in	ADP
dpc-2582	162	25	the	the	DET
dpc-2582	162	26	head	head	NOUN
dpc-2582	162	27	and	and	CCONJ
dpc-2582	162	28	neck	neck	NOUN
dpc-2582	162	29	region	region	NOUN
dpc-2582	163	1	[	[	X
dpc-2582	163	2	2,8,9	2,8,9	NUM
dpc-2582	163	3	]	]	X
dpc-2582	163	4	.	.	PUNCT
dpc-2582	164	1	histologically	histologically	ADV
dpc-2582	164	2	,	,	PUNCT
dpc-2582	164	3	most	most	ADJ
dpc-2582	164	4	cases	case	NOUN
dpc-2582	164	5	were	be	AUX
dpc-2582	164	6	made	make	VERB
dpc-2582	164	7	by	by	ADP
dpc-2582	164	8	epithelioid	epithelioid	NOUN
dpc-2582	164	9	cells	cell	NOUN
dpc-2582	164	10	,	,	PUNCT
dpc-2582	164	11	regardless	regardless	ADV
dpc-2582	164	12	of	of	ADP
dpc-2582	164	13	the	the	DET
dpc-2582	164	14	site	site	NOUN
dpc-2582	164	15	of	of	ADP
dpc-2582	164	16	origin	origin	NOUN
dpc-2582	164	17	.	.	PUNCT
dpc-2582	165	1	in	in	ADP
dpc-2582	165	2	many	many	ADJ
dpc-2582	165	3	cases	case	NOUN
dpc-2582	165	4	,	,	PUNCT
dpc-2582	165	5	pleomorphic	pleomorphic	ADJ
dpc-2582	165	6	original	original	ADJ
dpc-2582	165	7	article	article	NOUN
dpc-2582	165	8	|	|	ADV
dpc-2582	165	9	dermatol	dermatol	ADJ
dpc-2582	165	10	pract	pract	NOUN
dpc-2582	165	11	concept	concept	NOUN
dpc-2582	165	12	.	.	PUNCT
dpc-2582	166	1	2023;13(1):e2023057	2023;13(1):e2023057	NUM
dpc-2582	166	2	7	7	NUM
dpc-2582	166	3	table	table	NOUN
dpc-2582	166	4	4	4	NUM
dpc-2582	166	5	.	.	PUNCT
dpc-2582	166	6	multivariable	multivariable	ADJ
dpc-2582	166	7	model	model	NOUN
dpc-2582	166	8	of	of	ADP
dpc-2582	166	9	risk	risk	NOUN
dpc-2582	166	10	factors	factor	NOUN
dpc-2582	166	11	for	for	ADP
dpc-2582	166	12	mortality	mortality	NOUN
dpc-2582	166	13	in	in	ADP
dpc-2582	166	14	mucosal	mucosal	ADJ
dpc-2582	166	15	melanomas	melanoma	NOUN
dpc-2582	166	16	.	.	PUNCT
dpc-2582	167	1	hr	hr	NOUN
dpc-2582	167	2	95	95	NUM
dpc-2582	167	3	%	%	NOUN
dpc-2582	167	4	ci	ci	NOUN
dpc-2582	167	5	p	p	ADJ
dpc-2582	167	6	-	-	PUNCT
dpc-2582	167	7	value	value	NOUN
dpc-2582	167	8	age	age	NOUN
dpc-2582	167	9	at	at	ADP
dpc-2582	167	10	diagnosis	diagnosis	NOUN
dpc-2582	167	11	1.02	1.02	NUM
dpc-2582	167	12	(	(	PUNCT
dpc-2582	167	13	0.96	0.96	NUM
dpc-2582	167	14	-	-	SYM
dpc-2582	167	15	1.09	1.09	NUM
dpc-2582	167	16	)	)	PUNCT
dpc-2582	167	17	0.574	0.574	NUM
dpc-2582	167	18	gender	gender	NOUN
dpc-2582	167	19	female	female	ADJ
dpc-2582	167	20	ref	ref	NOUN
dpc-2582	167	21	.	.	PUNCT
dpc-2582	168	1	male	male	NOUN
dpc-2582	168	2	3.33	3.33	NUM
dpc-2582	168	3	(	(	PUNCT
dpc-2582	168	4	0.98	0.98	NUM
dpc-2582	168	5	-	-	SYM
dpc-2582	168	6	11.25	11.25	NUM
dpc-2582	168	7	)	)	PUNCT
dpc-2582	168	8	0.107	0.107	NUM
dpc-2582	168	9	metastasis	metastasis	NOUN
dpc-2582	168	10	at	at	ADP
dpc-2582	168	11	diagnosis	diagnosis	NOUN
dpc-2582	168	12	no	no	DET
dpc-2582	168	13	ref	ref	NOUN
dpc-2582	168	14	.	.	PUNCT
dpc-2582	169	1	yes	yes	INTJ
dpc-2582	169	2	26.55	26.55	NUM
dpc-2582	169	3	(	(	PUNCT
dpc-2582	169	4	3.18	3.18	NUM
dpc-2582	169	5	-	-	SYM
dpc-2582	169	6	221.42	221.42	NUM
dpc-2582	169	7	)	)	PUNCT
dpc-2582	169	8	0.001	0.001	NUM
dpc-2582	169	9	first	first	ADJ
dpc-2582	169	10	-	-	PUNCT
dpc-2582	169	11	line	line	NOUN
dpc-2582	169	12	biological	biological	ADJ
dpc-2582	169	13	therapy	therapy	NOUN
dpc-2582	169	14	no	no	DET
dpc-2582	169	15	ref	ref	NOUN
dpc-2582	169	16	.	.	PUNCT
dpc-2582	170	1	nivolumab	nivolumab	ADP
dpc-2582	170	2	0.10	0.10	NUM
dpc-2582	170	3	(	(	PUNCT
dpc-2582	170	4	0.01	0.01	NUM
dpc-2582	170	5	-	-	PUNCT
dpc-2582	170	6	0.75	0.75	NUM
dpc-2582	170	7	)	)	PUNCT
dpc-2582	170	8	0.025	0.025	NUM
dpc-2582	170	9	pembrolizumab	pembrolizumab	NOUN
dpc-2582	170	10	0.04	0.04	NUM
dpc-2582	170	11	(	(	PUNCT
dpc-2582	170	12	0.01	0.01	NUM
dpc-2582	170	13	-	-	PUNCT
dpc-2582	170	14	0.91	0.91	NUM
dpc-2582	170	15	)	)	PUNCT
dpc-2582	170	16	0.044	0.044	NUM
dpc-2582	170	17	imatinib	imatinib	NOUN
dpc-2582	170	18	0.09	0.09	NUM
dpc-2582	170	19	(	(	PUNCT
dpc-2582	170	20	0.0	0.0	NUM
dpc-2582	170	21	-	-	SYM
dpc-2582	170	22	2.02	2.02	NUM
dpc-2582	170	23	)	)	PUNCT
dpc-2582	170	24	0.133	0.133	NUM
dpc-2582	170	25	ci	ci	NOUN
dpc-2582	170	26	:	:	PUNCT
dpc-2582	170	27	confidence	confidence	NOUN
dpc-2582	170	28	interval	interval	NOUN
dpc-2582	170	29	figure	figure	NOUN
dpc-2582	170	30	3	3	NUM
dpc-2582	170	31	.	.	NOUN
dpc-2582	170	32	vulvar	vulvar	NOUN
dpc-2582	170	33	melanoma	melanoma	NOUN
dpc-2582	170	34	(	(	PUNCT
dpc-2582	170	35	a	a	NOUN
dpc-2582	170	36	)	)	PUNCT
dpc-2582	170	37	clinical	clinical	ADJ
dpc-2582	170	38	overview	overview	NOUN
dpc-2582	170	39	of	of	ADP
dpc-2582	170	40	a	a	DET
dpc-2582	170	41	nodular	nodular	ADJ
dpc-2582	170	42	hyperpigmented	hyperpigmented	ADJ
dpc-2582	170	43	lesion	lesion	NOUN
dpc-2582	170	44	of	of	ADP
dpc-2582	170	45	the	the	DET
dpc-2582	170	46	vulva	vulva	NOUN
dpc-2582	170	47	.	.	PUNCT
dpc-2582	171	1	(	(	PUNCT
dpc-2582	171	2	b	b	X
dpc-2582	171	3	)	)	PUNCT
dpc-2582	171	4	dermoscopy	dermoscopy	NOUN
dpc-2582	171	5	of	of	ADP
dpc-2582	171	6	the	the	DET
dpc-2582	171	7	nodular	nodular	ADJ
dpc-2582	171	8	part	part	NOUN
dpc-2582	171	9	shows	show	VERB
dpc-2582	171	10	a	a	DET
dpc-2582	171	11	blue	blue	ADJ
dpc-2582	171	12	-	-	PUNCT
dpc-2582	171	13	black	black	ADJ
dpc-2582	171	14	structureless	structureless	ADJ
dpc-2582	171	15	area	area	NOUN
dpc-2582	171	16	with	with	ADP
dpc-2582	171	17	shiny	shiny	ADJ
dpc-2582	171	18	white	white	ADJ
dpc-2582	171	19	structures	structure	NOUN
dpc-2582	171	20	and	and	CCONJ
dpc-2582	171	21	negative	negative	ADJ
dpc-2582	171	22	pigment	pigment	NOUN
dpc-2582	171	23	network	network	NOUN
dpc-2582	171	24	at	at	ADP
dpc-2582	171	25	the	the	DET
dpc-2582	171	26	implant	implant	ADJ
dpc-2582	171	27	base	base	NOUN
dpc-2582	171	28	.	.	PUNCT
dpc-2582	172	1	(	(	PUNCT
dpc-2582	172	2	c	c	X
dpc-2582	172	3	)	)	PUNCT
dpc-2582	172	4	dermoscopy	dermoscopy	NOUN
dpc-2582	172	5	of	of	ADP
dpc-2582	172	6	the	the	DET
dpc-2582	172	7	flat	flat	ADJ
dpc-2582	172	8	part	part	NOUN
dpc-2582	172	9	shows	show	VERB
dpc-2582	172	10	blue	blue	ADJ
dpc-2582	172	11	and	and	CCONJ
dpc-2582	172	12	black	black	ADJ
dpc-2582	172	13	globules	globule	NOUN
dpc-2582	172	14	and	and	CCONJ
dpc-2582	172	15	blotches	blotch	NOUN
dpc-2582	172	16	,	,	PUNCT
dpc-2582	172	17	a	a	DET
dpc-2582	172	18	blue	blue	ADJ
dpc-2582	172	19	-	-	PUNCT
dpc-2582	172	20	white	white	ADJ
dpc-2582	172	21	veil	veil	NOUN
dpc-2582	172	22	,	,	PUNCT
dpc-2582	172	23	and	and	CCONJ
dpc-2582	172	24	shiny	shiny	ADJ
dpc-2582	172	25	white	white	ADJ
dpc-2582	172	26	structures	structure	NOUN
dpc-2582	172	27	.	.	PUNCT
dpc-2582	173	1	(	(	PUNCT
dpc-2582	173	2	d	d	X
dpc-2582	173	3	)	)	PUNCT
dpc-2582	173	4	histology	histology	NOUN
dpc-2582	173	5	:	:	PUNCT
dpc-2582	173	6	the	the	DET
dpc-2582	173	7	neoplasm	neoplasm	NOUN
dpc-2582	173	8	is	be	AUX
dpc-2582	173	9	largely	largely	ADV
dpc-2582	173	10	ulcerated	ulcerated	ADJ
dpc-2582	173	11	,	,	PUNCT
dpc-2582	173	12	shows	show	VERB
dpc-2582	173	13	discrete	discrete	ADJ
dpc-2582	173	14	necrotic	necrotic	ADJ
dpc-2582	173	15	areas	area	NOUN
dpc-2582	173	16	,	,	PUNCT
dpc-2582	173	17	and	and	CCONJ
dpc-2582	173	18	reaches	reach	VERB
dpc-2582	173	19	11	11	NUM
dpc-2582	173	20	mm	mm	NOUN
dpc-2582	173	21	thickness	thickness	NOUN
dpc-2582	173	22	according	accord	VERB
dpc-2582	173	23	to	to	ADP
dpc-2582	173	24	breslow	breslow	NOUN
dpc-2582	173	25	.	.	PUNCT
dpc-2582	174	1	at	at	ADP
dpc-2582	174	2	a	a	DET
dpc-2582	174	3	higher	high	ADJ
dpc-2582	174	4	power	power	NOUN
dpc-2582	174	5	view	view	NOUN
dpc-2582	174	6	,	,	PUNCT
dpc-2582	174	7	vascular	vascular	ADJ
dpc-2582	174	8	invasion	invasion	NOUN
dpc-2582	174	9	of	of	ADP
dpc-2582	174	10	neoplastic	neoplastic	ADJ
dpc-2582	174	11	cells	cell	NOUN
dpc-2582	174	12	is	be	AUX
dpc-2582	174	13	visible	visible	ADJ
dpc-2582	174	14	(	(	PUNCT
dpc-2582	174	15	arrow	arrow	NOUN
dpc-2582	174	16	)	)	PUNCT
dpc-2582	174	17	.	.	PUNCT
dpc-2582	175	1	8	8	NUM
dpc-2582	175	2	original	original	ADJ
dpc-2582	175	3	article	article	NOUN
dpc-2582	175	4	|	|	ADV
dpc-2582	175	5	dermatol	dermatol	ADJ
dpc-2582	175	6	pract	pract	NOUN
dpc-2582	175	7	concept	concept	NOUN
dpc-2582	175	8	.	.	PUNCT
dpc-2582	176	1	2023;13(1):e2023057	2023;13(1):e2023057	NUM
dpc-2582	176	2	figure	figure	NOUN
dpc-2582	176	3	4	4	NUM
dpc-2582	176	4	.	.	PUNCT
dpc-2582	177	1	architectural	architectural	ADJ
dpc-2582	177	2	features	feature	NOUN
dpc-2582	177	3	of	of	ADP
dpc-2582	177	4	mucosal	mucosal	ADJ
dpc-2582	177	5	melanoma	melanoma	NOUN
dpc-2582	177	6	in	in	ADP
dpc-2582	177	7	hematoxylin	hematoxylin	PROPN
dpc-2582	177	8	and	and	CCONJ
dpc-2582	177	9	eosin	eosin	NOUN
dpc-2582	177	10	.	.	PUNCT
dpc-2582	178	1	(	(	PUNCT
dpc-2582	178	2	a	a	X
dpc-2582	178	3	)	)	PUNCT
dpc-2582	178	4	a	a	DET
dpc-2582	178	5	sinonasal	sinonasal	ADJ
dpc-2582	178	6	melanoma	melanoma	NOUN
dpc-2582	178	7	growing	grow	VERB
dpc-2582	178	8	as	as	ADP
dpc-2582	178	9	a	a	DET
dpc-2582	178	10	polypoid	polypoid	ADJ
dpc-2582	178	11	,	,	PUNCT
dpc-2582	178	12	edematous	edematous	ADJ
dpc-2582	178	13	,	,	PUNCT
dpc-2582	178	14	and	and	CCONJ
dpc-2582	178	15	highly	highly	ADV
dpc-2582	178	16	vascularized	vascularized	ADJ
dpc-2582	178	17	mass	mass	NOUN
dpc-2582	178	18	.	.	PUNCT
dpc-2582	179	1	melanoma	melanoma	NOUN
dpc-2582	179	2	involves	involve	VERB
dpc-2582	179	3	the	the	DET
dpc-2582	179	4	entire	entire	ADJ
dpc-2582	179	5	polyp	polyp	NOUN
dpc-2582	179	6	with	with	ADP
dpc-2582	179	7	multiple	multiple	ADJ
dpc-2582	179	8	confluent	confluent	ADJ
dpc-2582	179	9	nodules	nodule	NOUN
dpc-2582	179	10	,	,	PUNCT
dpc-2582	179	11	reaching	reach	VERB
dpc-2582	179	12	at	at	ADV
dpc-2582	179	13	least	least	ADV
dpc-2582	179	14	1	1	NUM
dpc-2582	179	15	mm	mm	NOUN
dpc-2582	179	16	breslow	breslow	NOUN
dpc-2582	179	17	thickness	thickness	NOUN
dpc-2582	179	18	.	.	PUNCT
dpc-2582	180	1	the	the	DET
dpc-2582	180	2	transitional	transitional	ADJ
dpc-2582	180	3	respiratory	respiratory	ADJ
dpc-2582	180	4	epithelium	epithelium	NOUN
dpc-2582	180	5	is	be	AUX
dpc-2582	180	6	still	still	ADV
dpc-2582	180	7	recognizable	recognizable	ADJ
dpc-2582	180	8	all	all	ADV
dpc-2582	180	9	around	around	ADV
dpc-2582	180	10	.	.	PUNCT
dpc-2582	181	1	(	(	PUNCT
dpc-2582	181	2	b	b	X
dpc-2582	181	3	)	)	PUNCT
dpc-2582	181	4	a	a	DET
dpc-2582	181	5	nodular	nodular	ADJ
dpc-2582	181	6	melanoma	melanoma	NOUN
dpc-2582	181	7	arising	arise	VERB
dpc-2582	181	8	at	at	ADP
dpc-2582	181	9	the	the	DET
dpc-2582	181	10	interface	interface	NOUN
dpc-2582	181	11	between	between	ADP
dpc-2582	181	12	intestinal	intestinal	ADJ
dpc-2582	181	13	and	and	CCONJ
dpc-2582	181	14	squamous	squamous	ADJ
dpc-2582	181	15	perianal	perianal	ADJ
dpc-2582	181	16	epithelium	epithelium	NOUN
dpc-2582	181	17	.	.	PUNCT
dpc-2582	181	18	 	 	SPACE
dpc-2582	182	1	breslow	breslow	ADJ
dpc-2582	182	2	thickness	thickness	NOUN
dpc-2582	182	3	is	be	AUX
dpc-2582	182	4	14	14	NUM
dpc-2582	182	5	mm	mm	NOUN
dpc-2582	182	6	(	(	PUNCT
dpc-2582	182	7	c	c	NOUN
dpc-2582	182	8	)	)	PUNCT
dpc-2582	182	9	a	a	DET
dpc-2582	182	10	vaginal	vaginal	ADJ
dpc-2582	182	11	nodular	nodular	ADJ
dpc-2582	182	12	melanoma	melanoma	NOUN
dpc-2582	182	13	without	without	ADP
dpc-2582	182	14	any	any	DET
dpc-2582	182	15	visible	visible	ADJ
dpc-2582	182	16	in	in	ADP
dpc-2582	182	17	situ	situ	ADJ
dpc-2582	182	18	component	component	NOUN
dpc-2582	182	19	in	in	ADP
dpc-2582	182	20	the	the	DET
dpc-2582	182	21	squamous	squamous	ADJ
dpc-2582	182	22	vaginal	vaginal	ADJ
dpc-2582	182	23	epithelium	epithelium	NOUN
dpc-2582	182	24	.	.	PUNCT
dpc-2582	183	1	the	the	DET
dpc-2582	183	2	tumor	tumor	NOUN
dpc-2582	183	3	is	be	AUX
dpc-2582	183	4	superficially	superficially	ADV
dpc-2582	183	5	ulcerated	ulcerated	ADJ
dpc-2582	183	6	,	,	PUNCT
dpc-2582	183	7	and	and	CCONJ
dpc-2582	183	8	breslow	breslow	ADJ
dpc-2582	183	9	thickness	thickness	NOUN
dpc-2582	183	10	is	be	AUX
dpc-2582	183	11	9	9	NUM
dpc-2582	183	12	mm	mm	NOUN
dpc-2582	183	13	.	.	PUNCT
dpc-2582	184	1	areas	area	NOUN
dpc-2582	184	2	with	with	ADP
dpc-2582	184	3	bizarre	bizarre	ADJ
dpc-2582	184	4	,	,	PUNCT
dpc-2582	184	5	giant	giant	ADJ
dpc-2582	184	6	cells	cell	NOUN
dpc-2582	184	7	were	be	AUX
dpc-2582	184	8	present	present	ADJ
dpc-2582	184	9	.	.	PUNCT
dpc-2582	185	1	only	only	ADV
dpc-2582	185	2	two	two	NUM
dpc-2582	185	3	cases	case	NOUN
dpc-2582	185	4	of	of	ADP
dpc-2582	185	5	spindle	spindle	NOUN
dpc-2582	185	6	cell	cell	NOUN
dpc-2582	185	7	melanomas	melanomas	NOUN
dpc-2582	185	8	were	be	AUX
dpc-2582	185	9	recorded	record	VERB
dpc-2582	185	10	,	,	PUNCT
dpc-2582	185	11	even	even	ADV
dpc-2582	185	12	if	if	SCONJ
dpc-2582	185	13	spindle	spindle	NOUN
dpc-2582	185	14	cell	cell	NOUN
dpc-2582	185	15	areas	area	NOUN
dpc-2582	185	16	occurred	occur	VERB
dpc-2582	185	17	in	in	ADP
dpc-2582	185	18	three	three	NUM
dpc-2582	185	19	cases	case	NOUN
dpc-2582	185	20	with	with	ADP
dpc-2582	185	21	a	a	DET
dpc-2582	185	22	mixed	mixed	ADJ
dpc-2582	185	23	pattern	pattern	NOUN
dpc-2582	185	24	of	of	ADP
dpc-2582	185	25	growth	growth	NOUN
dpc-2582	185	26	.	.	PUNCT
dpc-2582	186	1	the	the	DET
dpc-2582	186	2	epithelioid	epithelioid	NOUN
dpc-2582	186	3	features	feature	NOUN
dpc-2582	186	4	and	and	CCONJ
dpc-2582	186	5	the	the	DET
dpc-2582	186	6	presence	presence	NOUN
dpc-2582	186	7	of	of	ADP
dpc-2582	186	8	melanin	melanin	NOUN
dpc-2582	186	9	,	,	PUNCT
dpc-2582	186	10	which	which	PRON
dpc-2582	186	11	in	in	ADP
dpc-2582	186	12	rare	rare	ADJ
dpc-2582	186	13	cases	case	NOUN
dpc-2582	186	14	can	can	AUX
dpc-2582	186	15	be	be	AUX
dpc-2582	186	16	massive	massive	ADJ
dpc-2582	186	17	,	,	PUNCT
dpc-2582	186	18	simplified	simplify	VERB
dpc-2582	186	19	the	the	DET
dpc-2582	186	20	diagnosis	diagnosis	NOUN
dpc-2582	186	21	;	;	PUNCT
dpc-2582	186	22	vice	vice	NOUN
dpc-2582	186	23	versa	versa	ADV
dpc-2582	186	24	,	,	PUNCT
dpc-2582	186	25	differential	differential	ADJ
dpc-2582	186	26	diagnosis	diagnosis	NOUN
dpc-2582	186	27	resulted	result	VERB
dpc-2582	186	28	challenging	challenge	VERB
dpc-2582	186	29	in	in	ADP
dpc-2582	186	30	two	two	NUM
dpc-2582	186	31	cases	case	NOUN
dpc-2582	186	32	of	of	ADP
dpc-2582	186	33	lymphoma	lymphoma	NOUN
dpc-2582	186	34	-	-	PUNCT
dpc-2582	186	35	like	like	ADJ
dpc-2582	186	36	melanoma	melanoma	NOUN
dpc-2582	186	37	(	(	PUNCT
dpc-2582	186	38	one	one	NUM
dpc-2582	186	39	anorectal	anorectal	ADJ
dpc-2582	186	40	and	and	CCONJ
dpc-2582	186	41	one	one	NUM
dpc-2582	186	42	genital	genital	ADJ
dpc-2582	186	43	)	)	PUNCT
dpc-2582	186	44	and	and	CCONJ
dpc-2582	186	45	an	an	DET
dpc-2582	186	46	immunohistochemical	immunohistochemical	ADJ
dpc-2582	186	47	panel	panel	NOUN
dpc-2582	186	48	of	of	ADP
dpc-2582	186	49	stains	stain	NOUN
dpc-2582	186	50	was	be	AUX
dpc-2582	186	51	necessary	necessary	ADJ
dpc-2582	186	52	to	to	PART
dpc-2582	186	53	rule	rule	VERB
dpc-2582	186	54	out	out	ADP
dpc-2582	186	55	a	a	DET
dpc-2582	186	56	lymphoproliferative	lymphoproliferative	ADJ
dpc-2582	186	57	process	process	NOUN
dpc-2582	186	58	.	.	PUNCT
dpc-2582	187	1	more	more	ADJ
dpc-2582	187	2	than	than	ADP
dpc-2582	187	3	half	half	NOUN
dpc-2582	187	4	of	of	ADP
dpc-2582	187	5	mucosal	mucosal	ADJ
dpc-2582	187	6	melanomas	melanomas	NOUN
dpc-2582	187	7	(	(	PUNCT
dpc-2582	187	8	54.4	54.4	NUM
dpc-2582	187	9	%	%	NOUN
dpc-2582	187	10	)	)	PUNCT
dpc-2582	187	11	manifested	manifest	VERB
dpc-2582	187	12	with	with	ADP
dpc-2582	187	13	metastasis	metastasis	NOUN
dpc-2582	187	14	at	at	ADP
dpc-2582	187	15	diagnosis	diagnosis	NOUN
dpc-2582	187	16	.	.	PUNCT
dpc-2582	188	1	patients	patient	NOUN
dpc-2582	188	2	who	who	PRON
dpc-2582	188	3	were	be	AUX
dpc-2582	188	4	discovered	discover	VERB
dpc-2582	188	5	with	with	ADP
dpc-2582	188	6	metastasis	metastasis	NOUN
dpc-2582	188	7	have	have	VERB
dpc-2582	188	8	an	an	DET
dpc-2582	188	9	increased	increase	VERB
dpc-2582	188	10	hr	hr	NOUN
dpc-2582	188	11	for	for	ADP
dpc-2582	188	12	death	death	NOUN
dpc-2582	188	13	as	as	SCONJ
dpc-2582	188	14	highlighted	highlight	VERB
dpc-2582	188	15	by	by	ADP
dpc-2582	188	16	univariate	univariate	ADJ
dpc-2582	188	17	analysis	analysis	NOUN
dpc-2582	188	18	(	(	PUNCT
dpc-2582	188	19	table	table	NOUN
dpc-2582	188	20	3	3	NUM
dpc-2582	188	21	)	)	PUNCT
dpc-2582	188	22	;	;	PUNCT
dpc-2582	188	23	in	in	ADP
dpc-2582	188	24	addition	addition	NOUN
dpc-2582	188	25	,	,	PUNCT
dpc-2582	188	26	the	the	DET
dpc-2582	188	27	prognostic	prognostic	ADJ
dpc-2582	188	28	value	value	NOUN
dpc-2582	188	29	of	of	ADP
dpc-2582	188	30	metastatic	metastatic	ADJ
dpc-2582	188	31	status	status	NOUN
dpc-2582	188	32	at	at	ADP
dpc-2582	188	33	diagnosis	diagnosis	NOUN
dpc-2582	188	34	was	be	AUX
dpc-2582	188	35	reported	report	VERB
dpc-2582	188	36	by	by	ADP
dpc-2582	188	37	the	the	DET
dpc-2582	188	38	multivariate	multivariate	NOUN
dpc-2582	188	39	model	model	NOUN
dpc-2582	188	40	.	.	PUNCT
dpc-2582	189	1	these	these	DET
dpc-2582	189	2	findings	finding	NOUN
dpc-2582	189	3	corroborate	corroborate	VERB
dpc-2582	189	4	the	the	DET
dpc-2582	189	5	evidence	evidence	NOUN
dpc-2582	189	6	that	that	SCONJ
dpc-2582	189	7	diagnosing	diagnose	VERB
dpc-2582	189	8	advanced	advanced	ADJ
dpc-2582	189	9	-	-	PUNCT
dpc-2582	189	10	stage	stage	NOUN
dpc-2582	189	11	tumors	tumor	NOUN
dpc-2582	189	12	has	have	AUX
dpc-2582	189	13	a	a	DET
dpc-2582	189	14	relevant	relevant	ADJ
dpc-2582	189	15	influence	influence	NOUN
dpc-2582	189	16	on	on	ADP
dpc-2582	189	17	prognosis	prognosis	NOUN
dpc-2582	189	18	[	[	X
dpc-2582	189	19	14	14	NUM
dpc-2582	189	20	]	]	PUNCT
dpc-2582	189	21	.	.	PUNCT
dpc-2582	190	1	as	as	SCONJ
dpc-2582	190	2	previously	previously	ADV
dpc-2582	190	3	discussed	discuss	VERB
dpc-2582	190	4	[	[	X
dpc-2582	190	5	9	9	NUM
dpc-2582	190	6	]	]	PUNCT
dpc-2582	190	7	,	,	PUNCT
dpc-2582	190	8	the	the	DET
dpc-2582	190	9	site	site	NOUN
dpc-2582	190	10	of	of	ADP
dpc-2582	190	11	origin	origin	NOUN
dpc-2582	190	12	of	of	ADP
dpc-2582	190	13	neoplasia	neoplasia	NOUN
dpc-2582	190	14	,	,	PUNCT
dpc-2582	190	15	mostly	mostly	ADV
dpc-2582	190	16	anatomically	anatomically	ADV
dpc-2582	190	17	occult	occult	NOUN
dpc-2582	190	18	,	,	PUNCT
dpc-2582	190	19	is	be	AUX
dpc-2582	190	20	a	a	DET
dpc-2582	190	21	relevant	relevant	ADJ
dpc-2582	190	22	cause	cause	NOUN
dpc-2582	190	23	of	of	ADP
dpc-2582	190	24	late	late	ADJ
dpc-2582	190	25	diagnosis	diagnosis	NOUN
dpc-2582	190	26	.	.	PUNCT
dpc-2582	191	1	incidence	incidence	NOUN
dpc-2582	191	2	of	of	ADP
dpc-2582	191	3	mucosal	mucosal	ADJ
dpc-2582	191	4	melanomas	melanoma	NOUN
dpc-2582	191	5	in	in	ADP
dpc-2582	191	6	older	old	ADJ
dpc-2582	191	7	age	age	NOUN
dpc-2582	191	8	could	could	AUX
dpc-2582	191	9	be	be	AUX
dpc-2582	191	10	an	an	DET
dpc-2582	191	11	additional	additional	ADJ
dpc-2582	191	12	cause	cause	NOUN
dpc-2582	191	13	,	,	PUNCT
dpc-2582	191	14	as	as	SCONJ
dpc-2582	191	15	older	old	ADJ
dpc-2582	191	16	people	people	NOUN
dpc-2582	191	17	can	can	AUX
dpc-2582	191	18	delay	delay	VERB
dpc-2582	191	19	seeking	seek	VERB
dpc-2582	191	20	physician	physician	NOUN
dpc-2582	191	21	consultation	consultation	NOUN
dpc-2582	191	22	.	.	PUNCT
dpc-2582	192	1	the	the	DET
dpc-2582	192	2	multivariate	multivariate	NOUN
dpc-2582	192	3	model	model	NOUN
dpc-2582	192	4	also	also	ADV
dpc-2582	192	5	showed	show	VERB
dpc-2582	192	6	that	that	SCONJ
dpc-2582	192	7	the	the	DET
dpc-2582	192	8	administration	administration	NOUN
dpc-2582	192	9	of	of	ADP
dpc-2582	192	10	immunotherapy	immunotherapy	NOUN
dpc-2582	192	11	as	as	ADP
dpc-2582	192	12	a	a	DET
dpc-2582	192	13	first	first	ADJ
dpc-2582	192	14	-	-	PUNCT
dpc-2582	192	15	line	line	NOUN
dpc-2582	192	16	treatment	treatment	NOUN
dpc-2582	192	17	was	be	AUX
dpc-2582	192	18	a	a	DET
dpc-2582	192	19	protective	protective	ADJ
dpc-2582	192	20	factor	factor	NOUN
dpc-2582	192	21	for	for	ADP
dpc-2582	192	22	death	death	NOUN
dpc-2582	192	23	,	,	PUNCT
dpc-2582	192	24	with	with	ADP
dpc-2582	192	25	a	a	DET
dpc-2582	192	26	statistical	statistical	ADJ
dpc-2582	192	27	significance	significance	NOUN
dpc-2582	192	28	both	both	CCONJ
dpc-2582	192	29	for	for	ADP
dpc-2582	192	30	nivolumab	nivolumab	NOUN
dpc-2582	192	31	and	and	CCONJ
dpc-2582	192	32	pembrolizumab	pembrolizumab	NOUN
dpc-2582	192	33	.	.	PUNCT
dpc-2582	193	1	no	no	DET
dpc-2582	193	2	significance	significance	NOUN
dpc-2582	193	3	has	have	AUX
dpc-2582	193	4	been	be	AUX
dpc-2582	193	5	obtained	obtain	VERB
dpc-2582	193	6	for	for	ADP
dpc-2582	193	7	imatinib	imatinib	NOUN
dpc-2582	193	8	,	,	PUNCT
dpc-2582	193	9	because	because	SCONJ
dpc-2582	193	10	of	of	ADP
dpc-2582	193	11	the	the	DET
dpc-2582	193	12	small	small	ADJ
dpc-2582	193	13	sample	sample	NOUN
dpc-2582	193	14	.	.	PUNCT
dpc-2582	194	1	it	it	PRON
dpc-2582	194	2	is	be	AUX
dpc-2582	194	3	interesting	interesting	ADJ
dpc-2582	194	4	to	to	PART
dpc-2582	194	5	highlight	highlight	VERB
dpc-2582	194	6	that	that	PRON
dpc-2582	194	7	,	,	PUNCT
dpc-2582	194	8	despite	despite	SCONJ
dpc-2582	194	9	the	the	DET
dpc-2582	194	10	small	small	ADJ
dpc-2582	194	11	sample	sample	NOUN
dpc-2582	194	12	size	size	NOUN
dpc-2582	194	13	in	in	ADP
dpc-2582	194	14	the	the	DET
dpc-2582	194	15	current	current	ADJ
dpc-2582	194	16	study	study	NOUN
dpc-2582	194	17	,	,	PUNCT
dpc-2582	194	18	our	our	PRON
dpc-2582	194	19	data	datum	NOUN
dpc-2582	194	20	support	support	VERB
dpc-2582	194	21	the	the	DET
dpc-2582	194	22	utility	utility	NOUN
dpc-2582	194	23	of	of	ADP
dpc-2582	194	24	original	original	ADJ
dpc-2582	194	25	article	article	NOUN
dpc-2582	194	26	|	|	ADV
dpc-2582	194	27	dermatol	dermatol	ADJ
dpc-2582	194	28	pract	pract	NOUN
dpc-2582	194	29	concept	concept	NOUN
dpc-2582	194	30	.	.	PUNCT
dpc-2582	195	1	2023;13(1):e2023057	2023;13(1):e2023057	NUM
dpc-2582	195	2	9	9	NUM
dpc-2582	195	3	also	also	ADV
dpc-2582	195	4	reported	report	VERB
dpc-2582	195	5	[	[	X
dpc-2582	195	6	18,19	18,19	X
dpc-2582	195	7	]	]	PUNCT
dpc-2582	195	8	that	that	SCONJ
dpc-2582	195	9	females	female	NOUN
dpc-2582	195	10	diagnosed	diagnose	VERB
dpc-2582	195	11	with	with	ADP
dpc-2582	195	12	mucosal	mucosal	NOUN
dpc-2582	195	13	melanomas	melanoma	NOUN
dpc-2582	195	14	have	have	VERB
dpc-2582	195	15	higher	high	ADJ
dpc-2582	195	16	survival	survival	NOUN
dpc-2582	195	17	,	,	PUNCT
dpc-2582	195	18	unrelated	unrelated	ADJ
dpc-2582	195	19	to	to	ADP
dpc-2582	195	20	the	the	DET
dpc-2582	195	21	site	site	NOUN
dpc-2582	195	22	of	of	ADP
dpc-2582	195	23	origin	origin	NOUN
dpc-2582	195	24	;	;	PUNCT
dpc-2582	195	25	thus	thus	ADV
dpc-2582	195	26	,	,	PUNCT
dpc-2582	195	27	the	the	DET
dpc-2582	195	28	longer	long	ADJ
dpc-2582	195	29	survival	survival	NOUN
dpc-2582	195	30	in	in	ADP
dpc-2582	195	31	this	this	DET
dpc-2582	195	32	cohort	cohort	NOUN
dpc-2582	195	33	could	could	AUX
dpc-2582	195	34	also	also	ADV
dpc-2582	195	35	be	be	AUX
dpc-2582	195	36	driven	drive	VERB
dpc-2582	195	37	by	by	ADP
dpc-2582	195	38	the	the	DET
dpc-2582	195	39	prevalence	prevalence	NOUN
dpc-2582	195	40	of	of	ADP
dpc-2582	195	41	vulvovaginal	vulvovaginal	ADJ
dpc-2582	195	42	melanoma	melanoma	NOUN
dpc-2582	195	43	in	in	ADP
dpc-2582	195	44	the	the	DET
dpc-2582	195	45	subgroup	subgroup	NOUN
dpc-2582	195	46	.	.	PUNCT
dpc-2582	196	1	surgical	surgical	ADJ
dpc-2582	196	2	treatment	treatment	NOUN
dpc-2582	196	3	with	with	ADP
dpc-2582	196	4	radical	radical	ADJ
dpc-2582	196	5	intent	intent	NOUN
dpc-2582	196	6	,	,	PUNCT
dpc-2582	196	7	undergone	undergo	VERB
dpc-2582	196	8	by	by	ADP
dpc-2582	196	9	all	all	DET
dpc-2582	196	10	patients	patient	NOUN
dpc-2582	196	11	with	with	ADP
dpc-2582	196	12	urogenital	urogenital	ADJ
dpc-2582	196	13	melanoma	melanoma	NOUN
dpc-2582	196	14	in	in	ADP
dpc-2582	196	15	our	our	PRON
dpc-2582	196	16	series	series	NOUN
dpc-2582	196	17	,	,	PUNCT
dpc-2582	196	18	may	may	AUX
dpc-2582	196	19	be	be	AUX
dpc-2582	196	20	an	an	DET
dpc-2582	196	21	additional	additional	ADJ
dpc-2582	196	22	factor	factor	NOUN
dpc-2582	196	23	influencing	influence	VERB
dpc-2582	196	24	longer	long	ADJ
dpc-2582	196	25	survival	survival	NOUN
dpc-2582	196	26	.	.	PUNCT
dpc-2582	197	1	no	no	DET
dpc-2582	197	2	case	case	NOUN
dpc-2582	197	3	of	of	ADP
dpc-2582	197	4	male	male	ADJ
dpc-2582	197	5	urogenital	urogenital	ADJ
dpc-2582	197	6	melanomas	melanomas	NOUN
dpc-2582	197	7	was	be	AUX
dpc-2582	197	8	reported	report	VERB
dpc-2582	197	9	in	in	ADP
dpc-2582	197	10	the	the	DET
dpc-2582	197	11	database	database	NOUN
dpc-2582	197	12	of	of	ADP
dpc-2582	197	13	the	the	DET
dpc-2582	197	14	pathology	pathology	NOUN
dpc-2582	197	15	unit	unit	NOUN
dpc-2582	197	16	of	of	ADP
dpc-2582	197	17	our	our	PRON
dpc-2582	197	18	hospital	hospital	NOUN
dpc-2582	197	19	confirming	confirm	VERB
dpc-2582	197	20	that	that	SCONJ
dpc-2582	197	21	mucosal	mucosal	ADJ
dpc-2582	197	22	melanoma	melanoma	NOUN
dpc-2582	197	23	of	of	ADP
dpc-2582	197	24	the	the	DET
dpc-2582	197	25	male	male	ADJ
dpc-2582	197	26	genital	genital	ADJ
dpc-2582	197	27	tract	tract	NOUN
dpc-2582	197	28	is	be	AUX
dpc-2582	197	29	a	a	DET
dpc-2582	197	30	very	very	ADV
dpc-2582	197	31	rare	rare	ADJ
dpc-2582	197	32	occurrence	occurrence	NOUN
dpc-2582	197	33	[	[	X
dpc-2582	197	34	4	4	NUM
dpc-2582	197	35	]	]	PUNCT
dpc-2582	197	36	.	.	PUNCT
dpc-2582	198	1	urogenital	urogenital	ADJ
dpc-2582	198	2	melanomas	melanomas	NOUN
dpc-2582	198	3	in	in	ADP
dpc-2582	198	4	our	our	PRON
dpc-2582	198	5	database	database	NOUN
dpc-2582	198	6	manifested	manifest	VERB
dpc-2582	198	7	as	as	ADP
dpc-2582	198	8	a	a	DET
dpc-2582	198	9	vegetating	vegetate	VERB
dpc-2582	198	10	mass	mass	NOUN
dpc-2582	198	11	,	,	PUNCT
dpc-2582	198	12	new	new	ADJ
dpc-2582	198	13	pigmentation	pigmentation	NOUN
dpc-2582	198	14	of	of	ADP
dpc-2582	198	15	the	the	DET
dpc-2582	198	16	external	external	ADJ
dpc-2582	198	17	genitalia	genitalia	NOUN
dpc-2582	198	18	,	,	PUNCT
dpc-2582	198	19	or	or	CCONJ
dpc-2582	198	20	urogenital	urogenital	ADJ
dpc-2582	198	21	bleeding	bleeding	NOUN
dpc-2582	198	22	(	(	PUNCT
dpc-2582	198	23	table	table	NOUN
dpc-2582	198	24	2	2	NUM
dpc-2582	198	25	)	)	PUNCT
dpc-2582	198	26	.	.	PUNCT
dpc-2582	199	1	anorectal	anorectal	ADJ
dpc-2582	199	2	melanoma	melanoma	NOUN
dpc-2582	199	3	patients	patient	NOUN
dpc-2582	199	4	with	with	ADP
dpc-2582	199	5	anorectal	anorectal	ADJ
dpc-2582	199	6	melanoma	melanoma	NOUN
dpc-2582	199	7	showed	show	VERB
dpc-2582	199	8	a	a	DET
dpc-2582	199	9	younger	young	ADJ
dpc-2582	199	10	age	age	NOUN
dpc-2582	199	11	at	at	ADP
dpc-2582	199	12	diagnosis	diagnosis	NOUN
dpc-2582	199	13	(	(	PUNCT
dpc-2582	199	14	table	table	NOUN
dpc-2582	199	15	1	1	NUM
dpc-2582	199	16	)	)	PUNCT
dpc-2582	199	17	.	.	PUNCT
dpc-2582	200	1	immunotherapy	immunotherapy	NOUN
dpc-2582	200	2	to	to	PART
dpc-2582	200	3	prolong	prolong	VERB
dpc-2582	200	4	survival	survival	NOUN
dpc-2582	200	5	in	in	ADP
dpc-2582	200	6	metastatic	metastatic	ADJ
dpc-2582	200	7	mucosal	mucosal	ADJ
dpc-2582	200	8	melanoma	melanoma	NOUN
dpc-2582	201	1	[	[	X
dpc-2582	201	2	7	7	NUM
dpc-2582	201	3	]	]	PUNCT
dpc-2582	201	4	.	.	PUNCT
dpc-2582	202	1	a	a	DET
dpc-2582	202	2	recent	recent	ADJ
dpc-2582	202	3	international	international	ADJ
dpc-2582	202	4	cohort	cohort	NOUN
dpc-2582	202	5	study	study	NOUN
dpc-2582	202	6	[	[	X
dpc-2582	202	7	15	15	NUM
dpc-2582	202	8	]	]	PUNCT
dpc-2582	202	9	remarked	remark	VERB
dpc-2582	202	10	on	on	ADP
dpc-2582	202	11	the	the	DET
dpc-2582	202	12	efficacy	efficacy	NOUN
dpc-2582	202	13	of	of	ADP
dpc-2582	202	14	the	the	DET
dpc-2582	202	15	anti	anti	ADJ
dpc-2582	202	16	-	-	ADJ
dpc-2582	202	17	pd1	pd1	ADJ
dpc-2582	202	18	agent	agent	NOUN
dpc-2582	202	19	in	in	ADP
dpc-2582	202	20	prolonging	prolong	VERB
dpc-2582	202	21	survival	survival	NOUN
dpc-2582	202	22	in	in	ADP
dpc-2582	202	23	metastatic	metastatic	ADJ
dpc-2582	202	24	patients	patient	NOUN
dpc-2582	202	25	,	,	PUNCT
dpc-2582	202	26	even	even	ADV
dpc-2582	202	27	though	though	SCONJ
dpc-2582	202	28	to	to	ADP
dpc-2582	202	29	a	a	DET
dpc-2582	202	30	lesser	less	ADJ
dpc-2582	202	31	extent	extent	NOUN
dpc-2582	202	32	than	than	ADP
dpc-2582	202	33	in	in	ADP
dpc-2582	202	34	cutaneous	cutaneous	ADJ
dpc-2582	202	35	melanoma	melanoma	NOUN
dpc-2582	202	36	.	.	PUNCT
dpc-2582	203	1	in	in	ADP
dpc-2582	203	2	fact	fact	NOUN
dpc-2582	203	3	,	,	PUNCT
dpc-2582	203	4	mucosal	mucosal	ADJ
dpc-2582	203	5	melanoma	melanoma	NOUN
dpc-2582	203	6	has	have	AUX
dpc-2582	203	7	been	be	AUX
dpc-2582	203	8	reported	report	VERB
dpc-2582	203	9	to	to	PART
dpc-2582	203	10	have	have	VERB
dpc-2582	203	11	a	a	DET
dpc-2582	203	12	lower	low	ADJ
dpc-2582	203	13	expression	expression	NOUN
dpc-2582	203	14	of	of	ADP
dpc-2582	203	15	pd	pd	PROPN
dpc-2582	203	16	-	-	PROPN
dpc-2582	203	17	l1	l1	PROPN
dpc-2582	203	18	than	than	ADP
dpc-2582	203	19	its	its	PRON
dpc-2582	203	20	cutaneous	cutaneous	ADJ
dpc-2582	203	21	counterpart	counterpart	NOUN
dpc-2582	204	1	[	[	X
dpc-2582	204	2	16	16	NUM
dpc-2582	204	3	]	]	PUNCT
dpc-2582	204	4	and	and	CCONJ
dpc-2582	204	5	of	of	ADP
dpc-2582	204	6	being	be	AUX
dpc-2582	204	7	more	more	ADV
dpc-2582	204	8	tolerogenic	tolerogenic	ADJ
dpc-2582	204	9	 	 	SPACE
dpc-2582	204	10	[	[	X
dpc-2582	204	11	17	17	NUM
dpc-2582	204	12	]	]	PUNCT
dpc-2582	204	13	probably	probably	ADV
dpc-2582	204	14	because	because	SCONJ
dpc-2582	204	15	of	of	ADP
dpc-2582	204	16	the	the	DET
dpc-2582	204	17	absent	absent	ADJ
dpc-2582	204	18	mutagenic	mutagenic	ADJ
dpc-2582	204	19	role	role	NOUN
dpc-2582	204	20	of	of	ADP
dpc-2582	204	21	uv	uv	NOUN
dpc-2582	204	22	radiation	radiation	NOUN
dpc-2582	204	23	that	that	PRON
dpc-2582	204	24	prevents	prevent	VERB
dpc-2582	204	25	a	a	DET
dpc-2582	204	26	high	high	ADJ
dpc-2582	204	27	tumor	tumor	NOUN
dpc-2582	204	28	mutational	mutational	ADJ
dpc-2582	204	29	load	load	NOUN
dpc-2582	204	30	and	and	CCONJ
dpc-2582	204	31	immunogenicity	immunogenicity	NOUN
dpc-2582	204	32	.	.	PUNCT
dpc-2582	205	1	urogenital	urogenital	ADJ
dpc-2582	205	2	melanoma	melanoma	NOUN
dpc-2582	205	3	in	in	ADP
dpc-2582	205	4	our	our	PRON
dpc-2582	205	5	series	series	NOUN
dpc-2582	205	6	,	,	PUNCT
dpc-2582	205	7	urogenital	urogenital	ADJ
dpc-2582	205	8	melanoma	melanoma	NOUN
dpc-2582	205	9	showed	show	VERB
dpc-2582	205	10	4	4	NUM
dpc-2582	205	11	cases	case	NOUN
dpc-2582	205	12	of	of	ADP
dpc-2582	205	13	metastasis	metastasis	NOUN
dpc-2582	205	14	in	in	ADP
dpc-2582	205	15	locoregional	locoregional	ADJ
dpc-2582	205	16	lymph	lymph	NOUN
dpc-2582	205	17	nodes	node	NOUN
dpc-2582	205	18	and	and	CCONJ
dpc-2582	205	19	no	no	DET
dpc-2582	205	20	distant	distant	ADJ
dpc-2582	205	21	metastasis	metastasis	NOUN
dpc-2582	205	22	at	at	ADP
dpc-2582	205	23	diagnosis	diagnosis	NOUN
dpc-2582	205	24	.	.	PUNCT
dpc-2582	206	1	moreover	moreover	ADV
dpc-2582	206	2	,	,	PUNCT
dpc-2582	206	3	urogenital	urogenital	ADJ
dpc-2582	206	4	melanoma	melanoma	NOUN
dpc-2582	206	5	is	be	AUX
dpc-2582	206	6	the	the	DET
dpc-2582	206	7	subgroup	subgroup	NOUN
dpc-2582	206	8	with	with	ADP
dpc-2582	206	9	the	the	DET
dpc-2582	206	10	longer	long	ADJ
dpc-2582	206	11	os	os	NOUN
dpc-2582	206	12	,	,	PUNCT
dpc-2582	206	13	with	with	ADP
dpc-2582	206	14	full	full	ADJ
dpc-2582	206	15	survival	survival	NOUN
dpc-2582	206	16	at	at	ADP
dpc-2582	206	17	24	24	NUM
dpc-2582	206	18	months	month	NOUN
dpc-2582	206	19	and	and	CCONJ
dpc-2582	206	20	decreased	decrease	VERB
dpc-2582	206	21	survival	survival	NOUN
dpc-2582	206	22	only	only	ADV
dpc-2582	206	23	after	after	ADP
dpc-2582	206	24	26	26	NUM
dpc-2582	206	25	months	month	NOUN
dpc-2582	206	26	(	(	PUNCT
dpc-2582	206	27	figure	figure	NOUN
dpc-2582	206	28	2	2	NUM
dpc-2582	206	29	)	)	PUNCT
dpc-2582	206	30	.	.	PUNCT
dpc-2582	207	1	the	the	DET
dpc-2582	207	2	absence	absence	NOUN
dpc-2582	207	3	at	at	ADP
dpc-2582	207	4	diagnosis	diagnosis	NOUN
dpc-2582	207	5	of	of	ADP
dpc-2582	207	6	disseminated	disseminate	VERB
dpc-2582	207	7	disease	disease	NOUN
dpc-2582	207	8	is	be	AUX
dpc-2582	207	9	probably	probably	ADV
dpc-2582	207	10	the	the	DET
dpc-2582	207	11	most	most	ADV
dpc-2582	207	12	relevant	relevant	ADJ
dpc-2582	207	13	factor	factor	NOUN
dpc-2582	207	14	that	that	PRON
dpc-2582	207	15	influences	influence	VERB
dpc-2582	207	16	cohort	cohort	NOUN
dpc-2582	207	17	survival	survival	NOUN
dpc-2582	207	18	.	.	PUNCT
dpc-2582	208	1	it	it	PRON
dpc-2582	208	2	was	be	AUX
dpc-2582	208	3	figure	figure	NOUN
dpc-2582	208	4	5	5	NUM
dpc-2582	208	5	.	.	PUNCT
dpc-2582	208	6	unusual	unusual	ADJ
dpc-2582	208	7	cytological	cytological	ADJ
dpc-2582	208	8	features	feature	NOUN
dpc-2582	208	9	of	of	ADP
dpc-2582	208	10	mucosal	mucosal	ADJ
dpc-2582	208	11	melanoma	melanoma	NOUN
dpc-2582	208	12	in	in	ADP
dpc-2582	208	13	hematoxylin	hematoxylin	PROPN
dpc-2582	208	14	and	and	CCONJ
dpc-2582	208	15	eosin	eosin	NOUN
dpc-2582	208	16	.	.	PUNCT
dpc-2582	209	1	(	(	PUNCT
dpc-2582	209	2	a	a	X
dpc-2582	209	3	)	)	PUNCT
dpc-2582	209	4	pleomorphic	pleomorphic	ADJ
dpc-2582	209	5	areas	area	NOUN
dpc-2582	209	6	in	in	ADP
dpc-2582	209	7	an	an	DET
dpc-2582	209	8	epithelioid	epithelioid	NOUN
dpc-2582	209	9	vulvar	vulvar	NOUN
dpc-2582	209	10	melanoma	melanoma	NOUN
dpc-2582	209	11	.	.	PUNCT
dpc-2582	210	1	melanocytes	melanocyte	NOUN
dpc-2582	210	2	are	be	AUX
dpc-2582	210	3	irregularly	irregularly	ADV
dpc-2582	210	4	shaped	shape	VERB
dpc-2582	210	5	,	,	PUNCT
dpc-2582	210	6	and	and	CCONJ
dpc-2582	210	7	nuclei	nucleus	NOUN
dpc-2582	210	8	are	be	AUX
dpc-2582	210	9	bizarre	bizarre	ADJ
dpc-2582	210	10	.	.	PUNCT
dpc-2582	211	1	the	the	DET
dpc-2582	211	2	arrow	arrow	NOUN
dpc-2582	211	3	indicates	indicate	VERB
dpc-2582	211	4	an	an	DET
dpc-2582	211	5	abnormal	abnormal	ADJ
dpc-2582	211	6	mitotic	mitotic	ADJ
dpc-2582	211	7	figure	figure	NOUN
dpc-2582	211	8	.	.	PUNCT
dpc-2582	212	1	(	(	PUNCT
dpc-2582	212	2	b	b	X
dpc-2582	212	3	)	)	PUNCT
dpc-2582	212	4	a	a	DET
dpc-2582	212	5	hyperpigmented	hyperpigmente	VERB
dpc-2582	212	6	genital	genital	ADJ
dpc-2582	212	7	melanoma	melanoma	NOUN
dpc-2582	212	8	,	,	PUNCT
dpc-2582	212	9	composed	compose	VERB
dpc-2582	212	10	of	of	ADP
dpc-2582	212	11	middle	middle	ADJ
dpc-2582	212	12	-	-	PUNCT
dpc-2582	212	13	sized	sized	ADJ
dpc-2582	212	14	,	,	PUNCT
dpc-2582	212	15	mitotically	mitotically	ADV
dpc-2582	212	16	active	active	ADJ
dpc-2582	212	17	spindle	spindle	NOUN
dpc-2582	212	18	cells	cell	NOUN
dpc-2582	212	19	.	.	PUNCT
dpc-2582	213	1	(	(	PUNCT
dpc-2582	213	2	c	c	X
dpc-2582	213	3	)	)	PUNCT
dpc-2582	213	4	a	a	DET
dpc-2582	213	5	rectal	rectal	ADJ
dpc-2582	213	6	melanoma	melanoma	NOUN
dpc-2582	213	7	made	make	VERB
dpc-2582	213	8	up	up	ADP
dpc-2582	213	9	of	of	ADP
dpc-2582	213	10	small	small	ADJ
dpc-2582	213	11	,	,	PUNCT
dpc-2582	213	12	monomorphous	monomorphous	ADJ
dpc-2582	213	13	lymphocytic	lymphocytic	ADJ
dpc-2582	213	14	-	-	PUNCT
dpc-2582	213	15	like	like	ADJ
dpc-2582	213	16	cells	cell	NOUN
dpc-2582	213	17	.	.	PUNCT
dpc-2582	214	1	immunohistochemical	immunohistochemical	ADJ
dpc-2582	214	2	staining	staining	NOUN
dpc-2582	214	3	is	be	AUX
dpc-2582	214	4	necessary	necessary	ADJ
dpc-2582	214	5	to	to	PART
dpc-2582	214	6	confirm	confirm	VERB
dpc-2582	214	7	the	the	DET
dpc-2582	214	8	melanocytic	melanocytic	ADJ
dpc-2582	214	9	origin	origin	NOUN
dpc-2582	214	10	of	of	ADP
dpc-2582	214	11	the	the	DET
dpc-2582	214	12	tumor	tumor	NOUN
dpc-2582	214	13	(	(	PUNCT
dpc-2582	214	14	in	in	ADP
dpc-2582	214	15	the	the	DET
dpc-2582	214	16	inset	inset	NOUN
dpc-2582	214	17	,	,	PUNCT
dpc-2582	214	18	hmb45	hmb45	PROPN
dpc-2582	214	19	diffusely	diffusely	ADV
dpc-2582	214	20	stains	stain	VERB
dpc-2582	214	21	the	the	DET
dpc-2582	214	22	cells	cell	NOUN
dpc-2582	214	23	)	)	PUNCT
dpc-2582	214	24	.	.	PUNCT
dpc-2582	215	1	(	(	PUNCT
dpc-2582	215	2	d	d	X
dpc-2582	215	3	)	)	PUNCT
dpc-2582	215	4	a	a	DET
dpc-2582	215	5	rectal	rectal	ADJ
dpc-2582	215	6	melanoma	melanoma	NOUN
dpc-2582	215	7	with	with	ADP
dpc-2582	215	8	a	a	DET
dpc-2582	215	9	rhabdoid	rhabdoid	NOUN
dpc-2582	215	10	appearance	appearance	NOUN
dpc-2582	215	11	.	.	PUNCT
dpc-2582	216	1	neoplastic	neoplastic	ADJ
dpc-2582	216	2	cells	cell	NOUN
dpc-2582	216	3	show	show	VERB
dpc-2582	216	4	a	a	DET
dpc-2582	216	5	large	large	ADJ
dpc-2582	216	6	,	,	PUNCT
dpc-2582	216	7	eosinophilic	eosinophilic	ADJ
dpc-2582	216	8	cytoplasm	cytoplasm	NOUN
dpc-2582	216	9	and	and	CCONJ
dpc-2582	216	10	peripherally	peripherally	ADV
dpc-2582	216	11	located	locate	VERB
dpc-2582	216	12	round	round	ADJ
dpc-2582	216	13	nucleus	nucleus	NOUN
dpc-2582	216	14	.	.	PUNCT
dpc-2582	217	1	10	10	NUM
dpc-2582	217	2	original	original	ADJ
dpc-2582	217	3	article	article	NOUN
dpc-2582	217	4	|	|	ADV
dpc-2582	217	5	dermatol	dermatol	ADJ
dpc-2582	217	6	pract	pract	NOUN
dpc-2582	217	7	concept	concept	NOUN
dpc-2582	217	8	.	.	PUNCT
dpc-2582	218	1	2023;13(1):e2023057	2023;13(1):e2023057	NUM
dpc-2582	218	2	additional	additional	ADJ
dpc-2582	218	3	evidence	evidence	NOUN
dpc-2582	218	4	emerging	emerge	VERB
dpc-2582	218	5	from	from	ADP
dpc-2582	218	6	kaplan	kaplan	PROPN
dpc-2582	218	7	-	-	PUNCT
dpc-2582	218	8	meier	meier	PROPN
dpc-2582	218	9	analysis	analysis	NOUN
dpc-2582	218	10	is	be	AUX
dpc-2582	218	11	that	that	SCONJ
dpc-2582	218	12	the	the	DET
dpc-2582	218	13	mortality	mortality	NOUN
dpc-2582	218	14	of	of	ADP
dpc-2582	218	15	sinonasal	sinonasal	ADJ
dpc-2582	218	16	mucosal	mucosal	NOUN
dpc-2582	218	17	melanomas	melanoma	NOUN
dpc-2582	218	18	was	be	AUX
dpc-2582	218	19	higher	high	ADJ
dpc-2582	218	20	in	in	ADP
dpc-2582	218	21	the	the	DET
dpc-2582	218	22	first	first	ADJ
dpc-2582	218	23	24	24	NUM
dpc-2582	218	24	months	month	NOUN
dpc-2582	218	25	and	and	CCONJ
dpc-2582	218	26	then	then	ADV
dpc-2582	218	27	decreased	decrease	VERB
dpc-2582	218	28	,	,	PUNCT
dpc-2582	218	29	reaching	reach	VERB
dpc-2582	218	30	a	a	DET
dpc-2582	218	31	plateau	plateau	NOUN
dpc-2582	218	32	(	(	PUNCT
dpc-2582	218	33	figure	figure	NOUN
dpc-2582	218	34	2	2	NUM
dpc-2582	218	35	)	)	PUNCT
dpc-2582	218	36	.	.	PUNCT
dpc-2582	219	1	factors	factor	NOUN
dpc-2582	219	2	that	that	PRON
dpc-2582	219	3	may	may	AUX
dpc-2582	219	4	influence	influence	VERB
dpc-2582	219	5	this	this	DET
dpc-2582	219	6	behavior	behavior	NOUN
dpc-2582	219	7	,	,	PUNCT
dpc-2582	219	8	such	such	ADJ
dpc-2582	219	9	as	as	ADP
dpc-2582	219	10	radiation	radiation	NOUN
dpc-2582	219	11	therapy	therapy	NOUN
dpc-2582	219	12	,	,	PUNCT
dpc-2582	219	13	administered	administer	VERB
dpc-2582	219	14	to	to	ADP
dpc-2582	219	15	all	all	DET
dpc-2582	219	16	cohort	cohort	NOUN
dpc-2582	219	17	patients	patient	NOUN
dpc-2582	219	18	,	,	PUNCT
dpc-2582	219	19	are	be	AUX
dpc-2582	219	20	still	still	ADV
dpc-2582	219	21	unclear	unclear	ADJ
dpc-2582	219	22	and	and	CCONJ
dpc-2582	219	23	need	need	VERB
dpc-2582	219	24	to	to	PART
dpc-2582	219	25	be	be	AUX
dpc-2582	219	26	further	far	ADV
dpc-2582	219	27	analyzed	analyze	VERB
dpc-2582	219	28	in	in	ADP
dpc-2582	219	29	a	a	DET
dpc-2582	219	30	larger	large	ADJ
dpc-2582	219	31	sample	sample	NOUN
dpc-2582	219	32	.	.	PUNCT
dpc-2582	220	1	sinonasal	sinonasal	ADJ
dpc-2582	220	2	melanomas	melanomas	PROPN
dpc-2582	220	3	in	in	ADP
dpc-2582	220	4	our	our	PRON
dpc-2582	220	5	series	series	NOUN
dpc-2582	220	6	manifested	manifest	VERB
dpc-2582	220	7	with	with	ADP
dpc-2582	220	8	epistaxis	epistaxis	ADJ
dpc-2582	220	9	,	,	PUNCT
dpc-2582	220	10	nasal	nasal	ADJ
dpc-2582	220	11	obstruction	obstruction	NOUN
dpc-2582	220	12	,	,	PUNCT
dpc-2582	220	13	and	and	CCONJ
dpc-2582	220	14	one	one	NUM
dpc-2582	220	15	case	case	NOUN
dpc-2582	220	16	of	of	ADP
dpc-2582	220	17	eyelid	eyelid	NOUN
dpc-2582	220	18	ptosis	ptosis	NOUN
dpc-2582	220	19	(	(	PUNCT
dpc-2582	220	20	table	table	NOUN
dpc-2582	220	21	2	2	NUM
dpc-2582	220	22	)	)	PUNCT
dpc-2582	220	23	.	.	PUNCT
dpc-2582	221	1	conclusions	conclusion	NOUN
dpc-2582	221	2	in	in	ADP
dpc-2582	221	3	conclusion	conclusion	NOUN
dpc-2582	221	4	,	,	PUNCT
dpc-2582	221	5	different	different	ADJ
dpc-2582	221	6	strategies	strategy	NOUN
dpc-2582	221	7	have	have	VERB
dpc-2582	221	8	to	to	PART
dpc-2582	221	9	be	be	AUX
dpc-2582	221	10	developed	develop	VERB
dpc-2582	221	11	to	to	PART
dpc-2582	221	12	avoid	avoid	VERB
dpc-2582	221	13	late	late	ADJ
dpc-2582	221	14	diagnosis	diagnosis	NOUN
dpc-2582	221	15	;	;	PUNCT
dpc-2582	221	16	so	so	ADV
dpc-2582	221	17	far	far	ADV
dpc-2582	221	18	,	,	PUNCT
dpc-2582	221	19	there	there	PRON
dpc-2582	221	20	are	be	VERB
dpc-2582	221	21	no	no	DET
dpc-2582	221	22	targeting	targeting	NOUN
dpc-2582	221	23	campaigns	campaign	NOUN
dpc-2582	221	24	or	or	CCONJ
dpc-2582	221	25	specific	specific	ADJ
dpc-2582	221	26	advice	advice	NOUN
dpc-2582	221	27	that	that	PRON
dpc-2582	221	28	can	can	AUX
dpc-2582	221	29	help	help	VERB
dpc-2582	221	30	physicians	physician	NOUN
dpc-2582	221	31	from	from	ADP
dpc-2582	221	32	different	different	ADJ
dpc-2582	221	33	specialties	specialty	NOUN
dpc-2582	221	34	(	(	PUNCT
dpc-2582	221	35	i.e.	i.e.	X
dpc-2582	221	36	gynecologists	gynecologist	NOUN
dpc-2582	221	37	)	)	PUNCT
dpc-2582	221	38	to	to	PART
dpc-2582	221	39	get	get	VERB
dpc-2582	221	40	early	early	ADJ
dpc-2582	221	41	diagnoses	diagnosis	NOUN
dpc-2582	221	42	of	of	ADP
dpc-2582	221	43	this	this	DET
dpc-2582	221	44	rare	rare	ADJ
dpc-2582	221	45	melanoma	melanoma	NOUN
dpc-2582	221	46	subsets	subset	NOUN
dpc-2582	221	47	.	.	PUNCT
dpc-2582	222	1	as	as	ADP
dpc-2582	222	2	promising	promising	ADJ
dpc-2582	222	3	results	result	NOUN
dpc-2582	222	4	,	,	PUNCT
dpc-2582	222	5	the	the	DET
dpc-2582	222	6	use	use	NOUN
dpc-2582	222	7	of	of	ADP
dpc-2582	222	8	immunotherapy	immunotherapy	NOUN
dpc-2582	222	9	might	might	AUX
dpc-2582	222	10	impact	impact	VERB
dpc-2582	222	11	the	the	DET
dpc-2582	222	12	natural	natural	ADJ
dpc-2582	222	13	history	history	NOUN
dpc-2582	222	14	of	of	ADP
dpc-2582	222	15	mucosal	mucosal	ADJ
dpc-2582	222	16	melanomas	melanoma	NOUN
dpc-2582	222	17	in	in	ADP
dpc-2582	222	18	improving	improve	VERB
dpc-2582	222	19	overall	overall	ADJ
dpc-2582	222	20	or	or	CCONJ
dpc-2582	222	21	disease	disease	NOUN
dpc-2582	222	22	-	-	PUNCT
dpc-2582	222	23	free	free	ADJ
dpc-2582	222	24	survival	survival	NOUN
dpc-2582	222	25	.	.	PUNCT
dpc-2582	223	1	even	even	ADV
dpc-2582	223	2	though	though	SCONJ
dpc-2582	223	3	all	all	DET
dpc-2582	223	4	patients	patient	NOUN
dpc-2582	223	5	surgically	surgically	ADV
dpc-2582	223	6	managed	manage	VERB
dpc-2582	223	7	in	in	ADP
dpc-2582	223	8	this	this	DET
dpc-2582	223	9	subgroup	subgroup	NOUN
dpc-2582	223	10	underwent	undergo	VERB
dpc-2582	223	11	a	a	DET
dpc-2582	223	12	radical	radical	ADJ
dpc-2582	223	13	intent	intent	NOUN
dpc-2582	223	14	procedure	procedure	NOUN
dpc-2582	223	15	,	,	PUNCT
dpc-2582	223	16	kaplan	kaplan	PROPN
dpc-2582	223	17	-	-	PUNCT
dpc-2582	223	18	meier	meier	PROPN
dpc-2582	223	19	analysis	analysis	NOUN
dpc-2582	223	20	showed	show	VERB
dpc-2582	223	21	the	the	DET
dpc-2582	223	22	worst	bad	ADJ
dpc-2582	223	23	survival	survival	NOUN
dpc-2582	223	24	.	.	PUNCT
dpc-2582	224	1	this	this	DET
dpc-2582	224	2	result	result	NOUN
dpc-2582	224	3	is	be	AUX
dpc-2582	224	4	consistent	consistent	ADJ
dpc-2582	224	5	with	with	ADP
dpc-2582	224	6	previous	previous	ADJ
dpc-2582	224	7	reports	report	NOUN
dpc-2582	224	8	[	[	X
dpc-2582	224	9	15,18	15,18	NUM
dpc-2582	224	10	]	]	PUNCT
dpc-2582	224	11	.	.	PUNCT
dpc-2582	225	1	it	it	PRON
dpc-2582	225	2	is	be	AUX
dpc-2582	225	3	reasonable	reasonable	ADJ
dpc-2582	225	4	to	to	PART
dpc-2582	225	5	suppose	suppose	VERB
dpc-2582	225	6	that	that	SCONJ
dpc-2582	225	7	a	a	DET
dpc-2582	225	8	more	more	ADV
dpc-2582	225	9	widespread	widespread	ADJ
dpc-2582	225	10	metastatic	metastatic	ADJ
dpc-2582	225	11	disease	disease	NOUN
dpc-2582	225	12	at	at	ADP
dpc-2582	225	13	diagnosis	diagnosis	NOUN
dpc-2582	225	14	in	in	ADP
dpc-2582	225	15	this	this	DET
dpc-2582	225	16	subgroup	subgroup	NOUN
dpc-2582	225	17	is	be	AUX
dpc-2582	225	18	the	the	DET
dpc-2582	225	19	reason	reason	NOUN
dpc-2582	225	20	for	for	ADP
dpc-2582	225	21	this	this	DET
dpc-2582	225	22	difference	difference	NOUN
dpc-2582	225	23	(	(	PUNCT
dpc-2582	225	24	table	table	NOUN
dpc-2582	225	25	1	1	NUM
dpc-2582	225	26	)	)	PUNCT
dpc-2582	225	27	.	.	PUNCT
dpc-2582	226	1	it	it	PRON
dpc-2582	226	2	was	be	AUX
dpc-2582	226	3	demonstrated	demonstrate	VERB
dpc-2582	226	4	that	that	SCONJ
dpc-2582	226	5	anorectal	anorectal	ADJ
dpc-2582	226	6	melanoma	melanoma	NOUN
dpc-2582	226	7	has	have	VERB
dpc-2582	226	8	an	an	DET
dpc-2582	226	9	intrinsically	intrinsically	ADV
dpc-2582	226	10	aggressive	aggressive	ADJ
dpc-2582	226	11	behavior	behavior	NOUN
dpc-2582	226	12	because	because	SCONJ
dpc-2582	226	13	of	of	ADP
dpc-2582	226	14	the	the	DET
dpc-2582	226	15	high	high	ADJ
dpc-2582	226	16	propensity	propensity	NOUN
dpc-2582	226	17	to	to	PART
dpc-2582	226	18	develop	develop	VERB
dpc-2582	226	19	distant	distant	ADJ
dpc-2582	226	20	and	and	CCONJ
dpc-2582	226	21	brain	brain	NOUN
dpc-2582	226	22	metastases	metastasis	NOUN
dpc-2582	226	23	[	[	X
dpc-2582	226	24	18	18	NUM
dpc-2582	226	25	]	]	X
dpc-2582	226	26	;	;	PUNCT
dpc-2582	226	27	in	in	ADP
dpc-2582	226	28	our	our	PRON
dpc-2582	226	29	series	series	NOUN
dpc-2582	226	30	,	,	PUNCT
dpc-2582	226	31	this	this	DET
dpc-2582	226	32	subgroup	subgroup	NOUN
dpc-2582	226	33	is	be	AUX
dpc-2582	226	34	the	the	DET
dpc-2582	226	35	only	only	ADJ
dpc-2582	226	36	one	one	NUM
dpc-2582	226	37	manifesting	manifest	VERB
dpc-2582	226	38	with	with	ADP
dpc-2582	226	39	2	2	NUM
dpc-2582	226	40	cases	case	NOUN
dpc-2582	226	41	of	of	ADP
dpc-2582	226	42	cerebral	cerebral	ADJ
dpc-2582	226	43	metastasis	metastasis	NOUN
dpc-2582	226	44	and	and	CCONJ
dpc-2582	226	45	with	with	ADP
dpc-2582	226	46	3	3	NUM
dpc-2582	226	47	cases	case	NOUN
dpc-2582	226	48	of	of	ADP
dpc-2582	226	49	multiple	multiple	ADJ
dpc-2582	226	50	visceral	visceral	ADJ
dpc-2582	226	51	metastases	metastasis	NOUN
dpc-2582	226	52	at	at	ADP
dpc-2582	226	53	diagnosis	diagnosis	NOUN
dpc-2582	226	54	.	.	PUNCT
dpc-2582	227	1	anorectal	anorectal	ADJ
dpc-2582	227	2	melanomas	melanomas	NOUN
dpc-2582	227	3	diagnosed	diagnose	VERB
dpc-2582	227	4	in	in	ADP
dpc-2582	227	5	our	our	PRON
dpc-2582	227	6	clinics	clinic	NOUN
dpc-2582	227	7	had	have	AUX
dpc-2582	227	8	presenting	present	VERB
dpc-2582	227	9	symptoms	symptom	NOUN
dpc-2582	227	10	such	such	ADJ
dpc-2582	227	11	as	as	ADP
dpc-2582	227	12	rectal	rectal	ADJ
dpc-2582	227	13	bleeding	bleeding	NOUN
dpc-2582	227	14	,	,	PUNCT
dpc-2582	227	15	anemia	anemia	NOUN
dpc-2582	227	16	,	,	PUNCT
dpc-2582	227	17	and	and	CCONJ
dpc-2582	227	18	prolapse	prolapse	NOUN
dpc-2582	227	19	of	of	ADP
dpc-2582	227	20	the	the	DET
dpc-2582	227	21	tumor	tumor	NOUN
dpc-2582	227	22	mass	mass	NOUN
dpc-2582	227	23	(	(	PUNCT
dpc-2582	227	24	table	table	NOUN
dpc-2582	227	25	2	2	NUM
dpc-2582	227	26	)	)	PUNCT
dpc-2582	227	27	.	.	PUNCT
dpc-2582	228	1	sinonasal	sinonasal	ADJ
dpc-2582	228	2	melanoma	melanoma	NOUN
dpc-2582	228	3	in	in	ADP
dpc-2582	228	4	the	the	DET
dpc-2582	228	5	sinonasal	sinonasal	PROPN
dpc-2582	228	6	region	region	NOUN
dpc-2582	228	7	,	,	PUNCT
dpc-2582	228	8	breslow	breslow	ADJ
dpc-2582	228	9	thickness	thickness	NOUN
dpc-2582	228	10	is	be	AUX
dpc-2582	228	11	not	not	PART
dpc-2582	228	12	easy	easy	ADJ
dpc-2582	228	13	to	to	PART
dpc-2582	228	14	apply	apply	VERB
dpc-2582	228	15	because	because	SCONJ
dpc-2582	228	16	of	of	ADP
dpc-2582	228	17	biopsy	biopsy	NOUN
dpc-2582	228	18	sampling	sampling	NOUN
dpc-2582	228	19	.	.	PUNCT
dpc-2582	229	1	in	in	ADP
dpc-2582	229	2	fact	fact	NOUN
dpc-2582	229	3	,	,	PUNCT
dpc-2582	229	4	all	all	DET
dpc-2582	229	5	surgical	surgical	ADJ
dpc-2582	229	6	treatments	treatment	NOUN
dpc-2582	229	7	proposed	propose	VERB
dpc-2582	229	8	to	to	ADP
dpc-2582	229	9	this	this	DET
dpc-2582	229	10	cohort	cohort	NOUN
dpc-2582	229	11	of	of	ADP
dpc-2582	229	12	patients	patient	NOUN
dpc-2582	229	13	were	be	AUX
dpc-2582	229	14	debulking	debulke	VERB
dpc-2582	229	15	procedures	procedure	NOUN
dpc-2582	229	16	that	that	PRON
dpc-2582	229	17	usually	usually	ADV
dpc-2582	229	18	prevent	prevent	VERB
dpc-2582	229	19	obtaining	obtain	VERB
dpc-2582	229	20	a	a	DET
dpc-2582	229	21	well	well	ADV
dpc-2582	229	22	-	-	PUNCT
dpc-2582	229	23	oriented	orient	VERB
dpc-2582	229	24	full	full	ADJ
dpc-2582	229	25	-	-	PUNCT
dpc-2582	229	26	thickness	thickness	NOUN
dpc-2582	229	27	specimen	speciman	NOUN
dpc-2582	229	28	for	for	ADP
dpc-2582	229	29	histopathological	histopathological	ADJ
dpc-2582	229	30	analysis	analysis	NOUN
dpc-2582	229	31	.	.	PUNCT
dpc-2582	230	1	table	table	NOUN
dpc-2582	230	2	5	5	NUM
dpc-2582	230	3	.	.	PUNCT
dpc-2582	231	1	mucosal	mucosal	ADJ
dpc-2582	231	2	melanoma	melanoma	NOUN
dpc-2582	231	3	pathological	pathological	ADJ
dpc-2582	231	4	data	datum	NOUN
dpc-2582	231	5	and	and	CCONJ
dpc-2582	231	6	stratification	stratification	NOUN
dpc-2582	231	7	by	by	ADP
dpc-2582	231	8	the	the	DET
dpc-2582	231	9	site	site	NOUN
dpc-2582	231	10	of	of	ADP
dpc-2582	231	11	origin	origin	NOUN
dpc-2582	231	12	.	.	PUNCT
dpc-2582	232	1	mucosal	mucosal	ADJ
dpc-2582	232	2	melanomas	melanomas	NOUN
dpc-2582	232	3	(	(	PUNCT
dpc-2582	232	4	n=33	n=33	NOUN
dpc-2582	232	5	,	,	PUNCT
dpc-2582	232	6	100	100	NUM
dpc-2582	232	7	%	%	NOUN
dpc-2582	232	8	)	)	PUNCT
dpc-2582	232	9	sinunasal	sinunasal	NOUN
dpc-2582	232	10	(	(	PUNCT
dpc-2582	232	11	n=9	n=9	PROPN
dpc-2582	232	12	,	,	PUNCT
dpc-2582	232	13	27.3	27.3	NUM
dpc-2582	232	14	%	%	NOUN
dpc-2582	232	15	)	)	PUNCT
dpc-2582	232	16	anorectal	anorectal	ADJ
dpc-2582	232	17	(	(	PUNCT
dpc-2582	232	18	n=13	n=13	PROPN
dpc-2582	232	19	,	,	PUNCT
dpc-2582	232	20	39.4	39.4	NUM
dpc-2582	232	21	%	%	NOUN
dpc-2582	232	22	)	)	PUNCT
dpc-2582	233	1	urogenital	urogenital	PROPN
dpc-2582	233	2	(	(	PUNCT
dpc-2582	233	3	n=11	n=11	ADJ
dpc-2582	233	4	,	,	PUNCT
dpc-2582	233	5	33.3	33.3	NUM
dpc-2582	233	6	%	%	NOUN
dpc-2582	233	7	)	)	PUNCT
dpc-2582	233	8	breslow	breslow	NOUN
dpc-2582	233	9	,	,	PUNCT
dpc-2582	233	10	n	n	CCONJ
dpc-2582	233	11	,	,	PUNCT
dpc-2582	233	12	mean	mean	VERB
dpc-2582	233	13	±	±	NUM
dpc-2582	233	14	sd	sd	NOUN
dpc-2582	233	15	(	(	PUNCT
dpc-2582	233	16	range	range	NOUN
dpc-2582	233	17	)	)	PUNCT
dpc-2582	233	18	10	10	NUM
dpc-2582	233	19	,	,	PUNCT
dpc-2582	233	20	6.7	6.7	NUM
dpc-2582	233	21	±5.2	±5.2	NOUN
dpc-2582	233	22	(	(	PUNCT
dpc-2582	233	23	0.6	0.6	NUM
dpc-2582	233	24	-	-	SYM
dpc-2582	233	25	17	17	NUM
dpc-2582	233	26	)	)	PUNCT
dpc-2582	233	27	3	3	NUM
dpc-2582	233	28	,	,	PUNCT
dpc-2582	233	29	7.1	7.1	NUM
dpc-2582	233	30	±5.3	±5.3	NOUN
dpc-2582	233	31	(	(	PUNCT
dpc-2582	233	32	1.4	1.4	NUM
dpc-2582	233	33	-	-	SYM
dpc-2582	233	34	12	12	NUM
dpc-2582	233	35	)	)	PUNCT
dpc-2582	233	36	7	7	NUM
dpc-2582	233	37	,	,	PUNCT
dpc-2582	233	38	6.5	6.5	NUM
dpc-2582	233	39	±5.6	±5.6	PROPN
dpc-2582	233	40	(	(	PUNCT
dpc-2582	233	41	0.6	0.6	NUM
dpc-2582	233	42	-	-	SYM
dpc-2582	233	43	17	17	NUM
dpc-2582	233	44	)	)	PUNCT
dpc-2582	233	45	ulceration	ulceration	NOUN
dpc-2582	233	46	no	no	DET
dpc-2582	233	47	1	1	NUM
dpc-2582	233	48	(	(	PUNCT
dpc-2582	233	49	3.0	3.0	NUM
dpc-2582	233	50	)	)	PUNCT
dpc-2582	233	51	0	0	NUM
dpc-2582	233	52	(	(	PUNCT
dpc-2582	233	53	0.0	0.0	NUM
dpc-2582	233	54	)	)	PUNCT
dpc-2582	233	55	0	0	NUM
dpc-2582	233	56	1	1	NUM
dpc-2582	233	57	(	(	PUNCT
dpc-2582	233	58	9.1	9.1	NUM
dpc-2582	233	59	)	)	PUNCT
dpc-2582	233	60	yes	yes	INTJ
dpc-2582	233	61	11	11	NUM
dpc-2582	233	62	(	(	PUNCT
dpc-2582	233	63	33.3	33.3	NUM
dpc-2582	233	64	)	)	PUNCT
dpc-2582	233	65	0	0	NUM
dpc-2582	233	66	(	(	PUNCT
dpc-2582	233	67	0.0	0.0	NUM
dpc-2582	233	68	)	)	PUNCT
dpc-2582	233	69	5	5	NUM
dpc-2582	233	70	(	(	PUNCT
dpc-2582	233	71	38.5	38.5	NUM
dpc-2582	233	72	)	)	PUNCT
dpc-2582	233	73	6	6	NUM
dpc-2582	233	74	(	(	PUNCT
dpc-2582	233	75	54.5	54.5	NUM
dpc-2582	233	76	)	)	PUNCT
dpc-2582	233	77	cytology	cytology	NOUN
dpc-2582	233	78	epithelioid	epithelioid	NOUN
dpc-2582	233	79	cells	cell	NOUN
dpc-2582	233	80	25	25	NUM
dpc-2582	233	81	(	(	PUNCT
dpc-2582	233	82	75.7	75.7	NUM
dpc-2582	233	83	)	)	PUNCT
dpc-2582	233	84	9	9	NUM
dpc-2582	233	85	(	(	PUNCT
dpc-2582	233	86	100	100	NUM
dpc-2582	233	87	)	)	PUNCT
dpc-2582	233	88	10	10	NUM
dpc-2582	233	89	(	(	PUNCT
dpc-2582	233	90	76.9	76.9	NUM
dpc-2582	233	91	)	)	PUNCT
dpc-2582	233	92	6	6	NUM
dpc-2582	233	93	(	(	PUNCT
dpc-2582	233	94	54.5	54.5	NUM
dpc-2582	233	95	)	)	PUNCT
dpc-2582	233	96	spindle	spindle	NOUN
dpc-2582	233	97	cells	cell	NOUN
dpc-2582	233	98	2	2	NUM
dpc-2582	233	99	(	(	PUNCT
dpc-2582	233	100	6.1	6.1	NUM
dpc-2582	233	101	)	)	PUNCT
dpc-2582	233	102	0	0	NUM
dpc-2582	234	1	(	(	PUNCT
dpc-2582	234	2	0.0	0.0	NUM
dpc-2582	234	3	)	)	PUNCT
dpc-2582	234	4	1	1	NUM
dpc-2582	234	5	(	(	PUNCT
dpc-2582	234	6	7.6	7.6	NUM
dpc-2582	234	7	)	)	SYM
dpc-2582	234	8	1	1	NUM
dpc-2582	234	9	(	(	PUNCT
dpc-2582	234	10	9.1	9.1	NUM
dpc-2582	234	11	)	)	PUNCT
dpc-2582	234	12	small	small	ADJ
dpc-2582	234	13	cells	cell	NOUN
dpc-2582	234	14	2	2	NUM
dpc-2582	234	15	(	(	PUNCT
dpc-2582	234	16	6.1	6.1	NUM
dpc-2582	234	17	)	)	PUNCT
dpc-2582	234	18	0	0	NUM
dpc-2582	234	19	(	(	PUNCT
dpc-2582	234	20	0.0	0.0	NUM
dpc-2582	234	21	)	)	PUNCT
dpc-2582	234	22	1	1	NUM
dpc-2582	234	23	(	(	PUNCT
dpc-2582	234	24	7.6	7.6	NUM
dpc-2582	234	25	)	)	SYM
dpc-2582	234	26	1	1	NUM
dpc-2582	234	27	(	(	PUNCT
dpc-2582	234	28	9.1	9.1	NUM
dpc-2582	234	29	)	)	PUNCT
dpc-2582	234	30	rhabdoid	rhabdoid	NOUN
dpc-2582	234	31	cells	cell	NOUN
dpc-2582	234	32	2	2	NUM
dpc-2582	234	33	(	(	PUNCT
dpc-2582	234	34	6.1	6.1	NUM
dpc-2582	234	35	)	)	PUNCT
dpc-2582	234	36	0	0	NUM
dpc-2582	234	37	(	(	PUNCT
dpc-2582	234	38	0.0	0.0	NUM
dpc-2582	234	39	)	)	PUNCT
dpc-2582	234	40	1	1	NUM
dpc-2582	234	41	(	(	PUNCT
dpc-2582	234	42	7.6	7.6	NUM
dpc-2582	234	43	)	)	PUNCT
dpc-2582	234	44	0	0	NUM
dpc-2582	234	45	(	(	PUNCT
dpc-2582	234	46	0.0	0.0	NUM
dpc-2582	234	47	)	)	PUNCT
dpc-2582	234	48	mixed	mixed	ADJ
dpc-2582	234	49	3	3	NUM
dpc-2582	234	50	(	(	PUNCT
dpc-2582	234	51	9.1	9.1	NUM
dpc-2582	234	52	)	)	PUNCT
dpc-2582	234	53	0	0	NUM
dpc-2582	234	54	(	(	PUNCT
dpc-2582	234	55	0.0	0.0	NUM
dpc-2582	234	56	)	)	PUNCT
dpc-2582	234	57	0	0	NUM
dpc-2582	234	58	(	(	PUNCT
dpc-2582	234	59	0.0	0.0	NUM
dpc-2582	234	60	)	)	PUNCT
dpc-2582	234	61	3	3	NUM
dpc-2582	234	62	(	(	PUNCT
dpc-2582	234	63	27.2	27.2	NUM
dpc-2582	234	64	)	)	PUNCT
dpc-2582	234	65	lvi	lvi	NOUN
dpc-2582	234	66	no	no	DET
dpc-2582	234	67	7	7	NUM
dpc-2582	234	68	(	(	PUNCT
dpc-2582	234	69	21.2	21.2	NUM
dpc-2582	234	70	)	)	SYM
dpc-2582	234	71	1	1	NUM
dpc-2582	234	72	(	(	PUNCT
dpc-2582	234	73	11.1	11.1	NUM
dpc-2582	234	74	)	)	SYM
dpc-2582	234	75	1	1	NUM
dpc-2582	234	76	(	(	PUNCT
dpc-2582	234	77	7.7	7.7	NUM
dpc-2582	234	78	)	)	SYM
dpc-2582	234	79	5	5	NUM
dpc-2582	234	80	(	(	PUNCT
dpc-2582	234	81	45.5	45.5	NUM
dpc-2582	234	82	)	)	PUNCT
dpc-2582	234	83	yes	yes	INTJ
dpc-2582	234	84	5	5	NUM
dpc-2582	234	85	(	(	PUNCT
dpc-2582	234	86	15.2	15.2	NUM
dpc-2582	234	87	)	)	SYM
dpc-2582	234	88	1	1	NUM
dpc-2582	234	89	(	(	PUNCT
dpc-2582	234	90	11.1	11.1	NUM
dpc-2582	234	91	)	)	SYM
dpc-2582	234	92	2	2	NUM
dpc-2582	234	93	(	(	PUNCT
dpc-2582	234	94	15.4	15.4	NUM
dpc-2582	234	95	)	)	PUNCT
dpc-2582	234	96	2	2	NUM
dpc-2582	234	97	(	(	PUNCT
dpc-2582	234	98	18.2	18.2	NUM
dpc-2582	234	99	)	)	PUNCT
dpc-2582	234	100	braf	braf	NOUN
dpc-2582	234	101	,	,	PUNCT
dpc-2582	234	102	wt	wt	PROPN
dpc-2582	234	103	25	25	NUM
dpc-2582	234	104	(	(	PUNCT
dpc-2582	234	105	75.8	75.8	NUM
dpc-2582	234	106	)	)	PUNCT
dpc-2582	234	107	8	8	NUM
dpc-2582	234	108	(	(	PUNCT
dpc-2582	234	109	88.9	88.9	NUM
dpc-2582	234	110	)	)	PUNCT
dpc-2582	234	111	10	10	NUM
dpc-2582	234	112	(	(	PUNCT
dpc-2582	234	113	76.9	76.9	NUM
dpc-2582	234	114	)	)	PUNCT
dpc-2582	234	115	7	7	NUM
dpc-2582	234	116	(	(	PUNCT
dpc-2582	234	117	63.6	63.6	NUM
dpc-2582	234	118	)	)	PUNCT
dpc-2582	234	119	c	c	NOUN
dpc-2582	234	120	-	-	PUNCT
dpc-2582	234	121	kit	kit	NOUN
dpc-2582	234	122	v560d	v560d	PROPN
dpc-2582	234	123	3	3	NUM
dpc-2582	234	124	(	(	PUNCT
dpc-2582	234	125	9.1	9.1	NUM
dpc-2582	234	126	)	)	PUNCT
dpc-2582	234	127	0	0	NUM
dpc-2582	234	128	(	(	PUNCT
dpc-2582	234	129	0.0	0.0	NUM
dpc-2582	234	130	)	)	PUNCT
dpc-2582	234	131	1	1	NUM
dpc-2582	234	132	(	(	PUNCT
dpc-2582	234	133	7.7	7.7	NUM
dpc-2582	234	134	)	)	SYM
dpc-2582	234	135	2	2	NUM
dpc-2582	234	136	(	(	PUNCT
dpc-2582	234	137	18.2	18.2	NUM
dpc-2582	234	138	)	)	PUNCT
dpc-2582	234	139	wt	wt	ADP
dpc-2582	234	140	8	8	NUM
dpc-2582	234	141	(	(	PUNCT
dpc-2582	234	142	24.2	24.2	NUM
dpc-2582	234	143	)	)	SYM
dpc-2582	234	144	2	2	NUM
dpc-2582	234	145	(	(	PUNCT
dpc-2582	234	146	22.2	22.2	NUM
dpc-2582	234	147	)	)	SYM
dpc-2582	234	148	5	5	NUM
dpc-2582	234	149	(	(	PUNCT
dpc-2582	234	150	38.5	38.5	NUM
dpc-2582	234	151	)	)	SYM
dpc-2582	234	152	1	1	NUM
dpc-2582	234	153	(	(	PUNCT
dpc-2582	234	154	9.1	9.1	NUM
dpc-2582	234	155	)	)	PUNCT
dpc-2582	234	156	nras	nra	NOUN
dpc-2582	234	157	,	,	PUNCT
dpc-2582	234	158	wt	wt	PROPN
dpc-2582	234	159	9	9	NUM
dpc-2582	234	160	(	(	PUNCT
dpc-2582	234	161	27.3	27.3	NUM
dpc-2582	234	162	)	)	PUNCT
dpc-2582	234	163	3	3	NUM
dpc-2582	234	164	(	(	PUNCT
dpc-2582	234	165	33.3	33.3	NUM
dpc-2582	234	166	)	)	SYM
dpc-2582	234	167	4	4	NUM
dpc-2582	234	168	(	(	PUNCT
dpc-2582	234	169	30.8	30.8	NUM
dpc-2582	234	170	)	)	SYM
dpc-2582	234	171	2	2	NUM
dpc-2582	234	172	(	(	PUNCT
dpc-2582	234	173	18.2	18.2	NUM
dpc-2582	234	174	)	)	PUNCT
dpc-2582	234	175	kras	kra	NOUN
dpc-2582	234	176	p.a146v	p.a146v	PROPN
dpc-2582	234	177	1	1	NUM
dpc-2582	234	178	(	(	PUNCT
dpc-2582	234	179	3.0	3.0	NUM
dpc-2582	234	180	)	)	PUNCT
dpc-2582	234	181	0	0	NUM
dpc-2582	234	182	(	(	PUNCT
dpc-2582	234	183	0.0	0.0	NUM
dpc-2582	234	184	)	)	PUNCT
dpc-2582	234	185	1	1	NUM
dpc-2582	234	186	(	(	PUNCT
dpc-2582	234	187	7.7	7.7	NUM
dpc-2582	234	188	)	)	PUNCT
dpc-2582	234	189	0	0	NUM
dpc-2582	234	190	(	(	PUNCT
dpc-2582	234	191	0.0	0.0	NUM
dpc-2582	234	192	)	)	PUNCT
dpc-2582	234	193	p.g12a	p.g12a	PROPN
dpc-2582	234	194	1	1	NUM
dpc-2582	234	195	(	(	PUNCT
dpc-2582	234	196	3.0	3.0	NUM
dpc-2582	234	197	)	)	SYM
dpc-2582	234	198	1	1	NUM
dpc-2582	234	199	(	(	PUNCT
dpc-2582	234	200	11.1	11.1	NUM
dpc-2582	234	201	)	)	PUNCT
dpc-2582	234	202	0	0	NUM
dpc-2582	235	1	(	(	PUNCT
dpc-2582	235	2	0.0	0.0	NUM
dpc-2582	235	3	)	)	PUNCT
dpc-2582	235	4	0	0	NUM
dpc-2582	236	1	(	(	PUNCT
dpc-2582	236	2	0.0	0.0	NUM
dpc-2582	236	3	)	)	PUNCT
dpc-2582	236	4	p.g12c	p.g12c	PROPN
dpc-2582	236	5	1	1	NUM
dpc-2582	236	6	(	(	PUNCT
dpc-2582	236	7	3.0	3.0	NUM
dpc-2582	236	8	)	)	PUNCT
dpc-2582	236	9	0	0	NUM
dpc-2582	236	10	(	(	PUNCT
dpc-2582	236	11	0.0	0.0	NUM
dpc-2582	236	12	)	)	PUNCT
dpc-2582	236	13	1	1	NUM
dpc-2582	236	14	(	(	PUNCT
dpc-2582	236	15	7.7	7.7	NUM
dpc-2582	236	16	)	)	PUNCT
dpc-2582	236	17	0	0	NUM
dpc-2582	236	18	(	(	PUNCT
dpc-2582	236	19	0.0	0.0	NUM
dpc-2582	236	20	)	)	PUNCT
dpc-2582	236	21	wt	wt	ADP
dpc-2582	236	22	1	1	NUM
dpc-2582	236	23	(	(	PUNCT
dpc-2582	236	24	3.0	3.0	NUM
dpc-2582	236	25	)	)	SYM
dpc-2582	236	26	1	1	NUM
dpc-2582	236	27	(	(	PUNCT
dpc-2582	236	28	11.1	11.1	NUM
dpc-2582	236	29	)	)	PUNCT
dpc-2582	236	30	0	0	NUM
dpc-2582	236	31	(	(	PUNCT
dpc-2582	236	32	0.0	0.0	NUM
dpc-2582	236	33	)	)	PUNCT
dpc-2582	236	34	0	0	NUM
dpc-2582	236	35	(	(	PUNCT
dpc-2582	236	36	0.0	0.0	NUM
dpc-2582	236	37	)	)	PUNCT
dpc-2582	236	38	lvi	lvi	NOUN
dpc-2582	236	39	:	:	PUNCT
dpc-2582	236	40	lymphovascular	lymphovascular	ADJ
dpc-2582	236	41	invasion	invasion	NOUN
dpc-2582	236	42	original	original	ADJ
dpc-2582	236	43	article	article	NOUN
dpc-2582	236	44	|	|	ADV
dpc-2582	236	45	dermatol	dermatol	ADJ
dpc-2582	236	46	pract	pract	NOUN
dpc-2582	236	47	concept	concept	NOUN
dpc-2582	236	48	.	.	PUNCT
dpc-2582	237	1	2023;13(1):e2023057	2023;13(1):e2023057	NUM
dpc-2582	237	2	11	11	NUM
dpc-2582	237	3	11	11	NUM
dpc-2582	237	4	.	.	PUNCT
dpc-2582	238	1	larkin	larkin	PROPN
dpc-2582	238	2	j	j	PROPN
dpc-2582	238	3	,	,	PUNCT
dpc-2582	238	4	chiarion	chiarion	NOUN
dpc-2582	238	5	-	-	PUNCT
dpc-2582	238	6	sileni	sileni	NOUN
dpc-2582	238	7	v	v	NOUN
dpc-2582	238	8	,	,	PUNCT
dpc-2582	238	9	gonzalez	gonzalez	PROPN
dpc-2582	238	10	r	r	PROPN
dpc-2582	238	11	,	,	PUNCT
dpc-2582	238	12	et	et	PROPN
dpc-2582	238	13	al	al	PROPN
dpc-2582	238	14	.	.	PROPN
dpc-2582	239	1	five	five	NUM
dpc-2582	239	2	-	-	PUNCT
dpc-2582	239	3	year	year	NOUN
dpc-2582	239	4	survival	survival	NOUN
dpc-2582	239	5	with	with	ADP
dpc-2582	239	6	combined	combined	ADJ
dpc-2582	239	7	nivolumab	nivolumab	NOUN
dpc-2582	239	8	and	and	CCONJ
dpc-2582	239	9	ipilimumab	ipilimumab	VERB
dpc-2582	239	10	in	in	ADP
dpc-2582	239	11	advanced	advanced	ADJ
dpc-2582	239	12	melanoma	melanoma	NOUN
dpc-2582	239	13	.	.	PUNCT
dpc-2582	240	1	n	n	PRON
dpc-2582	240	2	engl	engl	PROPN
dpc-2582	240	3	j	j	PROPN
dpc-2582	240	4	med	med	PROPN
dpc-2582	240	5	.	.	PUNCT
dpc-2582	240	6	2019;381(16	2019;381(16	PROPN
dpc-2582	240	7	)	)	PUNCT
dpc-2582	240	8	.	.	PUNCT
dpc-2582	241	1	doi:10.1056	doi:10.1056	PROPN
dpc-2582	241	2	/	/	SYM
dpc-2582	241	3	nejmoa1910836	nejmoa1910836	PROPN
dpc-2582	241	4	.	.	PUNCT
dpc-2582	242	1	pmid	pmid	NOUN
dpc-2582	242	2	:	:	PUNCT
dpc-2582	242	3	31562797	31562797	NUM
dpc-2582	242	4	.	.	PUNCT
dpc-2582	243	1	12	12	NUM
dpc-2582	243	2	.	.	PUNCT
dpc-2582	244	1	nccn	nccn	PROPN
dpc-2582	244	2	guidelines	guidelines	PROPN
dpc-2582	244	3	version	version	NOUN
dpc-2582	244	4	3.2022	3.2022	NUM
dpc-2582	244	5	melanoma	melanoma	NOUN
dpc-2582	244	6	:	:	PUNCT
dpc-2582	244	7	cutaneous	cutaneous	ADJ
dpc-2582	244	8	.	.	PUNCT
dpc-2582	245	1	updated	update	VERB
dpc-2582	245	2	april	april	PROPN
dpc-2582	245	3	2022	2022	NUM
dpc-2582	245	4	.	.	PUNCT
dpc-2582	246	1	accessed	access	VERB
dpc-2582	246	2	july	july	PROPN
dpc-2582	246	3	2022	2022	NUM
dpc-2582	246	4	.	.	PUNCT
dpc-2582	247	1	https://www.nccn.org	https://www.nccn.org	PUNCT
dpc-2582	247	2	/professionals	/professional	NOUN
dpc-2582	247	3	/	/	SYM
dpc-2582	247	4	physician_gls	physician_gls	NOUN
dpc-2582	247	5	/	/	SYM
dpc-2582	247	6	pdf	pdf	NOUN
dpc-2582	247	7	/	/	SYM
dpc-2582	247	8	cutaneous_melanoma.pdf	cutaneous_melanoma.pdf	NOUN
dpc-2582	247	9	13	13	NUM
dpc-2582	247	10	.	.	PUNCT
dpc-2582	248	1	gutiérrez	gutiérrez	NOUN
dpc-2582	248	2	-	-	PUNCT
dpc-2582	248	3	castañeda	castañeda	PROPN
dpc-2582	248	4	ld	ld	PROPN
dpc-2582	248	5	,	,	PUNCT
dpc-2582	248	6	nova	nova	PROPN
dpc-2582	248	7	ja	ja	PROPN
dpc-2582	248	8	,	,	PUNCT
dpc-2582	248	9	tovar	tovar	PROPN
dpc-2582	248	10	-	-	PUNCT
dpc-2582	248	11	parra	parra	PROPN
dpc-2582	248	12	jd	jd	PROPN
dpc-2582	248	13	.	.	PROPN
dpc-2582	248	14	frequency	frequency	PROPN
dpc-2582	248	15	of	of	ADP
dpc-2582	248	16	mutations	mutation	NOUN
dpc-2582	248	17	in	in	ADP
dpc-2582	248	18	braf	braf	NOUN
dpc-2582	248	19	,	,	PUNCT
dpc-2582	248	20	nras	nras	PROPN
dpc-2582	248	21	,	,	PUNCT
dpc-2582	248	22	and	and	CCONJ
dpc-2582	248	23	kit	kit	NOUN
dpc-2582	248	24	in	in	ADP
dpc-2582	248	25	different	different	ADJ
dpc-2582	248	26	populations	population	NOUN
dpc-2582	248	27	and	and	CCONJ
dpc-2582	248	28	histological	histological	ADJ
dpc-2582	248	29	subtypes	subtype	NOUN
dpc-2582	248	30	of	of	ADP
dpc-2582	248	31	melanoma	melanoma	NOUN
dpc-2582	248	32	:	:	PUNCT
dpc-2582	248	33	a	a	DET
dpc-2582	248	34	systemic	systemic	ADJ
dpc-2582	248	35	review	review	NOUN
dpc-2582	248	36	.	.	PUNCT
dpc-2582	249	1	melanoma	melanoma	NOUN
dpc-2582	249	2	res	re	NOUN
dpc-2582	249	3	.	.	PUNCT
dpc-2582	250	1	2020;30(1):62	2020;30(1):62	NUM
dpc-2582	250	2	-	-	SYM
dpc-2582	250	3	70	70	NUM
dpc-2582	250	4	.	.	PUNCT
dpc-2582	251	1	doi:10.1097	doi:10.1097	PROPN
dpc-2582	251	2	/	/	SYM
dpc-2582	252	1	cmr.0000000000000628	cmr.0000000000000628	X
dpc-2582	252	2	.	.	PUNCT
dpc-2582	253	1	pmid	pmid	NOUN
dpc-2582	253	2	:	:	PUNCT
dpc-2582	253	3	31274706	31274706	NUM
dpc-2582	253	4	.	.	PUNCT
dpc-2582	254	1	14	14	NUM
dpc-2582	254	2	.	.	PUNCT
dpc-2582	255	1	kuk	kuk	PROPN
dpc-2582	255	2	d	d	PROPN
dpc-2582	255	3	,	,	PUNCT
dpc-2582	255	4	shoushtari	shoushtari	PROPN
dpc-2582	255	5	an	an	PROPN
dpc-2582	255	6	,	,	PUNCT
dpc-2582	255	7	barker	barker	PROPN
dpc-2582	255	8	ca	ca	PROPN
dpc-2582	255	9	,	,	PUNCT
dpc-2582	255	10	et	et	PROPN
dpc-2582	255	11	al	al	PROPN
dpc-2582	255	12	.	.	PUNCT
dpc-2582	256	1	prognosis	prognosis	NOUN
dpc-2582	256	2	of	of	ADP
dpc-2582	256	3	mucosal	mucosal	NOUN
dpc-2582	256	4	,	,	PUNCT
dpc-2582	256	5	uveal	uveal	NOUN
dpc-2582	256	6	,	,	PUNCT
dpc-2582	256	7	acral	acral	ADJ
dpc-2582	256	8	,	,	PUNCT
dpc-2582	256	9	nonacral	nonacral	ADJ
dpc-2582	256	10	cutaneous	cutaneous	ADJ
dpc-2582	256	11	,	,	PUNCT
dpc-2582	256	12	and	and	CCONJ
dpc-2582	256	13	unknown	unknown	ADJ
dpc-2582	256	14	primary	primary	ADJ
dpc-2582	256	15	melanoma	melanoma	NOUN
dpc-2582	256	16	from	from	ADP
dpc-2582	256	17	the	the	DET
dpc-2582	256	18	time	time	NOUN
dpc-2582	256	19	of	of	ADP
dpc-2582	256	20	first	first	ADJ
dpc-2582	256	21	metastasis	metastasis	NOUN
dpc-2582	256	22	.	.	PUNCT
dpc-2582	257	1	the	the	DET
dpc-2582	257	2	oncologist	oncologist	NOUN
dpc-2582	257	3	.	.	PUNCT
dpc-2582	258	1	2016;21(7):848	2016;21(7):848	NUM
dpc-2582	258	2	-	-	PUNCT
dpc-2582	258	3	854	854	PROPN
dpc-2582	258	4	.	.	PUNCT
dpc-2582	258	5	doi:10.1634	doi:10.1634	PROPN
dpc-2582	258	6	/	/	SYM
dpc-2582	258	7	theoncologist.2015	theoncologist.2015	PROPN
dpc-2582	258	8	-	-	PUNCT
dpc-2582	258	9	0522	0522	NUM
dpc-2582	258	10	15	15	NUM
dpc-2582	258	11	.	.	PUNCT
dpc-2582	259	1	dimitriou	dimitriou	PROPN
dpc-2582	259	2	f	f	PROPN
dpc-2582	259	3	,	,	PUNCT
dpc-2582	259	4	namikawa	namikawa	PROPN
dpc-2582	259	5	k	k	PROPN
dpc-2582	259	6	,	,	PUNCT
dpc-2582	259	7	reijers	reijers	PROPN
dpc-2582	259	8	ilm	ilm	PROPN
dpc-2582	259	9	,	,	PUNCT
dpc-2582	259	10	et	et	PROPN
dpc-2582	259	11	al	al	PROPN
dpc-2582	259	12	.	.	PUNCT
dpc-2582	260	1	single	single	ADJ
dpc-2582	260	2	-	-	PUNCT
dpc-2582	260	3	agent	agent	NOUN
dpc-2582	260	4	anti	anti	NOUN
dpc-2582	260	5	-	-	ADJ
dpc-2582	260	6	pd-1	pd-1	ADJ
dpc-2582	260	7	or	or	CCONJ
dpc-2582	260	8	combined	combine	VERB
dpc-2582	260	9	with	with	ADP
dpc-2582	260	10	ipilimumab	ipilimumab	NOUN
dpc-2582	260	11	in	in	ADP
dpc-2582	260	12	patients	patient	NOUN
dpc-2582	260	13	with	with	ADP
dpc-2582	260	14	mucosal	mucosal	ADJ
dpc-2582	260	15	melanoma	melanoma	NOUN
dpc-2582	260	16	:	:	PUNCT
dpc-2582	260	17	an	an	DET
dpc-2582	260	18	international	international	ADJ
dpc-2582	260	19	,	,	PUNCT
dpc-2582	260	20	retrospective	retrospective	ADJ
dpc-2582	260	21	,	,	PUNCT
dpc-2582	260	22	cohort	cohort	NOUN
dpc-2582	260	23	study	study	NOUN
dpc-2582	260	24	.	.	PUNCT
dpc-2582	261	1	ann	ann	PROPN
dpc-2582	261	2	oncol	oncol	PROPN
dpc-2582	261	3	off	off	ADP
dpc-2582	261	4	j	j	PROPN
dpc-2582	261	5	eur	eur	PROPN
dpc-2582	261	6	soc	soc	PROPN
dpc-2582	261	7	med	me	VERB
dpc-2582	261	8	oncol	oncol	ADJ
dpc-2582	261	9	.	.	PUNCT
dpc-2582	262	1	published	publish	VERB
dpc-2582	262	2	online	online	ADJ
dpc-2582	262	3	june	june	PROPN
dpc-2582	262	4	16	16	NUM
dpc-2582	262	5	,	,	PUNCT
dpc-2582	262	6	2022	2022	NUM
dpc-2582	262	7	:	:	PUNCT
dpc-2582	262	8	s0923	s0923	NOUN
dpc-2582	262	9	-	-	PUNCT
dpc-2582	262	10	7534(22)01731	7534(22)01731	NUM
dpc-2582	262	11	-	-	SYM
dpc-2582	262	12	8	8	NUM
dpc-2582	262	13	.	.	PUNCT
dpc-2582	262	14	doi:10.1016	doi:10.1016	PROPN
dpc-2582	262	15	/	/	SYM
dpc-2582	262	16	j.annonc.2022.06.004	j.annonc.2022.06.004	PROPN
dpc-2582	262	17	.	.	PUNCT
dpc-2582	263	1	pmid	pmid	NOUN
dpc-2582	263	2	:	:	PUNCT
dpc-2582	263	3	35716907	35716907	NUM
dpc-2582	263	4	.	.	PUNCT
dpc-2582	264	1	16	16	NUM
dpc-2582	264	2	.	.	PUNCT
dpc-2582	264	3	kaunitz	kaunitz	PROPN
dpc-2582	264	4	gj	gj	PROPN
dpc-2582	264	5	,	,	PUNCT
dpc-2582	264	6	cottrell	cottrell	PROPN
dpc-2582	264	7	tr	tr	VERB
dpc-2582	264	8	,	,	PUNCT
dpc-2582	264	9	lilo	lilo	PROPN
dpc-2582	264	10	m	m	PROPN
dpc-2582	264	11	,	,	PUNCT
dpc-2582	264	12	et	et	PROPN
dpc-2582	264	13	al	al	PROPN
dpc-2582	264	14	.	.	PUNCT
dpc-2582	265	1	melanoma	melanoma	PROPN
dpc-2582	265	2	subtypes	subtype	NOUN
dpc-2582	265	3	demonstrate	demonstrate	VERB
dpc-2582	265	4	distinct	distinct	ADJ
dpc-2582	265	5	pd	pd	PROPN
dpc-2582	265	6	-	-	PUNCT
dpc-2582	265	7	l1	l1	PROPN
dpc-2582	265	8	expression	expression	NOUN
dpc-2582	265	9	profiles	profile	NOUN
dpc-2582	265	10	.	.	PUNCT
dpc-2582	266	1	lab	lab	NOUN
dpc-2582	266	2	investig	investig	NOUN
dpc-2582	266	3	j	j	PROPN
dpc-2582	266	4	tech	tech	NOUN
dpc-2582	266	5	methods	method	NOUN
dpc-2582	266	6	pathol	pathol	NOUN
dpc-2582	266	7	.	.	PUNCT
dpc-2582	267	1	2017;97(9):1063	2017;97(9):1063	NUM
dpc-2582	267	2	-	-	PUNCT
dpc-2582	267	3	1071	1071	NUM
dpc-2582	267	4	.	.	PUNCT
dpc-2582	268	1	doi:10.1038	doi:10.1038	NOUN
dpc-2582	268	2	/	/	SYM
dpc-2582	268	3	labinvest.2017.64	labinvest.2017.64	X
dpc-2582	268	4	.	.	PUNCT
dpc-2582	269	1	pmid	pmid	NOUN
dpc-2582	269	2	:	:	PUNCT
dpc-2582	269	3	28737763	28737763	NUM
dpc-2582	269	4	.	.	PUNCT
dpc-2582	270	1	17	17	NUM
dpc-2582	270	2	.	.	PUNCT
dpc-2582	271	1	goldemberg	goldemberg	PROPN
dpc-2582	271	2	dc	dc	PROPN
dpc-2582	271	3	,	,	PUNCT
dpc-2582	271	4	thuler	thuler	PROPN
dpc-2582	271	5	lcs	lcs	PROPN
dpc-2582	271	6	,	,	PUNCT
dpc-2582	271	7	de	de	PROPN
dpc-2582	271	8	melo	melo	PROPN
dpc-2582	271	9	ac	ac	PROPN
dpc-2582	271	10	.	.	PUNCT
dpc-2582	272	1	an	an	DET
dpc-2582	272	2	update	update	NOUN
dpc-2582	272	3	on	on	ADP
dpc-2582	272	4	mucosal	mucosal	ADJ
dpc-2582	272	5	melanoma	melanoma	NOUN
dpc-2582	272	6	:	:	PUNCT
dpc-2582	272	7	future	future	ADJ
dpc-2582	272	8	directions	direction	NOUN
dpc-2582	272	9	.	.	PUNCT
dpc-2582	273	1	acta	acta	PROPN
dpc-2582	273	2	dermatovenerol	dermatovenerol	PROPN
dpc-2582	273	3	croat	croat	PROPN
dpc-2582	273	4	adc	adc	PROPN
dpc-2582	273	5	.	.	PUNCT
dpc-2582	274	1	2019;27(1):11	2019;27(1):11	NUM
dpc-2582	274	2	-	-	SYM
dpc-2582	274	3	15	15	NUM
dpc-2582	274	4	.	.	PUNCT
dpc-2582	274	5	doi	doi	NOUN
dpc-2582	274	6	:	:	PUNCT
dpc-2582	274	7	.	.	PUNCT
dpc-2582	275	1	18	18	NUM
dpc-2582	275	2	.	.	PUNCT
dpc-2582	276	1	heppt	heppt	ADJ
dpc-2582	276	2	mv	mv	PROPN
dpc-2582	276	3	,	,	PUNCT
dpc-2582	276	4	roesch	roesch	PROPN
dpc-2582	276	5	a	a	DET
dpc-2582	276	6	,	,	PUNCT
dpc-2582	276	7	weide	weide	NOUN
dpc-2582	276	8	b	b	PROPN
dpc-2582	276	9	,	,	PUNCT
dpc-2582	276	10	et	et	PROPN
dpc-2582	276	11	al	al	PROPN
dpc-2582	276	12	.	.	PUNCT
dpc-2582	277	1	prognostic	prognostic	ADJ
dpc-2582	277	2	factors	factor	NOUN
dpc-2582	277	3	and	and	CCONJ
dpc-2582	277	4	treatment	treatment	NOUN
dpc-2582	277	5	outcomes	outcome	NOUN
dpc-2582	277	6	in	in	ADP
dpc-2582	277	7	444	444	NUM
dpc-2582	277	8	patients	patient	NOUN
dpc-2582	277	9	with	with	ADP
dpc-2582	277	10	mucosal	mucosal	ADJ
dpc-2582	277	11	melanoma	melanoma	NOUN
dpc-2582	277	12	.	.	PUNCT
dpc-2582	278	1	eur	eur	PROPN
dpc-2582	278	2	j	j	PROPN
dpc-2582	278	3	cancer	cancer	PROPN
dpc-2582	278	4	oxf	oxf	PROPN
dpc-2582	278	5	engl	engl	PROPN
dpc-2582	278	6	1990	1990	NUM
dpc-2582	278	7	.	.	PUNCT
dpc-2582	279	1	2017;81:36	2017;81:36	NUM
dpc-2582	279	2	-	-	SYM
dpc-2582	279	3	44	44	NUM
dpc-2582	279	4	.	.	PUNCT
dpc-2582	279	5	doi:10.1016	doi:10.1016	PROPN
dpc-2582	279	6	/	/	SYM
dpc-2582	279	7	j.	j.	PROPN
dpc-2582	279	8	ejca.2017.05.014	ejca.2017.05.014	PROPN
dpc-2582	279	9	.	.	PUNCT
dpc-2582	280	1	pmid	pmid	PROPN
dpc-2582	280	2	:	:	PUNCT
dpc-2582	280	3	28600969	28600969	NUM
dpc-2582	280	4	.	.	PUNCT
dpc-2582	281	1	19	19	NUM
dpc-2582	281	2	.	.	PUNCT
dpc-2582	281	3	cinotti	cinotti	VERB
dpc-2582	281	4	e	e	NOUN
dpc-2582	281	5	,	,	PUNCT
dpc-2582	281	6	chevallier	chevallier	NOUN
dpc-2582	281	7	j	j	PROPN
dpc-2582	281	8	,	,	PUNCT
dpc-2582	281	9	labeille	labeille	PROPN
dpc-2582	281	10	b	b	PROPN
dpc-2582	281	11	,	,	PUNCT
dpc-2582	281	12	et	et	PROPN
dpc-2582	281	13	al	al	PROPN
dpc-2582	281	14	.	.	PUNCT
dpc-2582	282	1	mucosal	mucosal	ADJ
dpc-2582	282	2	melanoma	melanoma	NOUN
dpc-2582	282	3	:	:	PUNCT
dpc-2582	283	1	clinical	clinical	ADJ
dpc-2582	283	2	,	,	PUNCT
dpc-2582	283	3	histological	histological	ADJ
dpc-2582	283	4	and	and	CCONJ
dpc-2582	283	5	c	c	NOUN
dpc-2582	283	6	-	-	PUNCT
dpc-2582	283	7	kit	kit	NOUN
dpc-2582	283	8	gene	gene	NOUN
dpc-2582	283	9	mutational	mutational	ADJ
dpc-2582	283	10	profile	profile	NOUN
dpc-2582	283	11	of	of	ADP
dpc-2582	283	12	86	86	NUM
dpc-2582	283	13	french	french	ADJ
dpc-2582	283	14	cases	case	NOUN
dpc-2582	283	15	.	.	PUNCT
dpc-2582	284	1	j	j	PROPN
dpc-2582	284	2	eur	eur	PROPN
dpc-2582	284	3	acad	acad	PROPN
dpc-2582	284	4	dermatol	dermatol	NOUN
dpc-2582	284	5	venereol	venereol	NOUN
dpc-2582	284	6	jeadv	jeadv	NOUN
dpc-2582	284	7	.	.	PUNCT
dpc-2582	285	1	2017;31(11	2017;31(11	NUM
dpc-2582	285	2	):	):	PUNCT
dpc-2582	285	3	1834	1834	NUM
dpc-2582	285	4	-	-	SYM
dpc-2582	285	5	1840	1840	NUM
dpc-2582	285	6	.	.	PUNCT
dpc-2582	286	1	doi:10.1111	doi:10.1111	ADJ
dpc-2582	286	2	/	/	SYM
dpc-2582	286	3	jdv.14353	jdv.14353	NUM
dpc-2582	286	4	references	reference	NOUN
dpc-2582	286	5	1	1	NUM
dpc-2582	286	6	.	.	PUNCT
dpc-2582	286	7	broit	broit	PROPN
dpc-2582	286	8	n	n	CCONJ
dpc-2582	286	9	,	,	PUNCT
dpc-2582	286	10	johansson	johansson	PROPN
dpc-2582	286	11	pa	pa	PROPN
dpc-2582	286	12	,	,	PUNCT
dpc-2582	286	13	rodgers	rodger	VERB
dpc-2582	286	14	cb	cb	PROPN
dpc-2582	286	15	.	.	PROPN
dpc-2582	287	1	meta	meta	VERB
dpc-2582	287	2	-	-	PUNCT
dpc-2582	287	3	analysis	analysis	NOUN
dpc-2582	287	4	and	and	CCONJ
dpc-2582	287	5	systematic	systematic	ADJ
dpc-2582	287	6	review	review	NOUN
dpc-2582	287	7	of	of	ADP
dpc-2582	287	8	the	the	DET
dpc-2582	287	9	genomics	genomic	NOUN
dpc-2582	287	10	of	of	ADP
dpc-2582	287	11	mucosal	mucosal	ADJ
dpc-2582	287	12	melanoma	melanoma	NOUN
dpc-2582	287	13	.	.	PUNCT
dpc-2582	288	1	mol	mol	ADP
dpc-2582	288	2	cancer	cancer	NOUN
dpc-2582	288	3	res	re	NOUN
dpc-2582	288	4	mcr	mcr	PROPN
dpc-2582	288	5	.	.	PUNCT
dpc-2582	289	1	2021;19(6):991	2021;19(6):991	NUM
dpc-2582	289	2	-	-	SYM
dpc-2582	289	3	1004	1004	NUM
dpc-2582	289	4	.	.	PUNCT
dpc-2582	290	1	doi:10.1158/1541	doi:10.1158/1541	PUNCT
dpc-2582	290	2	-	-	PUNCT
dpc-2582	290	3	7786	7786	NUM
dpc-2582	290	4	.	.	PUNCT
dpc-2582	291	1	mcr-20	mcr-20	PROPN
dpc-2582	291	2	-	-	PUNCT
dpc-2582	291	3	0839	0839	NUM
dpc-2582	291	4	.	.	PUNCT
dpc-2582	292	1	pmid	pmid	NOUN
dpc-2582	292	2	:	:	PUNCT
dpc-2582	292	3	33707307	33707307	NUM
dpc-2582	292	4	2	2	NUM
dpc-2582	292	5	.	.	PUNCT
dpc-2582	293	1	lópez	lópez	PROPN
dpc-2582	293	2	f	f	PROPN
dpc-2582	293	3	,	,	PUNCT
dpc-2582	293	4	rodrigo	rodrigo	PROPN
dpc-2582	293	5	jp	jp	PROPN
dpc-2582	293	6	,	,	PUNCT
dpc-2582	293	7	cardesa	cardesa	PROPN
dpc-2582	293	8	a.	a.	NOUN
dpc-2582	293	9	update	update	NOUN
dpc-2582	293	10	on	on	ADP
dpc-2582	293	11	primary	primary	ADJ
dpc-2582	293	12	head	head	NOUN
dpc-2582	293	13	and	and	CCONJ
dpc-2582	293	14	neck	neck	VERB
dpc-2582	293	15	mucosal	mucosal	ADJ
dpc-2582	293	16	melanoma	melanoma	NOUN
dpc-2582	293	17	.	.	PUNCT
dpc-2582	294	1	head	head	NOUN
dpc-2582	294	2	neck	neck	NOUN
dpc-2582	294	3	.	.	PUNCT
dpc-2582	295	1	2016;38(1):147	2016;38(1):147	NUM
dpc-2582	295	2	-	-	PUNCT
dpc-2582	295	3	155	155	NUM
dpc-2582	295	4	.	.	PUNCT
dpc-2582	295	5	doi:10.1002	doi:10.1002	NOUN
dpc-2582	295	6	/	/	SYM
dpc-2582	295	7	hed.23872	hed.23872	NOUN
dpc-2582	295	8	.	.	PUNCT
dpc-2582	296	1	pmid	pmid	NOUN
dpc-2582	296	2	:	:	PUNCT
dpc-2582	296	3	25242350	25242350	NUM
dpc-2582	296	4	.	.	PUNCT
dpc-2582	297	1	3	3	X
dpc-2582	297	2	.	.	X
dpc-2582	297	3	chang	chang	PROPN
dpc-2582	297	4	ae	ae	PROPN
dpc-2582	297	5	,	,	PUNCT
dpc-2582	297	6	karnell	karnell	PROPN
dpc-2582	297	7	lh	lh	PROPN
dpc-2582	297	8	,	,	PUNCT
dpc-2582	297	9	menck	menck	NOUN
dpc-2582	297	10	hr	hr	PROPN
dpc-2582	297	11	.	.	PUNCT
dpc-2582	298	1	the	the	DET
dpc-2582	298	2	national	national	PROPN
dpc-2582	298	3	cancer	cancer	PROPN
dpc-2582	298	4	data	data	PROPN
dpc-2582	298	5	base	base	PROPN
dpc-2582	298	6	report	report	NOUN
dpc-2582	298	7	on	on	ADP
dpc-2582	298	8	cutaneous	cutaneous	ADJ
dpc-2582	298	9	and	and	CCONJ
dpc-2582	298	10	noncutaneous	noncutaneous	ADJ
dpc-2582	298	11	melanoma	melanoma	NOUN
dpc-2582	298	12	:	:	PUNCT
dpc-2582	298	13	a	a	DET
dpc-2582	298	14	summary	summary	NOUN
dpc-2582	298	15	of	of	ADP
dpc-2582	298	16	84,836	84,836	NUM
dpc-2582	298	17	cases	case	NOUN
dpc-2582	298	18	from	from	ADP
dpc-2582	298	19	the	the	DET
dpc-2582	298	20	past	past	ADJ
dpc-2582	298	21	decade	decade	NOUN
dpc-2582	298	22	.	.	PUNCT
dpc-2582	299	1	the	the	DET
dpc-2582	299	2	american	american	PROPN
dpc-2582	299	3	college	college	PROPN
dpc-2582	299	4	of	of	ADP
dpc-2582	299	5	surgeons	surgeon	NOUN
dpc-2582	299	6	commission	commission	NOUN
dpc-2582	299	7	on	on	ADP
dpc-2582	299	8	cancer	cancer	NOUN
dpc-2582	299	9	and	and	CCONJ
dpc-2582	299	10	the	the	DET
dpc-2582	299	11	american	american	ADJ
dpc-2582	299	12	cancer	cancer	NOUN
dpc-2582	299	13	society	society	NOUN
dpc-2582	299	14	.	.	PUNCT
dpc-2582	300	1	cancer	cancer	NOUN
dpc-2582	300	2	.	.	PUNCT
dpc-2582	301	1	1998;83(8):1664	1998;83(8):1664	NUM
dpc-2582	301	2	-	-	SYM
dpc-2582	301	3	1678	1678	NUM
dpc-2582	301	4	.	.	PUNCT
dpc-2582	302	1	doi:10.1002	doi:10.1002	NOUN
dpc-2582	302	2	/(sici)1097	/(sici)1097	PROPN
dpc-2582	302	3	-	-	PUNCT
dpc-2582	302	4	0142(19981015)83:8<1664::aid	0142(19981015)83:8<1664::aid	PROPN
dpc-2582	302	5	-	-	PUNCT
dpc-2582	302	6	cncr23>3.0.co;2	cncr23>3.0.co;2	NOUN
dpc-2582	302	7	-	-	PUNCT
dpc-2582	302	8	g.	g.	NOUN
dpc-2582	302	9	pmid	pmid	PROPN
dpc-2582	302	10	:	:	PUNCT
dpc-2582	302	11	9781962	9781962	NUM
dpc-2582	302	12	4	4	NUM
dpc-2582	302	13	.	.	PUNCT
dpc-2582	303	1	mihajlovic	mihajlovic	PROPN
dpc-2582	303	2	m	m	PROPN
dpc-2582	303	3	,	,	PUNCT
dpc-2582	303	4	vlajkovic	vlajkovic	PROPN
dpc-2582	303	5	s	s	PROPN
dpc-2582	303	6	,	,	PUNCT
dpc-2582	303	7	jovanovic	jovanovic	PROPN
dpc-2582	303	8	p	p	NOUN
dpc-2582	303	9	,	,	PUNCT
dpc-2582	303	10	stefanovic	stefanovic	ADJ
dpc-2582	303	11	v.	v.	ADP
dpc-2582	303	12	primary	primary	ADJ
dpc-2582	303	13	mucosal	mucosal	NOUN
dpc-2582	303	14	melanomas	melanoma	NOUN
dpc-2582	303	15	:	:	PUNCT
dpc-2582	303	16	a	a	DET
dpc-2582	303	17	comprehensive	comprehensive	ADJ
dpc-2582	303	18	review	review	NOUN
dpc-2582	303	19	.	.	PUNCT
dpc-2582	304	1	int	int	PROPN
dpc-2582	305	1	j	j	PROPN
dpc-2582	305	2	clin	clin	PROPN
dpc-2582	305	3	exp	exp	NOUN
dpc-2582	305	4	pathol	pathol	NOUN
dpc-2582	305	5	.	.	PUNCT
dpc-2582	306	1	2012;5(8):739	2012;5(8):739	NUM
dpc-2582	306	2	-	-	SYM
dpc-2582	306	3	753	753	NUM
dpc-2582	306	4	.	.	PUNCT
dpc-2582	307	1	doi	doi	NOUN
dpc-2582	307	2	:	:	PUNCT
dpc-2582	307	3	.	.	PUNCT
dpc-2582	308	1	5	5	X
dpc-2582	308	2	.	.	X
dpc-2582	308	3	spencer	spencer	PROPN
dpc-2582	308	4	kr	kr	PROPN
dpc-2582	308	5	,	,	PUNCT
dpc-2582	308	6	mehnert	mehnert	PROPN
dpc-2582	308	7	jm	jm	PROPN
dpc-2582	308	8	.	.	PROPN
dpc-2582	308	9	mucosal	mucosal	ADJ
dpc-2582	308	10	melanoma	melanoma	NOUN
dpc-2582	308	11	:	:	PUNCT
dpc-2582	308	12	epidemiology	epidemiology	NOUN
dpc-2582	308	13	,	,	PUNCT
dpc-2582	308	14	biology	biology	NOUN
dpc-2582	308	15	and	and	CCONJ
dpc-2582	308	16	treatment	treatment	NOUN
dpc-2582	308	17	.	.	PUNCT
dpc-2582	309	1	cancer	cancer	NOUN
dpc-2582	309	2	treat	treat	NOUN
dpc-2582	309	3	res	re	NOUN
dpc-2582	309	4	.	.	PUNCT
dpc-2582	310	1	2016;167:295	2016;167:295	NUM
dpc-2582	310	2	-	-	SYM
dpc-2582	310	3	320	320	NUM
dpc-2582	310	4	.	.	PUNCT
dpc-2582	311	1	doi:10.1007/978	doi:10.1007/978	PROPN
dpc-2582	311	2	-	-	PUNCT
dpc-2582	311	3	3	3	NUM
dpc-2582	311	4	-	-	NUM
dpc-2582	311	5	319	319	NUM
dpc-2582	311	6	-	-	PUNCT
dpc-2582	311	7	22539	22539	NUM
dpc-2582	311	8	-	-	SYM
dpc-2582	311	9	5_13	5_13	NUM
dpc-2582	311	10	6	6	NUM
dpc-2582	311	11	.	.	PUNCT
dpc-2582	312	1	yde	yde	PROPN
dpc-2582	312	2	ss	ss	PROPN
dpc-2582	312	3	,	,	PUNCT
dpc-2582	312	4	sjoegren	sjoegren	PROPN
dpc-2582	312	5	p	p	PROPN
dpc-2582	312	6	,	,	PUNCT
dpc-2582	312	7	heje	heje	PROPN
dpc-2582	312	8	m	m	PROPN
dpc-2582	312	9	,	,	PUNCT
dpc-2582	312	10	stolle	stolle	PROPN
dpc-2582	312	11	lb	lb	PROPN
dpc-2582	312	12	.	.	PUNCT
dpc-2582	312	13	mucosal	mucosal	ADJ
dpc-2582	312	14	melanoma	melanoma	NOUN
dpc-2582	312	15	:	:	PUNCT
dpc-2582	312	16	a	a	DET
dpc-2582	312	17	literature	literature	NOUN
dpc-2582	312	18	review	review	NOUN
dpc-2582	312	19	.	.	PUNCT
dpc-2582	313	1	curr	curr	PROPN
dpc-2582	313	2	oncol	oncol	PROPN
dpc-2582	313	3	rep	rep	PROPN
dpc-2582	313	4	.	.	PROPN
dpc-2582	313	5	2018;20(3):28	2018;20(3):28	PROPN
dpc-2582	313	6	.	.	PROPN
dpc-2582	313	7	doi:10.1007	doi:10.1007	PROPN
dpc-2582	313	8	/s11912	/s11912	PROPN
dpc-2582	313	9	-	-	PUNCT
dpc-2582	313	10	018	018	NUM
dpc-2582	313	11	-	-	PUNCT
dpc-2582	313	12	0675	0675	NUM
dpc-2582	313	13	-	-	PUNCT
dpc-2582	313	14	0	0	NUM
dpc-2582	313	15	.	.	PUNCT
dpc-2582	314	1	pmid	pmid	NOUN
dpc-2582	314	2	:	:	PUNCT
dpc-2582	314	3	29569184	29569184	NUM
dpc-2582	314	4	.	.	PUNCT
dpc-2582	315	1	7	7	X
dpc-2582	315	2	.	.	X
dpc-2582	315	3	li	li	PROPN
dpc-2582	315	4	j	j	PROPN
dpc-2582	315	5	,	,	PUNCT
dpc-2582	315	6	kan	kan	PROPN
dpc-2582	315	7	h	h	PROPN
dpc-2582	315	8	,	,	PUNCT
dpc-2582	315	9	zhao	zhao	PROPN
dpc-2582	315	10	l	l	PROPN
dpc-2582	315	11	,	,	PUNCT
dpc-2582	315	12	sun	sun	PROPN
dpc-2582	315	13	z	z	PROPN
dpc-2582	315	14	,	,	PUNCT
dpc-2582	315	15	bai	bai	PROPN
dpc-2582	315	16	c.	c.	PROPN
dpc-2582	315	17	immune	immune	PROPN
dpc-2582	315	18	checkpoint	checkpoint	NOUN
dpc-2582	315	19	inhibitors	inhibitor	NOUN
dpc-2582	315	20	in	in	ADP
dpc-2582	315	21	advanced	advanced	ADJ
dpc-2582	315	22	or	or	CCONJ
dpc-2582	315	23	metastatic	metastatic	ADJ
dpc-2582	315	24	mucosal	mucosal	NOUN
dpc-2582	315	25	melanoma	melanoma	NOUN
dpc-2582	315	26	:	:	PUNCT
dpc-2582	315	27	a	a	DET
dpc-2582	315	28	systematic	systematic	ADJ
dpc-2582	315	29	review	review	NOUN
dpc-2582	315	30	.	.	PUNCT
dpc-2582	316	1	ther	ther	PROPN
dpc-2582	316	2	adv	adv	PROPN
dpc-2582	316	3	med	med	PROPN
dpc-2582	316	4	oncol	oncol	ADJ
dpc-2582	316	5	.	.	PUNCT
dpc-2582	317	1	2020;12:1758835920922028	2020;12:1758835920922028	X
dpc-2582	317	2	.	.	PUNCT
dpc-2582	317	3	doi:10.1177/1758835920922028	doi:10.1177/1758835920922028	NOUN
dpc-2582	317	4	.	.	PUNCT
dpc-2582	318	1	pmid	pmid	NOUN
dpc-2582	318	2	:	:	PUNCT
dpc-2582	318	3	32489431	32489431	NUM
dpc-2582	318	4	.	.	PUNCT
dpc-2582	319	1	8	8	X
dpc-2582	319	2	.	.	PUNCT
dpc-2582	320	1	linee	linee	PROPN
dpc-2582	320	2	guida	guida	PROPN
dpc-2582	320	3	melanoma	melanoma	PROPN
dpc-2582	320	4	aiom	aiom	ADJ
dpc-2582	320	5	2021	2021	NUM
dpc-2582	320	6	.	.	PUNCT
dpc-2582	321	1	aiom	aiom	ADJ
dpc-2582	321	2	.	.	PUNCT
dpc-2582	322	1	published	publish	VERB
dpc-2582	322	2	september	september	PROPN
dpc-2582	322	3	23	23	NUM
dpc-2582	322	4	,	,	PUNCT
dpc-2582	322	5	2021	2021	NUM
dpc-2582	322	6	.	.	PUNCT
dpc-2582	323	1	updated	update	VERB
dpc-2582	323	2	january	january	PROPN
dpc-2582	323	3	2022	2022	NUM
dpc-2582	323	4	.	.	PUNCT
dpc-2582	324	1	accessed	access	VERB
dpc-2582	324	2	january	january	PROPN
dpc-2582	324	3	2022./	2022./	PROPN
dpc-2582	325	1	https://www.aiom.it/linee-guida-aiom-2021-melanoma/	https://www.aiom.it/linee-guida-aiom-2021-melanoma/	NOUN
dpc-2582	325	2	9	9	NUM
dpc-2582	325	3	.	.	PUNCT
dpc-2582	326	1	patrick	patrick	PROPN
dpc-2582	326	2	rj	rj	PROPN
dpc-2582	326	3	,	,	PUNCT
dpc-2582	326	4	fenske	fenske	PROPN
dpc-2582	326	5	na	na	PROPN
dpc-2582	326	6	,	,	PUNCT
dpc-2582	326	7	messina	messina	PROPN
dpc-2582	326	8	jl	jl	PROPN
dpc-2582	326	9	.	.	PROPN
dpc-2582	326	10	primary	primary	ADJ
dpc-2582	326	11	mucosal	mucosal	ADJ
dpc-2582	326	12	melanoma	melanoma	NOUN
dpc-2582	326	13	.	.	PUNCT
dpc-2582	327	1	j	j	PROPN
dpc-2582	327	2	am	be	AUX
dpc-2582	327	3	acad	acad	ADJ
dpc-2582	327	4	dermatol	dermatol	NOUN
dpc-2582	327	5	.	.	PUNCT
dpc-2582	328	1	2007;56(5):828	2007;56(5):828	NOUN
dpc-2582	328	2	-	-	SYM
dpc-2582	328	3	834	834	NUM
dpc-2582	328	4	.	.	PUNCT
dpc-2582	328	5	doi:10.1016	doi:10.1016	PROPN
dpc-2582	328	6	/	/	SYM
dpc-2582	328	7	j	j	PROPN
dpc-2582	328	8	.jaad.2006.06.017	.jaad.2006.06.017	PUNCT
dpc-2582	328	9	.	.	PUNCT
dpc-2582	329	1	pmid	pmid	NOUN
dpc-2582	329	2	:	:	PUNCT
dpc-2582	329	3	17349716	17349716	NUM
dpc-2582	329	4	.	.	PUNCT
dpc-2582	330	1	10	10	NUM
dpc-2582	330	2	.	.	PUNCT
dpc-2582	331	1	seth	seth	PROPN
dpc-2582	331	2	r	r	PROPN
dpc-2582	331	3	,	,	PUNCT
dpc-2582	331	4	messersmith	messersmith	ADJ
dpc-2582	331	5	h	h	PROPN
dpc-2582	331	6	,	,	PUNCT
dpc-2582	331	7	kaur	kaur	PROPN
dpc-2582	331	8	v	v	PROPN
dpc-2582	331	9	,	,	PUNCT
dpc-2582	331	10	et	et	PROPN
dpc-2582	331	11	al	al	PROPN
dpc-2582	331	12	.	.	PUNCT
dpc-2582	332	1	systemic	systemic	ADJ
dpc-2582	332	2	therapy	therapy	NOUN
dpc-2582	332	3	for	for	ADP
dpc-2582	332	4	melanoma	melanoma	NOUN
dpc-2582	332	5	:	:	PUNCT
dpc-2582	332	6	asco	asco	PROPN
dpc-2582	332	7	guideline	guideline	NOUN
dpc-2582	332	8	.	.	PUNCT
dpc-2582	333	1	j	j	PROPN
dpc-2582	333	2	clin	clin	PROPN
dpc-2582	333	3	oncol	oncol	PROPN
dpc-2582	333	4	off	off	ADP
dpc-2582	333	5	j	j	PROPN
dpc-2582	333	6	am	be	AUX
dpc-2582	333	7	soc	soc	PROPN
dpc-2582	333	8	clin	clin	PROPN
dpc-2582	333	9	oncol	oncol	PROPN
dpc-2582	333	10	.	.	PUNCT
dpc-2582	334	1	2020;38(33):3947	2020;38(33):3947	X
dpc-2582	334	2	-	-	SYM
dpc-2582	334	3	3970	3970	NUM
dpc-2582	334	4	.	.	PUNCT
dpc-2582	335	1	doi:10.1200	doi:10.1200	PROPN
dpc-2582	335	2	/	/	SYM
dpc-2582	335	3	jco.20.00198	jco.20.00198	PROPN
dpc-2582	335	4	.	.	PUNCT
dpc-2582	336	1	pmid	pmid	NOUN
dpc-2582	336	2	:	:	PUNCT
dpc-2582	336	3	32228358	32228358	NUM
dpc-2582	336	4	.	.	PUNCT